Bill Text: NY A06447 | 2013-2014 | General Assembly | Introduced


Bill Title: Enacts the drug-free workplace act to promote the goal of drug-free workplaces within government through drug testing; establishes rules for the use of drug testing in workplaces in the private sector; creates a drug offender punishment program for the rehabilitation of nonviolent felony drug offenders; provides for confidentiality of testing results; encourages employers to provide employees who have a drug problem with an opportunity to participate in an employee assistance program or an alcohol and drug rehabilitation program.

Spectrum: Partisan Bill (Republican 1-0)

Status: (Introduced - Dead) 2014-05-13 - held for consideration in governmental employees [A06447 Detail]

Download: New_York-2013-A06447-Introduced.html
                           S T A T E   O F   N E W   Y O R K
       ________________________________________________________________________
                                         6447
                              2013-2014 Regular Sessions
                                 I N  A S S E M B L Y
                                     April 1, 2013
                                      ___________
       Introduced  by  M. of A. KOLB -- read once and referred to the Committee
         on Governmental Employees
       AN ACT to amend the civil service law, the labor law  and  the  criminal
         procedure law, in relation to drug-free workplaces
         THE  PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM-
       BLY, DO ENACT AS FOLLOWS:
    1    Section 1. Article 5 of the civil service law is amended by  adding  a
    2  new title F to read as follows:
    3                                   TITLE F
    4                            DRUG-FREE WORKPLACES
    5  SECTION 84.   SHORT TITLE.
    6          84-A. PURPOSE.
    7          84-B. FINDINGS.
    8          84-C. NO LEGAL DUTY TO TEST.
    9          84-D. DEFINITIONS.
   10          84-E. NOTICE TO EMPLOYEES.
   11          84-F. TYPES OF TESTING.
   12          84-G. PROCEDURES AND EMPLOYEE PROTECTION.
   13          84-H. CONFIRMATION TESTING.
   14          84-I. EMPLOYEE PROTECTION.
   15          84-J. CONFIDENTIALITY.
   16          84-K. DRUG TESTING STANDARDS; LABORATORIES.
   17          84-L. RULES.
   18          84-M. DISCIPLINE REMEDIES.
   19          84-N. NONDISCIPLINE REMEDIES.
   20          84-O. FEDERAL COMPLIANCE.
   21          84-P. LICENSE FEE.
   22    S  84. SHORT TITLE.  THIS TITLE SHALL BE KNOWN AND MAY BE CITED AS THE
   23  "DRUG-FREE WORKPLACE ACT".
   24    S 84-A. PURPOSE.  THIS TITLE IS INTENDED TO:
        EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                             [ ] is old law to be omitted.
                                                                  LBD09358-01-3
       A. 6447                             2
    1    (A) PROMOTE THE GOAL OF DRUG-FREE WORKPLACES WITHIN GOVERNMENT THROUGH
    2  FAIR AND REASONABLE DRUG TESTING METHODS FOR THE  PROTECTION  OF  PUBLIC
    3  EMPLOYEES AND EMPLOYERS.
    4    (B)  ENCOURAGE  EMPLOYERS TO PROVIDE EMPLOYEES WHO HAVE DRUG USE PROB-
    5  LEMS WITH AN  OPPORTUNITY  TO  PARTICIPATE  IN  AN  EMPLOYEE  ASSISTANCE
    6  PROGRAM OR AN ALCOHOL AND DRUG REHABILITATION PROGRAM.
    7    (C) PROVIDE FOR CONFIDENTIALITY OF TESTING RESULTS.
    8    S 84-B. FINDINGS.  THE LEGISLATURE FINDS THAT:
    9    (A) DRUG USE HAS SERIOUS ADVERSE EFFECTS UPON A SIGNIFICANT PORTION OF
   10  THE  WORK  FORCE, RESULTING IN BILLIONS OF DOLLARS WORTH OF LOST PRODUC-
   11  TIVITY EACH YEAR AND POSING A THREAT TO  THE  WORKPLACE  AND  TO  PUBLIC
   12  SAFETY AND SECURITY.
   13    (B)  MAINTAINING  A  HEALTHY  AND  PRODUCTIVE WORK FORCE, SAFE WORKING
   14  CONDITIONS FREE FROM THE EFFECTS OF  DRUGS,  AND  QUALITY  PRODUCTS  AND
   15  SERVICES IS IMPORTANT TO EMPLOYERS, EMPLOYEES, AND THE GENERAL PUBLIC IN
   16  THIS STATE.  THE LEGISLATURE FURTHER FINDS THAT DRUG USE CREATES A VARI-
   17  ETY  OF  WORKPLACE  PROBLEMS,  INCLUDING  INCREASED  INJURY  ON THE JOB,
   18  INCREASED ABSENTEEISM, INCREASED FINANCIAL BURDEN ON HEALTH AND  BENEFIT
   19  PROGRAMS,   INCREASED   WORKPLACE   THEFT,  DECREASED  EMPLOYEE  MORALE,
   20  DECREASED PRODUCTIVITY, AND A DECLINE IN THE  QUALITY  OF  PRODUCTS  AND
   21  SERVICES.
   22    (C)  CERTAIN  DRUG  TESTING STANDARDS ARE NECESSARY TO PROTECT PERSONS
   23  PARTICIPATING IN WORKPLACE DRUG TESTING PROGRAMS.
   24    (D) IN BALANCING  THE  INTERESTS  OF  EMPLOYERS,  EMPLOYEES,  AND  THE
   25  WELFARE  OF THE GENERAL PUBLIC, THE ESTABLISHMENT OF STANDARDS TO ASSURE
   26  FAIR AND ACCURATE TESTING FOR DRUGS IN THE  WORKPLACE  IS  IN  THE  BEST
   27  INTERESTS OF ALL.
   28    S  84-C. NO LEGAL DUTY TO TEST.  ALL DRUG TESTING CONDUCTED BY EMPLOY-
   29  ERS SHALL BE IN CONFORMITY WITH THE STANDARDS ESTABLISHED IN THIS  TITLE
   30  AND  ALL  APPLICABLE RULES PROMULGATED PURSUANT TO THIS TITLE.  HOWEVER,
   31  EMPLOYERS SHALL NOT HAVE A LEGAL DUTY UNDER THIS  TITLE  TO  REQUEST  AN
   32  EMPLOYEE OR JOB APPLICANT TO UNDERGO DRUG TESTING. NO TESTING OF EMPLOY-
   33  EES  SHALL  TAKE  EFFECT UNTIL LOCAL DRUG ABUSE ASSISTANCE PROGRAMS HAVE
   34  BEEN IDENTIFIED.
   35    S 84-D. DEFINITIONS.  EXCEPT WHERE THE CONTEXT OTHERWISE REQUIRES,  AS
   36  USED IN THIS TITLE:
   37    (A)  "DRUG"  MEANS  ALCOHOL,  INCLUDING  DISTILLED SPIRITS, WINE, MALT
   38  BEVERAGES,  AND  INTOXICATING   LIQUORS;   AMPHETAMINES;   CANNABINOIDS;
   39  COCAINE;  PHENCYCLIDINE  (PCP);  HALLUCINOGENS;  METHAQUALONE;  OPIATES;
   40  BARBITURATES; BENZODIAZEPINES; SYNTHETIC NARCOTICS; DESIGNER DRUGS; OR A
   41  METABOLITE OF ANY OF THE SUBSTANCES LISTED HEREIN.
   42    (B) "DRUG TEST" OR "TEST" MEANS ANY CHEMICAL, BIOLOGICAL, OR  PHYSICAL
   43  INSTRUMENTAL  ANALYSIS  ADMINISTERED  FOR THE PURPOSE OF DETERMINING THE
   44  PRESENCE OR ABSENCE OF A DRUG OR ITS METABOLITES.
   45    (C) "INITIAL DRUG TEST" MEANS A SENSITIVE, RAPID, AND RELIABLE  PROCE-
   46  DURE  TO  IDENTIFY  NEGATIVE  AND  PRESUMPTIVE POSITIVE SPECIMENS.   ALL
   47  INITIAL TESTS SHALL USE AN IMMUNOASSAY PROCEDURE OR  AN  EQUIVALENT,  OR
   48  SHALL USE A MORE ACCURATE SCIENTIFICALLY ACCEPTED METHOD APPROVED BY THE
   49  OFFICE  OF ALCOHOLISM AND SUBSTANCE ABUSE SERVICES AS SUCH MORE ACCURATE
   50  TECHNOLOGY BECOMES AVAILABLE IN A COST-EFFECTIVE FORM.
   51    (D)  "CONFIRMATION TEST", "CONFIRMED TEST", OR "CONFIRMED  DRUG  TEST"
   52  MEANS  A  SECOND ANALYTICAL PROCEDURE USED TO IDENTIFY THE PRESENCE OF A
   53  SPECIFIC DRUG OR METABOLITE IN A SPECIMEN.  THE CONFIRMATION  TEST  MUST
   54  BE  DIFFERENT  IN  SCIENTIFIC  PRINCIPLE  FROM  THAT OF THE INITIAL TEST
   55  PROCEDURE.   THIS CONFIRMATION  METHOD  MUST  BE  CAPABLE  OF  PROVIDING
   56  REQUIRED SPECIFICITY, SENSITIVITY, AND QUANTITATIVE ACCURACY.
       A. 6447                             3
    1    (E) "CHAIN OF CUSTODY" REFERS TO THE METHODOLOGY OF TRACKING SPECIFIED
    2  MATERIALS  OR  SUBSTANCES  FOR  THE  PURPOSE  OF MAINTAINING CONTROL AND
    3  ACCOUNTABILITY FROM INITIAL COLLECTION TO FINAL DISPOSITION FOR ALL SUCH
    4  MATERIALS OR SUBSTANCES AND PROVIDING FOR ACCOUNTABILITY AT  EACH  STAGE
    5  IN HANDLING, TESTING, STORING SPECIMENS, AND REPORTING OF TEST RESULTS.
    6    (F)  "JOB APPLICANT" MEANS A PERSON WHO HAS APPLIED FOR A SPECIAL RISK
    7  OR SAFETY-SENSITIVE POSITION WITH  AN  EMPLOYER  AND  HAS  BEEN  OFFERED
    8  EMPLOYMENT CONDITIONED UPON SUCCESSFULLY PASSING A DRUG TEST.
    9    (G)  "EMPLOYEE" MEANS ANY PERSON WHO WORKS FOR SALARY, WAGES, OR OTHER
   10  REMUNERATION FOR AN EMPLOYER.
   11    (H) "EMPLOYER" MEANS ANY AGENCY WITHIN STATE GOVERNMENT  THAT  EMPLOYS
   12  INDIVIDUALS FOR SALARY, WAGES, OR OTHER REMUNERATION.
   13    (I) "PRESCRIPTION OR NONPRESCRIPTION MEDICATION" MEANS A DRUG OR MEDI-
   14  CATION  OBTAINED  PURSUANT  TO  A  PRESCRIPTION  OR A MEDICATION THAT IS
   15  AUTHORIZED PURSUANT TO FEDERAL OR STATE LAW FOR GENERAL DISTRIBUTION AND
   16  USE WITHOUT A PRESCRIPTION IN THE TREATMENT OF HUMAN DISEASES, AILMENTS,
   17  OR INJURIES.
   18    (J) "REASONABLE SUSPICION DRUG TESTING" MEANS DRUG TESTING BASED ON  A
   19  BELIEF  THAT THE EMPLOYEE IS USING OR HAS USED DRUGS IN VIOLATION OF THE
   20  EMPLOYER'S POLICY DRAWN FROM SPECIFIC OBJECTIVE  AND  ARTICULABLE  FACTS
   21  AND REASONABLE INFERENCES DRAWN FROM THOSE FACTS IN LIGHT OF EXPERIENCE.
   22  REASONABLE  SUSPICION DRUG TESTING SHALL NOT BE REQUIRED EXCEPT UPON THE
   23  RECOMMENDATION OF A SUPERVISOR WHO IS AT LEAST ONE LEVEL OF  SUPERVISION
   24  HIGHER THAN THE IMMEDIATE SUPERVISOR OF THE EMPLOYEE IN QUESTION.  AMONG
   25  OTHER THINGS, SUCH FACTS AND INFERENCES MAY BE BASED UPON:
   26    1.   OBSERVABLE PHENOMENA WHILE AT WORK, SUCH AS DIRECT OBSERVATION OF
   27  DRUG USE OR OF THE PHYSICAL SYMPTOMS OR MANIFESTATIONS  OF  BEING  UNDER
   28  THE INFLUENCE OF A DRUG.
   29    2. ABNORMAL CONDUCT OR ERRATIC BEHAVIOR WHILE AT WORK OR A SIGNIFICANT
   30  DETERIORATION IN WORK PERFORMANCE.
   31    3.  A  REPORT OF DRUG USE, PROVIDED BY A RELIABLE AND CREDIBLE SOURCE,
   32  WHICH HAS BEEN INDEPENDENTLY CORROBORATED.
   33    4. EVIDENCE THAT AN INDIVIDUAL HAS TAMPERED WITH A  DRUG  TEST  DURING
   34  HIS OR HER EMPLOYMENT WITH THE CURRENT EMPLOYER.
   35    5.    INFORMATION  THAT  AN EMPLOYEE HAS CAUSED, OR CONTRIBUTED TO, AN
   36  ACCIDENT WHILE AT WORK.
   37    6.  EVIDENCE THAT AN EMPLOYEE HAS USED, POSSESSED, SOLD, SOLICITED, OR
   38  TRANSFERRED DRUGS WHILE WORKING OR WHILE ON THE EMPLOYER'S  PREMISES  OR
   39  WHILE OPERATING THE EMPLOYER'S VEHICLE, MACHINERY, OR EQUIPMENT.
   40    (K)  "SPECIMEN" MEANS A TISSUE OR PRODUCT OF THE HUMAN BODY CAPABLE OF
   41  REVEALING THE PRESENCE OF DRUGS OR THEIR METABOLITES.
   42    (L)  "EMPLOYEE  ASSISTANCE  PROGRAM"  MEANS AN ESTABLISHED PROGRAM FOR
   43  EMPLOYEE ASSESSMENT, COUNSELING, AND POSSIBLE REFERRAL TO AN ALCOHOL AND
   44  DRUG REHABILITATION PROGRAM.
   45    (M) "SAFETY-SENSITIVE POSITION" MEANS ANY POSITION, INCLUDING A SUPER-
   46  VISORY OR MANAGEMENT POSITION, IN WHICH A DRUG IMPAIRMENT WOULD  CONSTI-
   47  TUTE AN IMMEDIATE AND DIRECT THREAT TO PUBLIC HEALTH OR SAFETY.
   48    S  84-E.    NOTICE  TO EMPLOYEES.   (A) EMPLOYERS WITH NO DRUG TESTING
   49  PROGRAM SHALL ENSURE THAT AT LEAST SIXTY DAYS ELAPSE BETWEEN  A  GENERAL
   50  ONE-TIME  NOTICE  TO  ALL EMPLOYEES THAT A DRUG TESTING PROGRAM IS BEING
   51  IMPLEMENTED AND THE BEGINNING OF ACTUAL DRUG TESTING.    EMPLOYERS  WITH
   52  DRUG  TESTING  PROGRAMS  IN  PLACE  PRIOR  TO THE EFFECTIVE DATE OF THIS
   53  SECTION ARE NOT REQUIRED TO PROVIDE A SIXTY-DAY NOTICE PERIOD.
   54    (B) PRIOR TO TESTING, ALL EMPLOYEES AND JOB APPLICANTS FOR  EMPLOYMENT
   55  SHALL  BE  GIVEN  A  WRITTEN  POLICY  STATEMENT  FROM THE EMPLOYER WHICH
   56  CONTAINS:
       A. 6447                             4
    1    1.  A GENERAL STATEMENT OF THE EMPLOYER'S POLICY ON EMPLOYEE DRUG USE,
    2  WHICH SHALL IDENTIFY:
    3    (I)  THE TYPES OF TESTING AN EMPLOYEE OR JOB APPLICANT MAY BE REQUIRED
    4  TO SUBMIT TO, INCLUDING REASONABLE SUSPICION OR OTHER BASIS; AND
    5    (II) THE ACTIONS THE EMPLOYER MAY TAKE  AGAINST  AN  EMPLOYEE  OR  JOB
    6  APPLICANT ON THE BASIS OF A POSITIVE CONFIRMED DRUG TEST RESULT.
    7    2. A STATEMENT ADVISING THE EMPLOYEE OR JOB APPLICANT OF THE EXISTENCE
    8  OF THIS SECTION.
    9    3. A GENERAL STATEMENT CONCERNING CONFIDENTIALITY.
   10    4.  PROCEDURES  FOR  EMPLOYEES  AND  JOB  APPLICANTS TO CONFIDENTIALLY
   11  REPORT THE USE  OF  PRESCRIPTION  OR  NONPRESCRIPTION  MEDICATIONS  BOTH
   12  BEFORE  AND  AFTER BEING TESTED.  ADDITIONALLY, EMPLOYEES AND JOB APPLI-
   13  CANTS SHALL RECEIVE NOTICE OF THE MOST COMMON MEDICATIONS BY BRAND  NAME
   14  OR  COMMON  NAME,  AS APPLICABLE, AS WELL AS BY CHEMICAL NAME, WHICH MAY
   15  ALTER OR AFFECT A DRUG TEST.  A LIST OF SUCH MEDICATIONS SHALL BE DEVEL-
   16  OPED BY THE OFFICE OF ALCOHOLISM AND SUBSTANCE ABUSE SERVICES.
   17    5.  THE CONSEQUENCES OF REFUSING TO SUBMIT TO A DRUG TEST.
   18    6.  NAMES, ADDRESSES, AND TELEPHONE  NUMBERS  OF  EMPLOYEE  ASSISTANCE
   19  PROGRAMS AND LOCAL ALCOHOL AND DRUG REHABILITATION PROGRAMS.
   20    7.  A STATEMENT THAT AN EMPLOYEE OR JOB APPLICANT WHO RECEIVES A POSI-
   21  TIVE CONFIRMED DRUG TEST RESULT MAY CONTEST OR EXPLAIN THE RESULT TO THE
   22  EMPLOYER  WITHIN  FIVE  WORKING  DAYS  AFTER WRITTEN NOTIFICATION OF THE
   23  POSITIVE TEST RESULT. IF AN EMPLOYEE OR JOB APPLICANT'S  EXPLANATION  OR
   24  CHALLENGE  IS UNSATISFACTORY TO THE EMPLOYER, THE PERSON MAY CONTEST THE
   25  DRUG TEST RESULT AS PROVIDED BY SECTIONS EIGHTY-FOUR-M AND EIGHTY-FOUR-N
   26  OF THIS TITLE.
   27    8. A STATEMENT INFORMING THE EMPLOYEE OR JOB APPLICANT OF HIS  OR  HER
   28  RESPONSIBILITY  TO  NOTIFY THE LABORATORY OF ANY ADMINISTRATIVE OR CIVIL
   29  ACTIONS BROUGHT PURSUANT TO THIS TITLE.
   30    9.  A LIST OF ALL DRUGS FOR WHICH THE EMPLOYER WILL TEST, DESCRIBED BY
   31  BRAND NAMES OR COMMON NAMES, AS  APPLICABLE,  AS  WELL  AS  BY  CHEMICAL
   32  NAMES.
   33    10.  A STATEMENT REGARDING ANY APPLICABLE COLLECTIVE BARGAINING AGREE-
   34  MENT OR CONTRACT AND THE RIGHT TO APPEAL TO THE APPROPRIATE AGENCY.
   35    11.  A STATEMENT NOTIFYING EMPLOYEES AND JOB APPLICANTS OF THEIR RIGHT
   36  TO CONSULT THE TESTING LABORATORY FOR  TECHNICAL  INFORMATION  REGARDING
   37  PRESCRIPTION AND NONPRESCRIPTION MEDICATION.
   38    (C)  AN  EMPLOYER  SHALL  INCLUDE  NOTICE  OF  DRUG TESTING ON VACANCY
   39  ANNOUNCEMENTS FOR THOSE POSITIONS WHERE  DRUG  TESTING  IS  REQUIRED.  A
   40  NOTICE  OF THE EMPLOYER'S DRUG TESTING POLICY SHALL ALSO BE POSTED IN AN
   41  APPROPRIATE AND CONSPICUOUS LOCATION ON  THE  EMPLOYER'S  PREMISES,  AND
   42  COPIES  OF  THE  POLICY  SHALL  BE  MADE AVAILABLE FOR INSPECTION BY THE
   43  GENERAL PUBLIC DURING REGULAR BUSINESS HOURS IN THE EMPLOYER'S PERSONNEL
   44  OFFICE OR OTHER SUITABLE LOCATIONS.
   45    S 84-F.   TYPES OF TESTING.    AN  EMPLOYER  IS  AUTHORIZED,  BUT  NOT
   46  REQUIRED, TO CONDUCT THE FOLLOWING TYPES OF DRUG TESTS:
   47    (A)  JOB APPLICANT TESTING.  AN EMPLOYER MAY REQUIRE JOB APPLICANTS TO
   48  SUBMIT TO A DRUG TEST AND MAY USE A REFUSAL TO SUBMIT TO A DRUG TEST  OR
   49  A  POSITIVE  CONFIRMED  DRUG TEST AS A BASIS FOR REFUSAL TO HIRE THE JOB
   50  APPLICANT.
   51    (B) REASONABLE SUSPICION. AN  EMPLOYER  MAY  REQUIRE  AN  EMPLOYEE  TO
   52  SUBMIT TO REASONABLE SUSPICION DRUG TESTING.
   53    (C)  ROUTINE  FITNESS FOR DUTY. AN EMPLOYER MAY REQUIRE AN EMPLOYEE TO
   54  SUBMIT TO A DRUG TEST IF THE TEST IS CONDUCTED AS PART  OF  A  ROUTINELY
   55  SCHEDULED  EMPLOYEE FITNESS FOR DUTY MEDICAL EXAMINATION THAT IS PART OF
       A. 6447                             5
    1  THE EMPLOYER'S ESTABLISHED POLICY OR THAT IS SCHEDULED ROUTINELY FOR ALL
    2  MEMBERS OF AN EMPLOYMENT CLASSIFICATION OR GROUP.
    3    (D)  FOLLOW-UP  TESTING.  IF  THE EMPLOYEE IN THE COURSE OF EMPLOYMENT
    4  ENTERS AN EMPLOYEE ASSISTANCE PROGRAM FOR DRUG-RELATED PROBLEMS,  OR  AN
    5  ALCOHOL  AND  DRUG REHABILITATION PROGRAM, THE EMPLOYER MAY REQUIRE SUCH
    6  EMPLOYEE TO SUBMIT TO A DRUG TEST AS A FOLLOW-UP TO SUCH PROGRAM, AND ON
    7  A QUARTERLY, SEMIANNUAL, OR ANNUAL BASIS FOR UP TO TWO YEARS THEREAFTER.
    8    S 84-G.  PROCEDURES AND EMPLOYEE PROTECTION.  ALL SPECIMEN  COLLECTION
    9  AND  TESTING FOR DRUGS UNDER THIS TITLE SHALL BE PERFORMED IN ACCORDANCE
   10  WITH THE FOLLOWING PROCEDURES:
   11    (A) A SAMPLE SHALL BE COLLECTED WITH DUE REGARD TO THE PRIVACY OF  THE
   12  INDIVIDUAL  PROVIDING  THE SAMPLE, AND IN A MANNER REASONABLY CALCULATED
   13  TO PREVENT SUBSTITUTION OR CONTAMINATION OF THE SAMPLE.
   14    (B) SPECIMEN COLLECTION SHALL BE  DOCUMENTED,  AND  THE  DOCUMENTATION
   15  PROCEDURES SHALL INCLUDE:
   16    1.    LABELING OF SPECIMEN CONTAINERS SO AS TO REASONABLY PRECLUDE THE
   17  LIKELIHOOD OF ERRONEOUS IDENTIFICATION OF TEST RESULTS.
   18    2.  A FORM FOR THE EMPLOYEE OR JOB APPLICANT TO PROVIDE  ANY  INFORMA-
   19  TION  HE OR SHE CONSIDERS RELEVANT TO THE TEST, INCLUDING IDENTIFICATION
   20  OF CURRENTLY OR RECENTLY USED PRESCRIPTION  OR  NONPRESCRIPTION  MEDICA-
   21  TION,  OR  OTHER  RELEVANT MEDICAL INFORMATION.  SUCH FORM SHALL PROVIDE
   22  NOTICE OF THE MOST COMMON MEDICATIONS BY BRAND NAME OR COMMON  NAME,  AS
   23  APPLICABLE,  AS  WELL  AS  BY CHEMICAL NAME, WHICH MAY ALTER OR AFFECT A
   24  DRUG TEST.  THE PROVIDING OF INFORMATION SHALL NOT PRECLUDE THE ADMINIS-
   25  TRATION OF THE DRUG TEST, BUT SHALL BE TAKEN INTO ACCOUNT IN  INTERPRET-
   26  ING ANY POSITIVE CONFIRMED RESULTS.
   27    (C)  SPECIMEN  COLLECTION,  STORAGE, AND TRANSPORTATION TO THE TESTING
   28  SITE SHALL BE PERFORMED IN A MANNER WHICH WILL REASONABLY PRECLUDE SPEC-
   29  IMEN CONTAMINATION OR ADULTERATION.
   30    (D)  EACH INITIAL AND CONFIRMATION TEST CONDUCTED  UNDER  THIS  TITLE,
   31  NOT INCLUDING THE TAKING OR COLLECTING OF A SPECIMEN TO BE TESTED, SHALL
   32  BE   CONDUCTED   BY  A  LICENSED  LABORATORY  AS  DESCRIBED  IN  SECTION
   33  EIGHTY-FOUR-K OF THIS TITLE.
   34    (E) A SPECIMEN FOR A DRUG TEST MAY BE TAKEN OR COLLECTED BY ANY OF THE
   35  FOLLOWING PERSONS:
   36    1.  A PHYSICIAN, A PHYSICIAN'S ASSISTANT,  A  REGISTERED  PROFESSIONAL
   37  NURSE,  A LICENSED PRACTICAL NURSE, A NURSE PRACTITIONER, OR A CERTIFIED
   38  PARAMEDIC WHO IS PRESENT AT THE SCENE OF AN ACCIDENT FOR THE PURPOSE  OF
   39  RENDERING EMERGENCY MEDICAL SERVICE OR TREATMENT.
   40    2.  A QUALIFIED PERSON EMPLOYED BY A LICENSED LABORATORY.
   41    (F)  A  PERSON  WHO  COLLECTS  OR  TAKES  A  SPECIMEN  FOR A DRUG TEST
   42  CONDUCTED PURSUANT TO THIS SECTION SHALL COLLECT  AN  AMOUNT  SUFFICIENT
   43  FOR  TWO  DRUG  TESTS  AS  DETERMINED  BY  THE  OFFICE OF ALCOHOLISM AND
   44  SUBSTANCE ABUSE SERVICES.
   45    (G)  ANY DRUG TEST CONDUCTED OR REQUESTED BY  AN  EMPLOYER  MAY  OCCUR
   46  BEFORE,  DURING,  OR  IMMEDIATELY  AFTER  THE REGULAR WORK PERIOD OF THE
   47  EMPLOYEE, AND SHALL BE DEEMED TO BE PERFORMED DURING WORK TIME  FOR  THE
   48  PURPOSES OF DETERMINING COMPENSATION AND BENEFITS FOR THE EMPLOYEE.
   49    (H)  EVERY SPECIMEN THAT PRODUCES A POSITIVE CONFIRMED RESULT SHALL BE
   50  PRESERVED BY THE LICENSED LABORATORY THAT CONDUCTS THE CONFIRMATION TEST
   51  FOR A PERIOD OF AT LEAST TWO HUNDRED TEN DAYS FROM THE TIME THE  RESULTS
   52  OF  THE  POSITIVE CONFIRMATION TEST ARE MAILED OR OTHERWISE DELIVERED TO
   53  THE EMPLOYER.  HOWEVER, IF AN EMPLOYEE OR JOB  APPLICANT  UNDERTAKES  AN
   54  ADMINISTRATIVE  OR  LEGAL  CHALLENGE TO THE TEST RESULT, THE EMPLOYEE OR
   55  JOB APPLICANT SHALL NOTIFY  THE  LABORATORY  AND  THE  SAMPLE  SHALL  BE
   56  RETAINED  BY  THE  LABORATORY UNTIL THE CASE OR ADMINISTRATIVE APPEAL IS
       A. 6447                             6
    1  SETTLED.  DURING THE ONE HUNDRED EIGHTY-DAY PERIOD AFTER WRITTEN NOTIFI-
    2  CATION OF A POSITIVE TEST RESULT, THE EMPLOYEE OR JOB APPLICANT WHO  HAS
    3  PROVIDED  THE  SPECIMEN  SHALL  BE  PERMITTED  BY THE EMPLOYER TO HAVE A
    4  PORTION  OF  THE  SPECIMEN  RETESTED, AT THE EMPLOYEE OR JOB APPLICANT'S
    5  EXPENSE, AT ANOTHER LABORATORY, LICENSED AND APPROVED BY THE  OFFICE  OF
    6  ALCOHOLISM  AND  SUBSTANCE ABUSE SERVICES, CHOSEN BY THE EMPLOYEE OR JOB
    7  APPLICANT.  THE SECOND LABORATORY MUST TEST AN EQUAL OR  GREATER  SENSI-
    8  TIVITY  FOR  THE  DRUG  IN  QUESTION AS THE FIRST LABORATORY.  THE FIRST
    9  LABORATORY WHICH PERFORMED THE TEST FOR THE EMPLOYER SHALL BE  RESPONSI-
   10  BLE  FOR THE TRANSFER OF THE PORTION OF THE SPECIMEN TO BE RETESTED, AND
   11  FOR THE INTEGRITY OF THE CHAIN OF CUSTODY DURING SUCH TRANSFER.
   12    (I) WITHIN FIVE WORKING DAYS AFTER RECEIPT  OF  A  POSITIVE  CONFIRMED
   13  TEST  RESULT  FROM  THE  TESTING LABORATORY, AN EMPLOYER SHALL INFORM AN
   14  EMPLOYEE OR JOB APPLICANT IN WRITING OF SUCH POSITIVE TEST  RESULT,  THE
   15  CONSEQUENCES  OF SUCH RESULTS, AND THE OPTIONS AVAILABLE TO THE EMPLOYEE
   16  OR JOB APPLICANT.
   17    (J) THE EMPLOYER SHALL PROVIDE TO THE EMPLOYEE OR JOB APPLICANT,  UPON
   18  REQUEST, A COPY OF THE TEST RESULTS.
   19    (K)  WITHIN  FIVE  WORKING  DAYS  AFTER RECEIVING NOTICE OF A POSITIVE
   20  CONFIRMED TEST RESULT, THE EMPLOYEE OR JOB APPLICANT MAY SUBMIT INFORMA-
   21  TION TO AN EMPLOYER EXPLAINING OR CONTESTING THE TEST RESULTS,  AND  WHY
   22  THE RESULTS DO NOT CONSTITUTE A VIOLATION OF THE EMPLOYER'S POLICY.
   23    (L)  IF AN EMPLOYEE OR JOB APPLICANT'S EXPLANATION OR CHALLENGE OF THE
   24  POSITIVE TEST RESULTS IS  UNSATISFACTORY  TO  THE  EMPLOYER,  A  WRITTEN
   25  EXPLANATION  AS  TO  WHY  THE EMPLOYEE OR JOB APPLICANT'S EXPLANATION IS
   26  UNSATISFACTORY, ALONG WITH THE REPORT  OF  POSITIVE  RESULTS,  SHALL  BE
   27  PROVIDED  BY  THE  EMPLOYER  TO  THE EMPLOYEE OR JOB APPLICANT. ALL SUCH
   28  DOCUMENTATION SHALL BE KEPT CONFIDENTIAL BY  THE  EMPLOYER  PURSUANT  TO
   29  SECTION EIGHTY-FOUR-J OF THIS TITLE AND SHALL BE RETAINED BY THE EMPLOY-
   30  ER FOR AT LEAST ONE YEAR.
   31    (M)  NO  EMPLOYER MAY DISCHARGE, DISCIPLINE, REFUSE TO HIRE, DISCRIMI-
   32  NATE AGAINST, OR REQUEST OR REQUIRE REHABILITATION OF AN EMPLOYEE OR JOB
   33  APPLICANT ON THE SOLE BASIS OF A POSITIVE TEST RESULT THAT HAS NOT  BEEN
   34  VERIFIED BY A CONFIRMATION TEST.
   35    (N)  IN  ADDITION  TO  THE  LIMITATION  UNDER  SUBDIVISION (M) OF THIS
   36  SECTION:
   37    1. NO EMPLOYER MAY DISCHARGE, DISCIPLINE, OR DISCRIMINATE  AGAINST  AN
   38  EMPLOYEE  ON  THE  SOLE BASIS OF THE EMPLOYEE'S FIRST POSITIVE CONFIRMED
   39  DRUG TEST, UNLESS THE EMPLOYER HAS FIRST GIVEN THE EMPLOYEE AN  OPPORTU-
   40  NITY  TO  PARTICIPATE  IN,  AT THE EMPLOYEE'S OWN EXPENSE OR PURSUANT TO
   41  COVERAGE UNDER A HEALTH INSURANCE PLAN, AN EMPLOYEE  ASSISTANCE  PROGRAM
   42  OR AN ALCOHOL AND DRUG REHABILITATION PROGRAM, AND:
   43    (I)  THE  EMPLOYEE  HAS  EITHER REFUSED TO PARTICIPATE IN THE EMPLOYEE
   44  ASSISTANCE PROGRAM OR THE ALCOHOL AND DRUG REHABILITATION PROGRAM OR HAS
   45  FAILED TO SUCCESSFULLY COMPLETE SUCH PROGRAM, AS EVIDENCED BY WITHDRAWAL
   46  FROM THE PROGRAM BEFORE ITS COMPLETION OR  A  REPORT  FROM  THE  PROGRAM
   47  INDICATING  UNSATISFACTORY COMPLIANCE, OR BY A POSITIVE TEST RESULT ON A
   48  CONFIRMATION TEST AFTER COMPLETION OF THE PROGRAM; OR
   49    (II) THE EMPLOYEE HAS FAILED OR REFUSED TO SIGN A WRITTEN CONSENT FORM
   50  ALLOWING THE EMPLOYER TO OBTAIN INFORMATION REGARDING THE  PROGRESS  AND
   51  SUCCESSFUL  COMPLETION  OF  AN EMPLOYEE ASSISTANCE PROGRAM OR AN ALCOHOL
   52  AND DRUG REHABILITATION PROGRAM.
   53    2. AN EMPLOYEE IN A SAFETY SENSITIVE POSITION SHALL BE PLACED  BY  THE
   54  EMPLOYER  IN  A  NON-SAFETY  SENSITIVE  POSITION, OR IF SUCH POSITION IS
   55  UNAVAILABLE, ON LEAVE STATUS WHILE PARTICIPATING IN AN EMPLOYEE  ASSIST-
   56  ANCE PROGRAM OR AN ALCOHOL AND DRUG REHABILITATION PROGRAM. IF PLACED ON
       A. 6447                             7
    1  LEAVE  STATUS  WITHOUT  PAY,  THE EMPLOYEE SHALL BE PERMITTED TO USE ANY
    2  ACCUMULATED LEAVE CREDITS PRIOR TO BEING PLACED ON LEAVE WITHOUT PAY.
    3    (O) UPON SUCCESSFUL COMPLETION OF AN EMPLOYEE ASSISTANCE PROGRAM OR AN
    4  ALCOHOL  AND  DRUG  REHABILITATION  PROGRAM, THE EMPLOYEE SHALL BE REIN-
    5  STATED TO THE SAME OR EQUIVALENT POSITION THAT WAS HELD  PRIOR  TO  SUCH
    6  REHABILITATION.
    7    (P)  NO EMPLOYER MAY DISCHARGE, DISCIPLINE, OR DISCRIMINATE AGAINST AN
    8  EMPLOYEE, OR REFUSE TO HIRE A JOB APPLICANT, ON THE BASIS OF  ANY  PRIOR
    9  MEDICAL HISTORY REVEALED TO THE EMPLOYER PURSUANT TO THIS TITLE.
   10    (Q) AN EMPLOYER WHO PERFORMS DRUG TESTING OR SPECIMEN COLLECTION SHALL
   11  USE CHAIN OF CUSTODY PROCEDURES AS ESTABLISHED BY THE OFFICE OF ALCOHOL-
   12  ISM  AND SUBSTANCE ABUSE SERVICES TO ENSURE PROPER RECORDKEEPING, HANDL-
   13  ING, LABELING, AND IDENTIFICATION OF ALL SPECIMENS TO BE TESTED.
   14    (R) AN EMPLOYER SHALL PAY THE COST OF  ALL  DRUG  TESTS,  INITIAL  AND
   15  CONFIRMATION, WHICH HE OR SHE REQUIRES OF EMPLOYEES.
   16    (S) AN EMPLOYEE OR JOB APPLICANT SHALL PAY THE COSTS OF ANY ADDITIONAL
   17  DRUG TESTS NOT REQUIRED BY THE EMPLOYER.
   18    (T)  NO  EMPLOYER SHALL DISCHARGE, DISCIPLINE, OR DISCRIMINATE AGAINST
   19  AN EMPLOYEE SOLELY UPON VOLUNTARILY SEEKING TREATMENT, WHILE  UNDER  THE
   20  EMPLOY  OF  THE EMPLOYER, FOR A DRUG-RELATED PROBLEM IF THE EMPLOYEE HAS
   21  NOT PREVIOUSLY TESTED POSITIVE FOR DRUG USE, ENTERED AN EMPLOYEE ASSIST-
   22  ANCE PROGRAM FOR DRUG-RELATED PROBLEMS, OR ENTERED AN ALCOHOL  AND  DRUG
   23  REHABILITATION PROGRAM.
   24    (U)  WHERE  TESTING  IS  CONDUCTED BASED ON REASONABLE SUSPICION, EACH
   25  EMPLOYER SHALL PROMPTLY DETAIL IN WRITING THE CIRCUMSTANCES WHICH FORMED
   26  THE BASIS OF THE DETERMINATION  THAT  REASONABLE  SUSPICION  EXISTED  TO
   27  WARRANT  THE TESTING. A COPY OF THIS DOCUMENTATION SHALL BE GIVEN TO THE
   28  EMPLOYEE UPON REQUEST AND  THE  ORIGINAL  DOCUMENTATION  SHALL  BE  KEPT
   29  CONFIDENTIAL  BY  THE EMPLOYER PURSUANT TO SECTION EIGHTY-FOUR-J OF THIS
   30  TITLE AND RETAINED BY THE EMPLOYER FOR AT LEAST ONE YEAR.
   31    (V) IF AN EMPLOYEE IS UNABLE TO PARTICIPATE  IN  OUTPATIENT  REHABILI-
   32  TATION,  THE  EMPLOYEE MAY BE PLACED ON LEAVE STATUS WHILE PARTICIPATING
   33  IN AN EMPLOYEE ASSISTANCE PROGRAM OR AN ALCOHOL AND DRUG  REHABILITATION
   34  PROGRAM.  IF  PLACED  ON LEAVE WITHOUT PAY STATUS, THE EMPLOYEE SHALL BE
   35  PERMITTED TO USE ANY ACCUMULATED LEAVE CREDITS PRIOR TO BEING PLACED  ON
   36  LEAVE  WITHOUT PAY. UPON SUCCESSFUL COMPLETION OF AN EMPLOYEE ASSISTANCE
   37  PROGRAM OR AN ALCOHOL AND  DRUG  REHABILITATION  PROGRAM,  THE  EMPLOYEE
   38  SHALL  BE  REINSTATED  TO  THE SAME OR EQUIVALENT POSITION THAT WAS HELD
   39  PRIOR TO SUCH REHABILITATION.
   40    S 84-H. CONFIRMATION TESTING.  (A) IF AN INITIAL DRUG  TEST  IS  NEGA-
   41  TIVE,  THE  EMPLOYER  MAY  IN  ITS SOLE DISCRETION AND AT THE EMPLOYER'S
   42  EXPENSE SEEK A CONFIRMATION TEST.
   43    (B) ONLY LICENSED LABORATORIES AS DESCRIBED IN  SECTION  EIGHTY-FOUR-K
   44  OF THIS TITLE SHALL CONDUCT CONFIRMATION DRUG TESTS.
   45    (C)   ALL   POSITIVE  INITIAL  TESTS  SHALL  BE  CONFIRMED  USING  GAS
   46  CHROMATOGRAPHY/MASS SPECTROMETRY (GC/MS) OR AN EQUIVALENT OR MORE  ACCU-
   47  RATE SCIENTIFICALLY ACCEPTED METHOD APPROVED BY THE OFFICE OF ALCOHOLISM
   48  AND  SUBSTANCE  ABUSE SERVICES AS SUCH TECHNOLOGY BECOMES AVAILABLE IN A
   49  COST EFFECTIVE FORM.
   50    S 84-I. EMPLOYEE PROTECTION. (A) NO EMPLOYEE OR  JOB  APPLICANT  WHOSE
   51  DRUG  TEST  RESULT  IS  CONFIRMED  AS  POSITIVE  IN  ACCORDANCE WITH THE
   52  PROVISIONS OF THIS TITLE SHALL, BY VIRTUE OF THE RESULT ALONE BE DEFINED
   53  AS A PERSON WITH A DISABILITY.
   54    (B) AN EMPLOYER WHO DISCHARGES OR DISCIPLINES AN EMPLOYEE  OR  REFUSES
   55  TO  HIRE  A JOB APPLICANT IN COMPLIANCE WITH THIS TITLE SHALL BE CONSID-
   56  ERED TO HAVE DISCHARGED, DISCIPLINED, OR REFUSED TO HIRE FOR CAUSE.
       A. 6447                             8
    1    (C) NO PHYSICIAN-PATIENT RELATIONSHIP IS CREATED BETWEEN  AN  EMPLOYEE
    2  OR  JOB APPLICANT AND AN EMPLOYER OR ANY PERSON PERFORMING OR EVALUATING
    3  A DRUG TEST, SOLELY BY THE ESTABLISHMENT,  IMPLEMENTATION,  OR  ADMINIS-
    4  TRATION OF A DRUG TESTING PROGRAM.
    5    (D)  NOTHING  IN  THIS TITLE SHALL BE CONSTRUED TO PREVENT AN EMPLOYER
    6  FROM ESTABLISHING REASONABLE WORK RULES RELATED TO EMPLOYEE  POSSESSION,
    7  USE,  SALE, OR SOLICITATION OF DRUGS, INCLUDING CONVICTIONS FOR DRUG-RE-
    8  LATED OFFENSES, AND TAKING ACTION BASED UPON A VIOLATION OF ANY OF THOSE
    9  RULES.
   10    (E) NOTHING IN THIS TITLE SHALL BE CONSTRUED TO OPERATE RETROACTIVELY,
   11  AND NOTHING IN THIS TITLE SHALL ABROGATE THE RIGHT OF AN EMPLOYER  UNDER
   12  STATE  LAW  TO  CONDUCT  DRUG TESTS PRIOR TO JANUARY FIRST, TWO THOUSAND
   13  FOURTEEN. A DRUG TEST CONDUCTED BY AN EMPLOYER PRIOR TO  JANUARY  FIRST,
   14  TWO THOUSAND FOURTEEN IS NOT SUBJECT TO THIS TITLE.
   15    (F)  IF AN EMPLOYEE OR JOB APPLICANT REFUSES TO SUBMIT TO A DRUG TEST,
   16  THE EMPLOYER SHALL NOT BE BARRED FROM DISCHARGING  OR  DISCIPLINING  THE
   17  EMPLOYEE,  OR  FROM REFUSING TO HIRE THE JOB APPLICANT. HOWEVER, NOTHING
   18  IN THIS SUBDIVISION SHALL  ABROGATE  THE  RIGHTS  AND  REMEDIES  OF  THE
   19  EMPLOYEE OR JOB APPLICANT AS OTHERWISE PROVIDED IN THIS TITLE.
   20    (G)  AN  EMPLOYER WHO REFUSES TO HIRE A JOB APPLICANT BASED ON A POSI-
   21  TIVE CONFIRMED DRUG TEST RESULT  SHALL  NOT  BE  REQUIRED  TO  HOLD  THE
   22  EMPLOYMENT  POSITION  VACANT WHILE THE JOB APPLICANT PURSUES ADMINISTRA-
   23  TIVE ACTION. HOWEVER, SHOULD THE JOB APPLICANT PREVAIL  IN  HIS  OR  HER
   24  ACTIONS,  THE  EMPLOYER  SHALL  PROVIDE  HIM  OR  HER THE OPPORTUNITY OF
   25  EMPLOYMENT IN THE NEXT AVAILABLE COMPARABLE POSITION.
   26    (H) AN EMPLOYER SHALL REFER AN EMPLOYEE WITH  A  FIRST  TIME  POSITIVE
   27  CONFIRMED DRUG TEST RESULT TO AN EMPLOYEE ASSISTANCE PROGRAM OR AN ALCO-
   28  HOL  AND  DRUG  REHABILITATION  PROGRAM.  IF THE RESULTS OF A SUBSEQUENT
   29  CONFIRMED DRUG TEST ARE POSITIVE, THE EMPLOYER MAY DISCHARGE  OR  DISCI-
   30  PLINE THE EMPLOYEE.
   31    (I)  NOTHING  IN THIS TITLE SHALL BE CONSTRUED TO PROHIBIT AN EMPLOYER
   32  FROM CONDUCTING MEDICAL SCREENING OR OTHER TESTS REQUIRED BY  ANY  STAT-
   33  UTE,  RULE,  OR  REGULATION  FOR  THE  PURPOSE OF MONITORING EXPOSURE OF
   34  EMPLOYEES TO TOXIC OR OTHER UNHEALTHY SUBSTANCES IN THE WORKPLACE OR  IN
   35  THE  PERFORMANCE  OF JOB RESPONSIBILITIES. SUCH SCREENING OR TESTS SHALL
   36  BE LIMITED TO THE SPECIFIC SUBSTANCES EXPRESSLY IDENTIFIED IN THE APPLI-
   37  CABLE STATUTE, RULE, OR REGULATION, UNLESS PRIOR WRITTEN CONSENT OF  THE
   38  EMPLOYEE IS OBTAINED FOR OTHER TESTS.
   39    (J) AN EMPLOYER SHALL PLACE A SAFETY SENSITIVE POSITION EMPLOYEE WHOSE
   40  DRUG  TEST  RESULT IS CONFIRMED POSITIVE IN A NON SAFETY SENSITIVE POSI-
   41  TION, OR IF SUCH A POSITION IS UNAVAILABLE, ON LEAVE  STATUS  WHILE  THE
   42  EMPLOYEE  PARTICIPATES  IN  AN EMPLOYEE ASSISTANCE PROGRAM OR AN ALCOHOL
   43  AND DRUG REHABILITATION PROGRAM. IF PLACED ON LEAVE STATUS WITHOUT  PAY,
   44  THE  EMPLOYEE  SHALL  BE  PERMITTED TO USE ANY ACCUMULATED LEAVE CREDITS
   45  PRIOR TO BEING PLACED ON LEAVE WITHOUT PAY.
   46    S 84-J. CONFIDENTIALITY. (A)  ALL  INFORMATION,  INTERVIEWS,  REPORTS,
   47  STATEMENTS,  MEMORANDA,  AND  DRUG  TEST  RESULTS, WRITTEN OR OTHERWISE,
   48  RECEIVED BY THE EMPLOYER THROUGH A DRUG TESTING PROGRAM ARE CONFIDENTIAL
   49  COMMUNICATIONS AND MAY NOT BE USED OR RECEIVED IN EVIDENCE, OBTAINED  IN
   50  DISCOVERY,  OR DISCLOSED IN ANY PUBLIC OR PRIVATE PROCEEDINGS, EXCEPT IN
   51  ACCORDANCE WITH THIS TITLE.
   52    (B) EMPLOYERS, LABORATORIES, EMPLOYEE ASSISTANCE  PROGRAMS,  DRUG  AND
   53  ALCOHOL  REHABILITATION  PROGRAMS,  AND THEIR AGENTS WHO RECEIVE OR HAVE
   54  ACCESS TO INFORMATION CONCERNING DRUG TEST RESULTS SHALL KEEP ALL INFOR-
   55  MATION CONFIDENTIAL. RELEASE OF SUCH INFORMATION UNDER ANY OTHER CIRCUM-
   56  STANCE SHALL BE SOLELY PURSUANT TO A WRITTEN CONSENT FORM SIGNED  VOLUN-
       A. 6447                             9
    1  TARILY BY THE PERSON TESTED, EXCEPT WHERE SUCH RELEASE IS COMPELLED BY A
    2  HEARING  OFFICER  OR  A  COURT  OF COMPETENT JURISDICTION PURSUANT TO AN
    3  APPEAL TAKEN UNDER THIS TITLE, OR WHERE DEEMED APPROPRIATE BY A  PROFES-
    4  SIONAL  OR  OCCUPATIONAL  LICENSING  BOARD  IN  A  RELATED  DISCIPLINARY
    5  PROCEEDING. THE CONSENT FORM MUST CONTAIN, AT A MINIMUM:
    6    1. THE NAME OF THE PERSON WHO IS AUTHORIZED TO OBTAIN THE INFORMATION.
    7    2. THE PURPOSE OF THE DISCLOSURE.
    8    3. THE PRECISE INFORMATION TO BE DISCLOSED.
    9    4. THE DURATION OF THE CONSENT.
   10    5. THE SIGNATURE OF THE PERSON AUTHORIZING RELEASE OF THE INFORMATION.
   11    (C) INFORMATION ON DRUG TEST RESULTS SHALL NOT BE RELEASED OR USED  IN
   12  ANY  CRIMINAL PROCEEDING AGAINST THE EMPLOYEE OR JOB APPLICANT. INFORMA-
   13  TION RELEASED CONTRARY TO THIS SECTION SHALL BE INADMISSIBLE AS EVIDENCE
   14  IN ANY SUCH CRIMINAL PROCEEDING.
   15    (D) NOTHING HEREIN SHALL BE CONSTRUED TO PROHIBIT CERTIFYING BODIES OF
   16  SPECIAL RISK EMPLOYEES FROM RECEIVING INFORMATION ON POSITIVE  CONFIRMED
   17  DRUG TEST RESULTS FOR THE PURPOSE OF REVIEWING CERTIFICATION.
   18    (E)  NOTHING HEREIN SHALL BE CONSTRUED TO PROHIBIT THE EMPLOYER, AGENT
   19  OF THE EMPLOYER, OR LABORATORY CONDUCTING A DRUG TEST FROM HAVING ACCESS
   20  TO EMPLOYEE DRUG TEST INFORMATION WHEN CONSULTING WITH LEGAL COUNSEL  IN
   21  CONNECTION  WITH  ACTIONS  BROUGHT  UNDER  OR RELATED TO THIS SECTION OR
   22  WHERE THE INFORMATION IS RELEVANT TO ITS DEFENSE IN A CIVIL OR  ADMINIS-
   23  TRATIVE MATTER.
   24    S  84-K.  DRUG TESTING STANDARDS; LABORATORIES.  (A) NO LABORATORY MAY
   25  ANALYZE INITIAL OR CONFIRMATION DRUG SPECIMENS UNLESS:
   26    1. THE LABORATORY IS LICENSED AND APPROVED BY THE OFFICE OF ALCOHOLISM
   27  AND SUBSTANCE ABUSE SERVICES USING CRITERIA ESTABLISHED BY THE  NATIONAL
   28  INSTITUTE  ON DRUG ABUSE AS GUIDELINES FOR MODELING THE STATE DRUG TEST-
   29  ING PROGRAM.
   30    2. THE LABORATORY HAS WRITTEN PROCEDURES TO ENSURE CHAIN OF CUSTODY.
   31    3. THE LABORATORY FOLLOWS PROPER QUALITY CONTROL  PROCEDURES,  INCLUD-
   32  ING, BUT NOT LIMITED TO:
   33    (I)  THE USE OF INTERNAL QUALITY CONTROLS INCLUDING THE USE OF SAMPLES
   34  OF KNOWN CONCENTRATIONS WHICH ARE USED  TO  CHECK  THE  PERFORMANCE  AND
   35  CALIBRATION  OF TESTING EQUIPMENT, AND PERIODIC USE OF BLIND SAMPLES FOR
   36  OVERALL ACCURACY.
   37    (II) AN INTERNAL  REVIEW  AND  CERTIFICATION  PROCESS  FOR  DRUG  TEST
   38  RESULTS, CONDUCTED BY A PERSON QUALIFIED TO PERFORM THAT FUNCTION IN THE
   39  TESTING LABORATORY.
   40    (III)  SECURITY  MEASURES  IMPLEMENTED  BY  THE  TESTING LABORATORY TO
   41  PRECLUDE ADULTERATION OF SPECIMENS AND DRUG TEST RESULTS.
   42    (IV) OTHER NECESSARY AND PROPER ACTIONS TAKEN TO ENSURE  RELIABLE  AND
   43  ACCURATE DRUG TEST RESULTS.
   44    (B)  A LABORATORY SHALL DISCLOSE TO THE EMPLOYER A WRITTEN TEST RESULT
   45  REPORT WITHIN SEVEN WORKING DAYS AFTER RECEIPT OF THE SAMPLE. ALL  LABO-
   46  RATORY REPORTS OF A DRUG TEST RESULT SHALL, AT A MINIMUM, STATE:
   47    1. THE NAME AND ADDRESS OF THE LABORATORY WHICH PERFORMED THE TEST AND
   48  THE POSITIVE IDENTIFICATION OF THE PERSON TESTED.
   49    2.  POSITIVE  RESULTS ON CONFIRMATION TESTS ONLY, OR NEGATIVE RESULTS,
   50  AS APPLICABLE.
   51    3. A LIST OF THE DRUGS FOR WHICH THE DRUG ANALYSES WERE CONDUCTED.
   52    4. THE TYPE OF TESTS CONDUCTED FOR BOTH INITIAL AND CONFIRMATION TESTS
   53  AND THE MINIMUM CUT OFF LEVELS OF THE TESTS.
   54    5. ANY CORRELATION BETWEEN MEDICATION REPORTED BY THE EMPLOYEE OR  JOB
   55  APPLICANT PURSUANT TO PARAGRAPH TWO OF SUBDIVISION (B) OF SECTION EIGHT-
   56  Y-FOUR-G OF THIS TITLE AND A POSITIVE CONFIRMED DRUG TEST RESULT.
       A. 6447                            10
    1    NO  REPORT  SHALL  DISCLOSE  THE PRESENCE OR ABSENCE OF ANY DRUG OTHER
    2  THAN A SPECIFIC DRUG AND ITS METABOLITES LISTED PURSUANT TO THIS TITLE.
    3    (C)  THE  LABORATORY  SHALL  SUBMIT  TO  THE  OFFICE OF ALCOHOLISM AND
    4  SUBSTANCE ABUSE SERVICES A MONTHLY REPORT WITH  STATISTICAL  INFORMATION
    5  REGARDING THE TESTING OF EMPLOYEES AND JOB APPLICANTS. THE REPORTS SHALL
    6  INCLUDE  INFORMATION  ON  THE  METHODS  OF ANALYSES CONDUCTED, THE DRUGS
    7  TESTED FOR, THE NUMBER OF POSITIVE AND NEGATIVE RESULTS FOR BOTH INITIAL
    8  AND CONFIRMATION TESTS, AND ANY OTHER INFORMATION DEEMED APPROPRIATE  BY
    9  THE OFFICE OF ALCOHOLISM AND SUBSTANCE ABUSE SERVICES. NO MONTHLY REPORT
   10  SHALL IDENTIFY SPECIFIC EMPLOYEES OR JOB APPLICANTS.
   11    (D)  LABORATORIES  SHALL PROVIDE TECHNICAL ASSISTANCE TO THE EMPLOYER,
   12  EMPLOYEE, OR JOB APPLICANT FOR THE PURPOSE OF INTERPRETING ANY  POSITIVE
   13  CONFIRMED  TEST  RESULTS WHICH COULD HAVE BEEN CAUSED BY PRESCRIPTION OR
   14  NONPRESCRIPTION MEDICATION TAKEN BY THE EMPLOYEE OR JOB APPLICANT.
   15    S 84-L. RULES. (A)  THE  OFFICE  OF  ALCOHOLISM  AND  SUBSTANCE  ABUSE
   16  SERVICES IS HEREBY AUTHORIZED TO PROMULGATE RULES, USING CRITERIA ESTAB-
   17  LISHED  BY THE NATIONAL INSTITUTE ON DRUG ABUSE AS GUIDELINES FOR MODEL-
   18  ING THE STATE DRUG TESTING PROGRAM, CONCERNING, BUT NOT LIMITED TO:
   19    1. STANDARDS FOR DRUG TESTING LABORATORY  LICENSING,  SUSPENSION,  AND
   20  REVOCATION OF A LICENSE.
   21    2.  BODY  SPECIMENS AND MINIMUM SPECIMEN AMOUNTS WHICH ARE APPROPRIATE
   22  FOR DRUG TESTING.
   23    3. METHODS OF ANALYSIS AND PROCEDURES TO ENSURE RELIABLE DRUG  TESTING
   24  RESULTS, INCLUDING STANDARDS FOR INITIAL TESTS AND CONFIRMATION TESTS.
   25    4. MINIMUM CUT OFF DETECTION LEVELS FOR DRUGS OR THEIR METABOLITES FOR
   26  THE PURPOSES OF DETERMINING A POSITIVE TEST RESULT.
   27    5. CHAIN OF CUSTODY PROCEDURES TO ENSURE PROPER IDENTIFICATION, LABEL-
   28  ING, AND HANDLING OF SPECIMENS BEING TESTED.
   29    6.  RETENTION,  STORAGE, AND TRANSPORTATION PROCEDURES TO ENSURE RELI-
   30  ABLE RESULTS ON CONFIRMATION TESTS AND RETESTS.
   31    7. A LIST OF THE MOST COMMON MEDICATIONS BY BRAND NAME OR COMMON NAME,
   32  AS APPLICABLE, AS WELL AS BY CHEMICAL NAME, WHICH MAY ALTER OR AFFECT  A
   33  DRUG TEST.
   34    (B)  THIS  TITLE  SHALL  NOT BE CONSTRUED TO ELIMINATE THE BARGAINABLE
   35  RIGHTS AS PROVIDED IN THE COLLECTIVE BARGAINING PROCESS  WHERE  APPLICA-
   36  BLE.
   37    S  84-M.  DISCIPLINE REMEDIES. (A) AN EXECUTIVE BRANCH EMPLOYEE WHO IS
   38  DISCIPLINED OR WHO IS A JOB APPLICANT FOR ANOTHER POSITION  AND  IS  NOT
   39  HIRED  PURSUANT  TO  THIS TITLE, MAY FILE AN APPEAL WITH THE APPROPRIATE
   40  AGENCY. ANY APPEAL MUST BE FILED WITHIN THIRTY CALENDAR DAYS OF  RECEIPT
   41  BY  THE  EMPLOYEE OR JOB APPLICANT OF NOTICE OF DISCIPLINE OR REFUSAL TO
   42  HIRE. THE NOTICE SHALL INFORM THE EMPLOYEE OR JOB APPLICANT OF THE RIGHT
   43  TO FILE AN APPEAL, OR IF AVAILABLE,  THE  RIGHT  TO  FILE  A  COLLECTIVE
   44  BARGAINING  GRIEVANCE. A HEARING ON THE APPEAL SHALL BE CONDUCTED WITHIN
   45  THIRTY DAYS OF  THE  FILING  OF  THE  APPEAL,  UNLESS  AN  EXTENSION  IS
   46  REQUESTED  BY THE EMPLOYEE OR JOB APPLICANT AND GRANTED BY THE APPROPRI-
   47  ATE AGENCY OR AN ARBITRATOR.
   48    (B) THE APPROPRIATE  AGENCY  SHALL  PROMULGATE  RULES  CONCERNING  THE
   49  RECEIPT,  PROCESSING,  AND  RESOLUTION OF APPEALS FILED PURSUANT TO THIS
   50  TITLE.
   51    (C) APPEALS TO THE APPROPRIATE AGENCY SHALL BE THE EXCLUSIVE  ADMINIS-
   52  TRATIVE  REMEDY FOR ANY EMPLOYEE WHO IS DISCIPLINED OR ANY JOB APPLICANT
   53  WHO IS NOT HIRED PURSUANT  TO  THIS  TITLE.  HOWEVER,  NOTHING  IN  THIS
   54  SECTION SHALL AFFECT THE RIGHT OF AN EMPLOYEE OR JOB APPLICANT TO FILE A
   55  COLLECTIVE  BARGAINING GRIEVANCE PROVIDED THAT AN EMPLOYEE OR JOB APPLI-
   56  CANT MAY NOT FILE BOTH AN APPEAL AND A GRIEVANCE.
       A. 6447                            11
    1    (D) AN EMPLOYEE OR A JOB APPLICANT WHO HAS BEEN DISCIPLINED OR WHO HAS
    2  NOT BEEN HIRED PURSUANT TO THIS TITLE MUST EXHAUST EITHER  THE  ADMINIS-
    3  TRATIVE  APPEAL  PROCESS  OR COLLECTIVE BARGAINING GRIEVANCE-ARBITRATION
    4  PROCESS.
    5    (E) UPON RESOLVING AN APPEAL FILED PURSUANT TO SUBDIVISION (C) OF THIS
    6  SECTION,  AND  FINDING A VIOLATION OF THIS TITLE, THE APPROPRIATE AGENCY
    7  MAY ORDER THE FOLLOWING RELIEF:
    8    1. RESCIND THE DISCIPLINARY ACTION, EXPUNGE RELATED RECORDS  FROM  THE
    9  PERSONNEL  FILE  OF  THE  EMPLOYEE  OR  JOB  APPLICANT AND REINSTATE THE
   10  EMPLOYEE.
   11    2. ORDER COMPLIANCE WITH SUBDIVISION (G) OF SECTION  EIGHTY-FOUR-I  OF
   12  THIS TITLE.
   13    3. AWARD BACK PAY AND BENEFITS.
   14    4.  AWARD THE PREVAILING EMPLOYEE OR JOB APPLICANT THE NECESSARY COSTS
   15  OF THE APPEAL, REASONABLE ATTORNEY'S FEES, AND EXPERT WITNESS FEES.
   16    S 84-N. NONDISCIPLINE REMEDIES. (A) ANY PERSON ALLEGING A VIOLATION OF
   17  THE PROVISIONS OF THIS TITLE, THAT IS NOT REMEDIABLE BY THE  APPROPRIATE
   18  AGENCY OR AN ARBITRATOR PURSUANT TO SECTION EIGHTY-FOUR-M OF THIS TITLE,
   19  MUST INSTITUTE A CIVIL ACTION FOR INJUNCTIVE RELIEF OR DAMAGES, OR BOTH,
   20  IN  A  COURT OF COMPETENT JURISDICTION WITHIN ONE HUNDRED EIGHTY DAYS OF
   21  THE ALLEGED VIOLATION, OR BE BARRED FROM OBTAINING THE FOLLOWING RELIEF.
   22  RELIEF IS LIMITED TO:
   23    1. AN ORDER RESTRAINING THE CONTINUED VIOLATION OF THIS TITLE.
   24    2. AN AWARD OF THE COSTS OF LITIGATION, EXPERT WITNESS  FEES,  REASON-
   25  ABLE  ATTORNEY'S  FEES,  AND  NONECONOMIC  DAMAGES PROVIDED THAT DAMAGES
   26  SHALL BE LIMITED TO THE RECOVERY  OF  DAMAGES  DIRECTLY  RESULTING  FROM
   27  INJURY OR LOSS CAUSED BY EACH VIOLATION OF THIS TITLE.
   28    (B)  ANY EMPLOYER WHO COMPLIES WITH THE PROVISIONS OF THIS TITLE SHALL
   29  BE WITHOUT LIABILITY FOR ALL CIVIL ACTIONS ARISING FROM ANY DRUG TESTING
   30  PROGRAM OR PROCEDURE PERFORMED IN COMPLIANCE WITH THIS TITLE.
   31    (C) PURSUANT TO ANY CLAIM ALLEGING A VIOLATION OF THIS TITLE,  INCLUD-
   32  ING  A  CLAIM  UNDER  THIS  TITLE WHERE IT IS ALLEGED THAT AN EMPLOYER'S
   33  ACTION WITH RESPECT TO A PERSON WAS BASED ON AN INCORRECT  TEST  RESULT,
   34  THERE  SHALL  BE A REBUTTABLE PRESUMPTION THAT THE TEST WAS VALID IF THE
   35  EMPLOYER COMPLIED WITH THE PROVISIONS OF THIS TITLE.
   36    (D) NO CAUSE OF ACTION SHALL ARISE IN FAVOR OF ANY PERSON  BASED  UPON
   37  THE  FAILURE  OF  AN  EMPLOYER TO ESTABLISH A PROGRAM OR POLICY FOR DRUG
   38  TESTING.
   39    S 84-O. FEDERAL COMPLIANCE. THE DRUG TESTING  PROCEDURES  PROVIDED  IN
   40  THIS  TITLE  DO  NOT  APPLY  WHERE  THE SPECIFIC WORK PERFORMED REQUIRES
   41  EMPLOYEES OR JOB APPLICANTS TO BE SUBJECT TO DRUG TESTING PURSUANT TO:
   42    (A) FEDERAL REGULATIONS THAT  SPECIFICALLY  PREEMPT  STATE  AND  LOCAL
   43  REGULATION OF DRUG TESTING WITH RESPECT TO SUCH EMPLOYEES AND JOB APPLI-
   44  CANTS;
   45    (B)  FEDERAL  REGULATIONS  OR  REQUIREMENTS  ENACTED OR IMPLEMENTED IN
   46  CONNECTION WITH THE OPERATION OF FEDERALLY REGULATED FACILITIES;
   47    (C) FEDERAL CONTRACTS WHERE THE DRUG TESTING IS CONDUCTED FOR  SAFETY,
   48  OR PROTECTION OF SENSITIVE OR PROPRIETARY DATA OR NATIONAL SECURITY; OR
   49    (D)  STATE  AGENCY  RULES THAT ADOPT FEDERAL REGULATIONS APPLICABLE TO
   50  THE INTERSTATE COMPONENT OF A FEDERALLY REGULATED ACTIVITY.
   51    S 84-P. LICENSE FEE. FEES FROM LICENSURE OF DRUG TESTING  LABORATORIES
   52  SHALL  BE SUFFICIENT TO CARRY OUT THE RESPONSIBILITIES OF THE DEPARTMENT
   53  FOR THE REGULATION OF DRUG TESTING LABORATORIES.   THE DEPARTMENT  SHALL
   54  COLLECT  FEES FOR ALL LICENSES ISSUED UNDER THIS TITLE. THE FEE SCHEDULE
   55  FOR FISCAL YEAR TWO THOUSAND THIRTEEN--TWO THOUSAND FOURTEEN  SHALL  NOT
   56  EXCEED THE MAXIMUM FEES PROVIDED HEREIN AND SUCH SCHEDULE ADOPTED BY THE
       A. 6447                            12
    1  RULE  BY  THE  DEPARTMENT PURSUANT TO THIS TITLE. EACH NONREFUNDABLE FEE
    2  SHALL BE DUE AT THE TIME OF APPLICATION AND  SHALL  BE  PAYABLE  TO  THE
    3  DEPARTMENT  TO  BE DEPOSITED IN A TRUST FUND ADMINISTERED BY THE DEPART-
    4  MENT  AND  USED ONLY FOR THE PURPOSES OF THIS TITLE. THE FEE SCHEDULE IS
    5  AS FOLLOWS: FOR LICENSURE AS A DRUG TESTING LABORATORY, AN ANNUAL FEE OF
    6  NOT LESS THAN EIGHT THOUSAND DOLLARS OR MORE THAN TEN  THOUSAND  DOLLARS
    7  PER FISCAL YEAR; FOR LATE FILING OF AN APPLICATION FOR RENEWAL, AN ADDI-
    8  TIONAL FEE OF FIVE HUNDRED DOLLARS PER DAY SHALL BE CHARGED.
    9    S  2. The labor law is amended by adding a new article 15-A to read as
   10  follows:
   11                                ARTICLE 15-A
   12                         DRUG-FREE WORKPLACE PROGRAM
   13  SECTION 440. LEGISLATIVE INTENT; DRUG-FREE WORKPLACES.
   14          441. DRUG-FREE WORKPLACE PROGRAM REQUIREMENTS.
   15          442. PREFERENCE TO BUSINESSES WITH DRUG-FREE WORKPLACE PROGRAMS.
   16    S 440. LEGISLATIVE INTENT; DRUG-FREE WORKPLACES. IT IS THE  INTENT  OF
   17  THE  LEGISLATURE TO PROMOTE DRUG-FREE WORKPLACES IN ORDER THAT EMPLOYERS
   18  IN THE STATE BE AFFORDED THE OPPORTUNITY TO  MAXIMIZE  THEIR  LEVELS  OF
   19  PRODUCTIVITY,  ENHANCE  THEIR  COMPETITIVE POSITIONS IN THE MARKETPLACE,
   20  AND REACH THEIR DESIRED  LEVELS  OF  SUCCESS  WITHOUT  EXPERIENCING  THE
   21  COSTS,  DELAYS,  AND  TRAGEDIES  ASSOCIATED  WITH WORK-RELATED ACCIDENTS
   22  RESULTING FROM DRUG ABUSE BY EMPLOYEES. IT IS FURTHER THE INTENT OF  THE
   23  LEGISLATURE THAT DRUG ABUSE BE DISCOURAGED AND THAT EMPLOYEES WHO CHOOSE
   24  TO ENGAGE IN DRUG ABUSE FACE THE RISK OF UNEMPLOYMENT AND THE FORFEITURE
   25  OF WORKERS' COMPENSATION BENEFITS. IF AN EMPLOYER IMPLEMENTS A DRUG-FREE
   26  WORKPLACE  PROGRAM  WHICH  INCLUDES  NOTICE,  EDUCATION, AND TESTING FOR
   27  DRUGS AND ALCOHOL PURSUANT TO RULES DEVELOPED  BY  THE  DEPARTMENT,  THE
   28  EMPLOYER  MAY  REQUIRE THE EMPLOYEE TO SUBMIT TO A TEST FOR THE PRESENCE
   29  OF DRUGS AND ALCOHOL AND, IF A DRUG OR ALCOHOL IS FOUND TO BE PRESENT IN
   30  THE EMPLOYEE'S SYSTEM AT A LEVEL PRESCRIBED BY RULE ADOPTED PURSUANT  TO
   31  THIS  ARTICLE,  THE  EMPLOYEE  MAY  BE  TERMINATED AND SHALL FORFEIT HIS
   32  ELIGIBILITY FOR MEDICAL AND INDEMNITY BENEFITS UPON  EXHAUSTION  OF  THE
   33  PROCEDURES  PRESCRIBED  IN  THIS ARTICLE. HOWEVER, A DRUG-FREE WORKPLACE
   34  PROGRAM SHALL REQUIRE THE EMPLOYER TO NOTIFY ALL EMPLOYEES THAT IT IS  A
   35  CONDITION  OF  EMPLOYMENT TO REFRAIN FROM TAKING DRUGS ON OR OFF THE JOB
   36  AND IF THE INJURED WORKER REFUSES TO SUBMIT TO A TEST FOR DRUGS OR ALCO-
   37  HOL, HE FORFEITS HIS ELIGIBILITY FOR MEDICAL AND INDEMNITY BENEFITS.
   38    S 441. DRUG-FREE WORKPLACE PROGRAM REQUIREMENTS. THE  FOLLOWING  SHALL
   39  APPLY  TO  A  DRUG-FREE  WORKPLACE PROGRAM IMPLEMENTED PURSUANT TO RULES
   40  ADOPTED BY THE DEPARTMENT:
   41    1. DEFINITIONS. EXCEPT WHERE THE CONTEXT OTHERWISE REQUIRES,  AS  USED
   42  IN THIS ARTICLE:
   43    A.  "DRUG"  MEANS  ALCOHOL,  INCLUDING  DISTILLED  SPIRITS, WINE, MALT
   44  BEVERAGES,  AND  INTOXICATING   LIQUORS;   AMPHETAMINES;   CANNABINOIDS;
   45  COCAINE;  PHENCYCLIDINE  (PCP);  HALLUCINOGENS;  METHAQUALONE;  OPIATES;
   46  BARBITURATES; BENZODIAZEPHINES; SYNTHETIC NARCOTICS; DESIGNER DRUGS;  OR
   47  A METABOLITE OF ANY OF THE SUBSTANCES LISTED HEREIN.
   48    B.  "DRUG  TEST" OR "TEST" MEANS ANY CHEMICAL, BIOLOGICAL, OR PHYSICAL
   49  INSTRUMENTAL ANALYSIS ADMINISTERED FOR THE PURPOSE  OF  DETERMINING  THE
   50  PRESENCE OR ABSENCE OF A DRUG OR ITS METABOLITES.
   51    C.  "INITIAL  DRUG TEST" MEANS A SENSITIVE, RAPID, AND RELIABLE PROCE-
   52  DURE TO IDENTIFY NEGATIVE  AND  PRESUMPTIVE  POSITIVE  SPECIMENS.    ALL
   53  INITIAL  TESTS  SHALL  USE AN IMMUNOASSAY PROCEDURE OR AN EQUIVALENT, OR
   54  SHALL USE A MORE ACCURATE SCIENTIFICALLY ACCEPTED METHOD APPROVED BY THE
   55  OFFICE OF ALCOHOLISM AND SUBSTANCE ABUSE SERVICES AS SUCH MORE  ACCURATE
   56  TECHNOLOGY BECOMES AVAILABLE IN A COST-EFFECTIVE FORM.
       A. 6447                            13
    1    D.  "CONFIRMATION  TESTS",  "CONFIRMED TEST", OR "CONFIRMED DRUG TEST"
    2  MEANS A SECOND ANALYTICAL PROCEDURE USED TO IDENTIFY THE PRESENCE  OF  A
    3  SPECIFIC DRUG OR METABOLITE IN A SPECIMEN. THE CONFIRMATION TEST MUST BE
    4  DIFFERENT  IN  SCIENTIFIC PRINCIPLE FROM THAT OF THE INITIAL TEST PROCE-
    5  DURE.  THIS  CONFIRMATION  METHOD MUST BE CAPABLE OF PROVIDING REQUISITE
    6  SPECIFICITY, SENSITIVITY, AND QUANTITATIVE ACCURACY.
    7    E. "CHAIN OF CUSTODY" REFERS TO THE METHODOLOGY OF TRACKING  SPECIFIED
    8  MATERIALS  OR  SUBSTANCES  FOR  THE  PURPOSE  OF MAINTAINING CONTROL AND
    9  ACCOUNTABILITY FROM INITIAL COLLECTION TO FINAL DISPOSITION FOR ALL SUCH
   10  MATERIALS OR SUBSTANCES AND PROVIDING FOR ACCOUNTABILITY AT  EACH  STAGE
   11  IN HANDLING, TESTING, AND STORING SPECIMENS AND REPORTING TEST RESULTS.
   12    F.  "JOB APPLICANT" MEANS A PERSON WHO HAS APPLIED FOR A POSITION WITH
   13  AN EMPLOYER AND HAS BEEN OFFERED EMPLOYMENT CONDITIONED UPON SUCCESSFUL-
   14  LY PASSING A DRUG TEST.
   15    G. "EMPLOYEE" MEANS ANY PERSON WHO WORKS FOR SALARY, WAGES,  OR  OTHER
   16  REMUNERATION FOR AN EMPLOYER.
   17    H.  "EMPLOYER" MEANS A PERSON OR ENTITY THAT EMPLOYS A PERSON AND THAT
   18  IS COVERED BY THE WORKERS' COMPENSATION LAW.
   19    I. "PRESCRIPTION OR NONPRESCRIPTION MEDICATION" MEANS A DRUG OR  MEDI-
   20  CATION  OBTAINED  PURSUANT  TO  A  PRESCRIPTION  OR A MEDICATION THAT IS
   21  AUTHORIZED PURSUANT TO FEDERAL OR STATE LAW FOR GENERAL DISTRIBUTION AND
   22  USE WITHOUT A PRESCRIPTION IN THE TREATMENT OF HUMAN DISEASES, AILMENTS,
   23  OR INJURIES.
   24    J. "REASONABLE SUSPICION DRUG TESTING" MEANS DRUG TESTING BASED  ON  A
   25  BELIEF  THAT  AN EMPLOYEE IS USING OR HAS USED DRUGS IN VIOLATION OF THE
   26  EMPLOYER'S POLICY DRAWN FROM SPECIFIC OBJECTIVE  AND  ARTICULABLE  FACTS
   27  AND REASONABLE INFERENCES DRAWN FROM THOSE FACTS IN LIGHT OF EXPERIENCE.
   28  AMONG OTHER THINGS, SUCH FACTS AND INFERENCES MAY BE BASED UPON:
   29    (1)  OBSERVABLE PHENOMENA WHILE AT WORK, SUCH AS DIRECT OBSERVATION OF
   30  DRUG USE OR OF THE PHYSICAL SYMPTOMS OR MANIFESTATIONS  OF  BEING  UNDER
   31  THE INFLUENCE OF A DRUG.
   32    (2)  ABNORMAL  CONDUCT  OR ERRATIC BEHAVIOR WHILE AT WORK OR A SIGNIF-
   33  ICANT DETERIORATION IN WORK PERFORMANCE.
   34    (3) A REPORT OF DRUG USE, PROVIDED BY A RELIABLE AND CREDIBLE  SOURCE,
   35  WHICH HAS BEEN INDEPENDENTLY CORROBORATED.
   36    (4)  EVIDENCE  THAT AN INDIVIDUAL HAS TAMPERED WITH A DRUG TEST DURING
   37  HIS EMPLOYMENT WITH THE CURRENT EMPLOYER.
   38    (5) INFORMATION THAT AN EMPLOYEE HAS CAUSED,  OR  CONTRIBUTED  TO,  AN
   39  ACCIDENT WHILE AT WORK.
   40    (6) EVIDENCE THAT AN EMPLOYEE HAS USED, POSSESSED, SOLD, SOLICITED, OR
   41  TRANSFERRED  DRUGS  WHILE WORKING OR WHILE ON THE EMPLOYER'S PREMISES OR
   42  WHILE OPERATING THE EMPLOYER'S VEHICLE, MACHINERY, OR EQUIPMENT.
   43    K. "SPECIMEN" MEANS TISSUE, HAIR, OR PRODUCT OF THE HUMAN BODY CAPABLE
   44  OF REVEALING THE PRESENCE OF DRUGS OR THEIR METABOLITES.
   45    L. "EMPLOYEE ASSISTANCE PROGRAM"  MEANS  AN  ESTABLISHED  PROGRAM  FOR
   46  EMPLOYEE ASSESSMENT, COUNSELING, AND POSSIBLE REFERRAL TO AN ALCOHOL AND
   47  DRUG REHABILITATION PROGRAM.
   48    2.  DRUG  TESTING. ALL DRUG TESTING CONDUCTED BY EMPLOYERS SHALL BE IN
   49  CONFORMITY WITH THE STANDARDS ESTABLISHED IN THIS SECTION AND ALL APPLI-
   50  CABLE RULES ADOPTED PURSUANT TO THIS SECTION. HOWEVER,  EMPLOYERS  SHALL
   51  NOT  HAVE  A LEGAL DUTY UNDER THIS SECTION TO REQUEST AN EMPLOYEE OR JOB
   52  APPLICANT TO UNDERGO DRUG TESTING.
   53    3. NOTICE TO EMPLOYEES AND  JOB  APPLICANTS.  PRIOR  TO  TESTING,  ALL
   54  EMPLOYEES  AND  JOB  APPLICANTS  FOR  EMPLOYMENT MUST BE GIVEN A WRITTEN
   55  POLICY STATEMENT FROM THE EMPLOYER WHICH CONTAINS:
       A. 6447                            14
    1    A. A GENERAL STATEMENT OF THE EMPLOYER'S POLICY ON EMPLOYEE DRUG  USE,
    2  WHICH SHALL IDENTIFY:
    3    (1)  THE TYPES OF TESTING AN EMPLOYEE OR JOB APPLICANT MAY BE REQUIRED
    4  TO SUBMIT TO, INCLUDING REASONABLE SUSPICION OR OTHER BASIS; AND
    5    (2) THE ACTIONS THE EMPLOYER MAY  TAKE  AGAINST  AN  EMPLOYEE  OR  JOB
    6  APPLICANT ON THE BASIS OF A POSITIVE CONFIRMED DRUG TEST RESULT.
    7    B. A STATEMENT ADVISING THE EMPLOYEE OR JOB APPLICANT OF THE EXISTENCE
    8  OF THIS SECTION.
    9    C. A GENERAL STATEMENT CONCERNING CONFIDENTIALITY.
   10    D.  PROCEDURES  FOR  EMPLOYEES  AND  JOB  APPLICANTS TO CONFIDENTIALLY
   11  REPORT THE USE  OF  PRESCRIPTION  OR  NONPRESCRIPTION  MEDICATIONS  BOTH
   12  BEFORE  AND  AFTER  BEING TESTED. ADDITIONALLY, EMPLOYEES AND JOB APPLI-
   13  CANTS SHALL RECEIVE NOTICE OF THE MOST COMMON MEDICATIONS BY BRAND  NAME
   14  OR  COMMON  NAME,  AS APPLICABLE, AS WELL AS BY CHEMICAL NAME, WHICH MAY
   15  ALTER OR AFFECT A DRUG TEST. A LIST OF SUCH MEDICATIONS AS DEVELOPED  BY
   16  THE OFFICE OF ALCOHOLISM AND SUBSTANCE ABUSE SERVICES SHALL BE AVAILABLE
   17  TO EMPLOYERS THROUGH THE DEPARTMENT.
   18    E. THE CONSEQUENCES OF REFUSING TO SUBMIT TO A DRUG TEST.
   19    F.  NAMES,  ADDRESSES,  AND  TELEPHONE  NUMBERS OF EMPLOYEE ASSISTANCE
   20  DEPARTMENTS AND LOCAL ALCOHOL AND DRUG REHABILITATION PROGRAMS.
   21    G. A STATEMENT THAT AN EMPLOYEE OR JOB APPLICANT WHO RECEIVES A  POSI-
   22  TIVE CONFIRMED DRUG TEST RESULT MAY CONTEST OR EXPLAIN THE RESULT TO THE
   23  EMPLOYER  WITHIN  FIVE  WORKING  DAYS  AFTER WRITTEN NOTIFICATION OF THE
   24  POSITIVE TEST RESULT. IF AN EMPLOYEE'S OR JOB APPLICANT'S EXPLANATION OR
   25  CHALLENGE IS UNSATISFACTORY TO THE EMPLOYER, THE PERSON MAY CONTEST  THE
   26  DRUG TEST RESULT PURSUANT TO RULES ADOPTED BY THE DEPARTMENT.
   27    H.  A STATEMENT INFORMING THE EMPLOYEE OR JOB APPLICANT OF HIS RESPON-
   28  SIBILITY TO NOTIFY THE LABORATORY OF ANY ADMINISTRATIVE OR CIVIL  ACTION
   29  BROUGHT PURSUANT TO THIS SECTION.
   30    I.  A LIST OF ALL DRUGS FOR WHICH THE EMPLOYER WILL TEST, DESCRIBED BY
   31  BRAND NAMES OR COMMON NAMES, AS  APPLICABLE,  AS  WELL  AS  BY  CHEMICAL
   32  NAMES.
   33    J.  A  STATEMENT REGARDING ANY APPLICABLE COLLECTIVE BARGAINING AGREE-
   34  MENT OR CONTRACT AND THE RIGHT TO APPEAL TO THE DEPARTMENT OR APPLICABLE
   35  COURT.
   36    K. A STATEMENT NOTIFYING EMPLOYEES AND JOB APPLICANTS OF  THEIR  RIGHT
   37  TO  CONSULT  THE  TESTING LABORATORY FOR TECHNICAL INFORMATION REGARDING
   38  PRESCRIPTION AND NONPRESCRIPTION MEDICATION.
   39    L. AN EMPLOYER NOT HAVING A DRUG TESTING PROGRAM SHALL ENSURE THAT  AT
   40  LEAST SIXTY DAYS ELAPSE BETWEEN A GENERAL ONE-TIME NOTICE TO ALL EMPLOY-
   41  EES  THAT  A DRUG TESTING PROGRAM IS BEING IMPLEMENTED AND THE BEGINNING
   42  OF ACTUAL DRUG TESTING. AN EMPLOYER HAVING A  DRUG  TESTING  PROGRAM  IN
   43  PLACE  PRIOR  TO  THE  EFFECTIVE DATE OF THIS SECTION IS NOT REQUIRED TO
   44  PROVIDE A SIXTY-DAY NOTICE PERIOD.
   45    M. AN EMPLOYER  SHALL  INCLUDE  NOTICE  OF  DRUG  TESTING  ON  VACANCY
   46  ANNOUNCEMENTS  FOR THOSE POSITIONS FOR WHICH DRUG TESTING IS REQUIRED. A
   47  NOTICE OF THE EMPLOYER'S DRUG TESTING POLICY MUST ALSO BE POSTED  IN  AN
   48  APPROPRIATE  AND  CONSPICUOUS  LOCATION  ON THE EMPLOYER'S PREMISES, AND
   49  COPIES OF THE POLICY MUST BE MADE AVAILABLE FOR INSPECTION BY THE GENER-
   50  AL PUBLIC DURING REGULAR BUSINESS  HOURS  IN  THE  EMPLOYER'S  PERSONNEL
   51  OFFICE OR OTHER SUITABLE LOCATIONS.
   52    4.  TYPES OF TESTING. AN EMPLOYER IS REQUIRED TO CONDUCT THE FOLLOWING
   53  TYPES OF DRUG TESTS IN  ORDER  TO  QUALIFY  FOR  PREFERENTIAL  TREATMENT
   54  PROVIDED BY SECTION FOUR HUNDRED FORTY-TWO OF THIS ARTICLE.
   55    A.  JOB  APPLICANT TESTING. AN EMPLOYER MUST REQUIRE JOB APPLICANTS TO
   56  SUBMIT TO A DRUG TEST AND MAY USE A REFUSAL TO SUBMIT TO A DRUG TEST  OR
       A. 6447                            15
    1  A  POSITIVE  CONFIRMED  DRUG TEST AS A BASIS FOR REFUSAL TO HIRE THE JOB
    2  APPLICANT.
    3    B.  REASONABLE  SUSPICION.  AN  EMPLOYER  MUST  REQUIRE AN EMPLOYEE TO
    4  SUBMIT TO REASONABLE SUSPICION DRUG TESTING.
    5    C. ROUTINE FITNESS-FOR-DUTY. AN EMPLOYER MUST REQUIRE AN  EMPLOYEE  TO
    6  SUBMIT  TO  A  DRUG TEST IF THE TEST IS CONDUCTED AS PART OF A ROUTINELY
    7  SCHEDULED EMPLOYEE FITNESS-FOR-DUTY MEDICAL EXAMINATION THAT IS PART  OF
    8  THE EMPLOYER'S ESTABLISHED POLICY OR THAT IS SCHEDULED ROUTINELY FOR ALL
    9  MEMBERS OF AN EMPLOYMENT CLASSIFICATION OR GROUP.
   10    D.  FOLLOW-UP  TESTING.  IF  THE  EMPLOYEE IN THE COURSE OF EMPLOYMENT
   11  ENTERS AN EMPLOYEE ASSISTANCE PROGRAM FOR DRUG-RELATED PROBLEMS,  OR  AN
   12  ALCOHOL  AND  DRUG REHABILITATION PROGRAM, THE EMPLOYER MUST REQUIRE THE
   13  EMPLOYEE TO SUBMIT TO A DRUG TEST AS A FOLLOW-UP TO SUCH PROGRAM, AND ON
   14  A QUARTERLY, SEMIANNUAL, OR ANNUAL BASIS FOR UP TO TWO YEARS THEREAFTER.
   15    5. PROCEDURES AND EMPLOYEE PROTECTION.  ALL  SPECIMEN  COLLECTION  AND
   16  TESTING  FOR  DRUGS  UNDER THIS SECTION SHALL BE PERFORMED IN ACCORDANCE
   17  WITH THE FOLLOWING PROCEDURES:
   18    A. A SAMPLE SHALL BE COLLECTED WITH DUE REGARD TO THE PRIVACY  OF  THE
   19  INDIVIDUAL  PROVIDING  THE SAMPLE, AND IN A MANNER REASONABLY CALCULATED
   20  TO PREVENT SUBSTITUTION OR CONTAMINATION OF THE SAMPLE.
   21    B. SPECIMEN COLLECTION SHALL  BE  DOCUMENTED,  AND  THE  DOCUMENTATION
   22  PROCEDURES SHALL INCLUDE:
   23    (1)  LABELING  OF SPECIMEN CONTAINERS SO AS TO REASONABLY PRECLUDE THE
   24  LIKELIHOOD OF ERRONEOUS IDENTIFICATION OF TEST RESULTS.
   25    (2) A FORM FOR THE EMPLOYEE OR JOB APPLICANT TO PROVIDE  ANY  INFORMA-
   26  TION  HE  CONSIDERS  RELEVANT  TO  THE TEST, INCLUDING IDENTIFICATION OF
   27  CURRENTLY OR RECENTLY USED PRESCRIPTION OR NONPRESCRIPTION MEDICATION OR
   28  OTHER RELEVANT MEDICAL INFORMATION. SUCH FORM SHALL  PROVIDE  NOTICE  OF
   29  THE MOST COMMON MEDICATIONS BY BRAND NAME OR COMMON NAME, AS APPLICABLE,
   30  AS WELL AS BY CHEMICAL NAME, WHICH MAY ALTER OR AFFECT A DRUG TEST.  THE
   31  PROVIDING  OF  INFORMATION  SHALL NOT PRECLUDE THE ADMINISTRATION OF THE
   32  DRUG TEST, BUT SHALL BE TAKEN INTO ACCOUNT IN INTERPRETING ANY  POSITIVE
   33  CONFIRMED RESULTS.
   34    C.  SPECIMEN  COLLECTION,  STORAGE,  AND TRANSPORTATION TO THE TESTING
   35  SITE SHALL BE PERFORMED IN A MANNER WHICH WILL REASONABLY PRECLUDE SPEC-
   36  IMEN CONTAMINATION OR ADULTERATION.
   37    D. EACH INITIAL AND CONFIRMATION TEST CONDUCTED  UNDER  THIS  SECTION,
   38  NOT INCLUDING THE TAKING OR COLLECTING OF A SPECIMEN TO BE TESTED, SHALL
   39  BE  CONDUCTED  BY A LICENSED LABORATORY AS DESCRIBED IN SUBDIVISION NINE
   40  OF THIS SECTION.
   41    E. A SPECIMEN FOR A DRUG TEST MAY BE TAKEN OR COLLECTED BY ANY OF  THE
   42  FOLLOWING PERSONS:
   43    (1)  A  PHYSICIAN,  A  PHYSICIAN  ASSISTANT, A REGISTERED PROFESSIONAL
   44  NURSE, A LICENSED PRACTICAL NURSE, OR A NURSE PRACTITIONER OR  A  CERTI-
   45  FIED  PARAMEDIC  WHO  IS  PRESENT  AT  THE  SCENE OF AN ACCIDENT FOR THE
   46  PURPOSE OF RENDERING EMERGENCY MEDICAL SERVICE OR TREATMENT.
   47    (2) A QUALIFIED PERSON EMPLOYED BY A LICENSED LABORATORY.
   48    F. A PERSON WHO COLLECTS OR TAKES A SPECIMEN FOR A DRUG TEST CONDUCTED
   49  PURSUANT TO THIS SECTION SHALL COLLECT AN AMOUNT SUFFICIENT FOR TWO DRUG
   50  TESTS AS DETERMINED BY THE OFFICE  OF  ALCOHOLISM  AND  SUBSTANCE  ABUSE
   51  SERVICES.
   52    G.  EVERY  SPECIMEN THAT PRODUCES A POSITIVE CONFIRMED RESULT SHALL BE
   53  PRESERVED BY THE LICENSED LABORATORY THAT CONDUCTS THE CONFIRMATION TEST
   54  FOR A PERIOD OF AT LEAST TWO HUNDRED TEN DAYS AFTER THE RESULTS  OF  THE
   55  POSITIVE  CONFIRMATION  TEST  ARE  MAILED  OR OTHERWISE DELIVERED TO THE
   56  EMPLOYER.  HOWEVER, IF AN EMPLOYEE OR JOB APPLICANT UNDERTAKES AN ADMIN-
       A. 6447                            16
    1  ISTRATIVE OR LEGAL CHALLENGE TO THE TEST RESULT,  THE  EMPLOYEE  OR  JOB
    2  APPLICANT  SHALL  NOTIFY THE LABORATORY AND THE SAMPLE SHALL BE RETAINED
    3  BY THE LABORATORY UNTIL THE CASE OR ADMINISTRATIVE  APPEAL  IS  SETTLED.
    4  DURING THE ONE HUNDRED EIGHTY DAY PERIOD AFTER WRITTEN NOTIFICATION OF A
    5  POSITIVE TEST RESULT, THE EMPLOYEE OR JOB APPLICANT WHO HAS PROVIDED THE
    6  SPECIMEN  SHALL  BE  PERMITTED  BY THE EMPLOYER TO HAVE A PORTION OF THE
    7  SPECIMEN RETESTED, AT THE EMPLOYEE'S  OR  JOB  APPLICANT'S  EXPENSE,  AT
    8  ANOTHER  LABORATORY,  LICENSED  AND APPROVED BY THE OFFICE OF ALCOHOLISM
    9  AND SUBSTANCE ABUSE SERVICES, CHOSEN BY THE EMPLOYEE OR  JOB  APPLICANT.
   10  THE  SECOND LABORATORY MUST TEST AT EQUAL OR GREATER SENSITIVITY FOR THE
   11  DRUG IN QUESTION AS THE FIRST LABORATORY.  THE  FIRST  LABORATORY  WHICH
   12  PERFORMED  THE TEST FOR THE EMPLOYER SHALL BE RESPONSIBLE FOR THE TRANS-
   13  FER OF THE PORTION OF THE SPECIMEN TO BE RETESTED, AND FOR THE INTEGRITY
   14  OF THE CHAIN OF CUSTODY DURING SUCH TRANSFER.
   15    H. WITHIN FIVE WORKING DAYS AFTER RECEIPT OF A POSITIVE CONFIRMED TEST
   16  RESULT FROM THE TESTING LABORATORY, AN EMPLOYER SHALL INFORM AN EMPLOYEE
   17  OR JOB APPLICANT IN WRITING OF SUCH POSITIVE  TEST  RESULT,  THE  CONSE-
   18  QUENCES  OF  SUCH  RESULTS, AND THE OPTIONS AVAILABLE TO THE EMPLOYEE OR
   19  JOB APPLICANT.
   20    I. THE EMPLOYER SHALL PROVIDE TO THE EMPLOYEE OR JOB  APPLICANT,  UPON
   21  REQUEST, A COPY OF THE TEST RESULTS.
   22    J.  WITHIN  FIVE  WORKING  DAYS  AFTER  RECEIVING NOTICE OF A POSITIVE
   23  CONFIRMED TEST RESULT, THE EMPLOYEE OR JOB APPLICANT MAY SUBMIT INFORMA-
   24  TION TO AN EMPLOYER EXPLAINING OR CONTESTING THE TEST RESULTS,  AND  WHY
   25  THE RESULTS DO NOT CONSTITUTE A VIOLATION OF THE EMPLOYER'S POLICY.
   26    K.  IF  THE  EMPLOYEE'S OR JOB APPLICANT'S EXPLANATION OR CHALLENGE OF
   27  THE POSITIVE TEST RESULTS IS UNSATISFACTORY TO THE EMPLOYER,  A  WRITTEN
   28  EXPLANATION  AS  TO WHY THE EMPLOYEE'S OR JOB APPLICANT'S EXPLANATION IS
   29  UNSATISFACTORY, ALONG WITH THE  REPORT  OF  POSITIVE  RESULTS  SHALL  BE
   30  PROVIDED  BY  THE EMPLOYER TO THE EMPLOYEE OR JOB APPLICANT AND ALL SUCH
   31  DOCUMENTATION SHALL BE KEPT CONFIDENTIAL BY  THE  EMPLOYER  PURSUANT  TO
   32  SUBDIVISION  EIGHT OF THIS SECTION AND SHALL BE RETAINED BY THE EMPLOYER
   33  FOR AT LEAST ONE YEAR.
   34    L. NO EMPLOYER MAY DISCHARGE, DISCIPLINE, REFUSE TO HIRE, DISCRIMINATE
   35  AGAINST, OR REQUEST OR REQUIRE REHABILITATION  OF  AN  EMPLOYEE  OR  JOB
   36  APPLICANT  ON THE SOLE BASIS OF A POSITIVE TEST RESULT THAT HAS NOT BEEN
   37  VERIFIED BY A CONFIRMATION TEST.
   38    M. AN EMPLOYER WHO PERFORMS DRUG TESTING OR SPECIMEN COLLECTION  SHALL
   39  USE CHAIN OF CUSTODY PROCEDURES AS ESTABLISHED BY THE OFFICE OF ALCOHOL-
   40  ISM  AND SUBSTANCE ABUSE SERVICES TO ENSURE PROPER RECORDKEEPING, HANDL-
   41  ING, LABELING, AND IDENTIFICATION OF ALL SPECIMENS TO BE TESTED.
   42    N. AN EMPLOYER SHALL PAY THE COST  OF  ALL  DRUG  TESTS,  INITIAL  AND
   43  CONFIRMATION, WHICH HE REQUIRES OF EMPLOYEES.
   44    O.  AN EMPLOYEE OR JOB APPLICANT SHALL PAY THE COSTS OF ANY ADDITIONAL
   45  DRUG TESTS NOT REQUIRED BY THE EMPLOYER.
   46    P. NO EMPLOYER SHALL DISCHARGE, DISCIPLINE, OR DISCRIMINATE AGAINST AN
   47  EMPLOYEE SOLELY UPON THE EMPLOYEE'S VOLUNTARILY SEEKING TREATMENT, WHILE
   48  UNDER THE EMPLOY OF THE EMPLOYER, FOR  A  DRUG-RELATED  PROBLEM  IF  THE
   49  EMPLOYEE  HAS  NOT  PREVIOUSLY  TESTED POSITIVE FOR DRUG USE, ENTERED AN
   50  EMPLOYEE ASSISTANCE PROGRAM FOR DRUG-RELATED  PROBLEMS,  OR  ENTERED  AN
   51  ALCOHOL AND DRUG REHABILITATION PROGRAM.
   52    Q. IF TESTING IS CONDUCTED BASED ON REASONABLE SUSPICION, THE EMPLOYER
   53  SHALL  PROMPTLY  DETAIL  IN  WRITING  THE CIRCUMSTANCES WHICH FORMED THE
   54  BASIS OF THE DETERMINATION THAT REASONABLE SUSPICION EXISTED TO  WARRANT
   55  THE TESTING. A COPY OF THIS DOCUMENTATION SHALL BE GIVEN TO THE EMPLOYEE
   56  UPON  REQUEST  AND THE ORIGINAL DOCUMENTATION SHALL BE KEPT CONFIDENTIAL
       A. 6447                            17
    1  BY THE EMPLOYER PURSUANT TO SUBDIVISION EIGHT OF THIS SECTION AND  SHALL
    2  BE RETAINED BY THE EMPLOYER FOR AT LEAST ONE YEAR.
    3    6.  CONFIRMATION TESTING.  A. IF AN INITIAL DRUG TEST IS NEGATIVE, THE
    4  EMPLOYER MAY IN ITS SOLE DISCRETION SEEK A CONFIRMATION TEST.
    5    B. ONLY LICENSED LABORATORIES AS DESCRIBED IN SUBDIVISION NINE OF THIS
    6  SECTION SHALL CONDUCT CONFIRMATION DRUG TESTS.
    7    C.  ALL  POSITIVE  INITIAL  TESTS  SHALL  BE   CONFIRMED   USING   GAS
    8  CHROMATOGRAPHY/MASS  SPECTROMETRY (GC/MS) OR AN EQUIVALENT OR MORE ACCU-
    9  RATE SCIENTIFICALLY ACCEPTED METHOD APPROVED BY THE OFFICE OF ALCOHOLISM
   10  AND SUBSTANCE ABUSE AS SUCH TECHNOLOGY BECOMES AVAILABLE IN  A  COST-EF-
   11  FECTIVE FORM.
   12    7. EMPLOYER PROTECTION.
   13    A. NO EMPLOYEE OR JOB APPLICANT WHOSE DRUG TEST RESULT IS CONFIRMED AS
   14  POSITIVE  IN  ACCORDANCE  WITH  THE PROVISIONS OF THIS SECTION SHALL, BY
   15  VIRTUE OF THE RESULT ALONE, BE DEFINED AS A PERSON HAVING A DISABILITY.
   16    B. AN EMPLOYER WHO DISCHARGES OR DISCIPLINES AN EMPLOYEE OR REFUSES TO
   17  HIRE A JOB APPLICANT IN COMPLIANCE WITH THIS SECTION SHALL BE CONSIDERED
   18  TO HAVE DISCHARGED, DISCIPLINED, OR REFUSED TO HIRE FOR CAUSE.
   19    C. NO PHYSICIAN-PATIENT RELATIONSHIP IS CREATED BETWEEN AN EMPLOYEE OR
   20  JOB APPLICANT AND AN EMPLOYER OR ANY PERSON PERFORMING OR  EVALUATING  A
   21  DRUG  TEST,  SOLELY  BY  THE  ESTABLISHMENT, IMPLEMENTATION, OR ADMINIS-
   22  TRATION OF A DRUG TESTING PROGRAM.
   23    D. NOTHING IN THIS SECTION SHALL BE CONSTRUED TO PREVENT  AN  EMPLOYER
   24  FROM  ESTABLISHING REASONABLE WORK RULES RELATED TO EMPLOYEE POSSESSION,
   25  USE, SALE, OR SOLICITATION OF DRUGS, INCLUDING CONVICTIONS FOR  DRUG-RE-
   26  LATED OFFENSES, AND TAKING ACTION BASED UPON A VIOLATION OF ANY OF THOSE
   27  RULES.
   28    E.  NOTHING IN THIS SECTION SHALL BE CONSTRUED TO OPERATE RETROACTIVE-
   29  LY, AND NOTHING IN THIS SECTION SHALL ABROGATE THE RIGHT OF AN  EMPLOYER
   30  UNDER  STATE LAW TO CONDUCT DRUG TESTS, OR IMPLEMENT EMPLOYEE DRUG TEST-
   31  ING PROGRAMS, PRIOR TO JANUARY FIRST, TWO THOUSAND FOURTEEN.
   32    F. IF AN EMPLOYEE OR JOB APPLICANT REFUSES TO SUBMIT TO A  DRUG  TEST,
   33  THE  EMPLOYER  SHALL  NOT BE BARRED FROM DISCHARGING OR DISCIPLINING THE
   34  EMPLOYEE OR FROM REFUSING TO HIRE THE JOB APPLICANT. HOWEVER, NOTHING IN
   35  THIS PARAGRAPH SHALL ABROGATE THE RIGHTS AND REMEDIES OF THE EMPLOYEE OR
   36  JOB APPLICANT AS OTHERWISE PROVIDED IN THIS SECTION.
   37    G. NOTHING IN THIS SECTION SHALL BE CONSTRUED TO PROHIBIT AN  EMPLOYER
   38  FROM  CONDUCTING  MEDICAL SCREENING OR OTHER TESTS REQUIRED BY ANY STAT-
   39  UTE, RULE, OR REGULATION FOR  THE  PURPOSE  OF  MONITORING  EXPOSURE  OF
   40  EMPLOYEES  TO TOXIC OR OTHER UNHEALTHY SUBSTANCES IN THE WORKPLACE OR IN
   41  THE PERFORMANCE OF JOB RESPONSIBILITIES. SUCH SCREENING OR  TESTS  SHALL
   42  BE LIMITED TO THE SPECIFIC SUBSTANCES EXPRESSLY IDENTIFIED IN THE APPLI-
   43  CABLE  STATUTE, RULE, OR REGULATION, UNLESS PRIOR WRITTEN CONSENT OF THE
   44  EMPLOYEE IS OBTAINED FOR OTHER TESTS.
   45    8. CONFIDENTIALITY.  A. ALL INFORMATION, INTERVIEWS,  REPORTS,  STATE-
   46  MENTS,  MEMORANDA,  AND DRUG TEST RESULTS, WRITTEN OR OTHERWISE RECEIVED
   47  BY THE EMPLOYER THROUGH A DRUG TESTING PROGRAM ARE CONFIDENTIAL COMMUNI-
   48  CATIONS AND MAY NOT BE USED OR RECEIVED IN EVIDENCE, OBTAINED IN DISCOV-
   49  ERY, OR DISCLOSED IN  ANY  PUBLIC  OR  PRIVATE  PROCEEDINGS,  EXCEPT  IN
   50  ACCORDANCE WITH THIS SECTION.
   51    B.  EMPLOYERS,  LABORATORIES,  EMPLOYEE  ASSISTANCE PROGRAMS, DRUG AND
   52  ALCOHOL REHABILITATION PROGRAMS, AND THEIR AGENTS WHO  RECEIVE  OR  HAVE
   53  ACCESS TO INFORMATION CONCERNING DRUG TEST RESULTS SHALL KEEP ALL INFOR-
   54  MATION CONFIDENTIAL. RELEASE OF SUCH INFORMATION UNDER ANY OTHER CIRCUM-
   55  STANCE  SHALL BE SOLELY PURSUANT TO A WRITTEN CONSENT FORM SIGNED VOLUN-
   56  TARILY BY THE PERSON TESTED, UNLESS  SUCH  RELEASE  IS  COMPELLED  BY  A
       A. 6447                            18
    1  HEARING  OFFICER  OR  A  COURT  OF COMPETENT JURISDICTION PURSUANT TO AN
    2  APPEAL TAKEN UNDER THIS SECTION,  OR  UNLESS  DEEMED  APPROPRIATE  BY  A
    3  PROFESSIONAL  OR  OCCUPATIONAL LICENSING BOARD IN A RELATED DISCIPLINARY
    4  PROCEEDING.  THE CONSENT FORM MUST CONTAIN, AT A MINIMUM:
    5    (1)  THE  NAME  OF THE PERSON WHO IS AUTHORIZED TO OBTAIN THE INFORMA-
    6  TION.
    7    (2) THE PURPOSE OF THE DISCLOSURE.
    8    (3) THE PRECISE INFORMATION TO BE DISCLOSED.
    9    (4) THE DURATION OF THE CONSENT.
   10    (5) THE SIGNATURE OF THE PERSON AUTHORIZING RELEASE  OF  THE  INFORMA-
   11  TION.
   12    C.  INFORMATION  ON DRUG TEST RESULTS SHALL NOT BE RELEASED OR USED IN
   13  ANY CRIMINAL PROCEEDING AGAINST THE EMPLOYEE OR JOB APPLICANT.  INFORMA-
   14  TION RELEASED CONTRARY TO THIS SECTION SHALL BE INADMISSIBLE AS EVIDENCE
   15  IN ANY SUCH CRIMINAL PROCEEDING.
   16    D.  NOTHING  HEREIN SHALL BE CONSTRUED TO PROHIBIT THE EMPLOYER, AGENT
   17  OF THE EMPLOYER, OR LABORATORY CONDUCTING A DRUG TEST FROM HAVING ACCESS
   18  TO EMPLOYEE DRUG TEST INFORMATION WHEN CONSULTING WITH LEGAL COUNSEL  IN
   19  CONNECTION WITH ACTIONS BROUGHT UNDER OR RELATED TO THIS SECTION OR WHEN
   20  THE  INFORMATION IS RELEVANT TO ITS DEFENSE IN A CIVIL OR ADMINISTRATIVE
   21  MATTER.
   22    9. DRUG TESTING STANDARDS; LABORATORIES.  A. NO LABORATORY MAY ANALYZE
   23  INITIAL OR CONFIRMATION DRUG SPECIMENS UNLESS:
   24    (1) THE LABORATORY IS LICENSED AND APPROVED BY THE OFFICE OF  ALCOHOL-
   25  ISM  AND  SUBSTANCE  ABUSE  SERVICES  USING  CRITERIA ESTABLISHED BY THE
   26  NATIONAL INSTITUTE ON DRUG ABUSE AS GUIDELINES FOR  MODELING  THE  STATE
   27  DRUG TESTING PROGRAM PURSUANT TO THIS SECTION.
   28    (2)  THE  LABORATORY  HAS  WRITTEN  PROCEDURES  TO ENSURE THE CHAIN OF
   29  CUSTODY.
   30    (3) THE LABORATORY FOLLOWS PROPER QUALITY CONTROL PROCEDURES,  INCLUD-
   31  ING, BUT NOT LIMITED TO:
   32    (A)  THE USE OF INTERNAL QUALITY CONTROLS INCLUDING THE USE OF SAMPLES
   33  OF KNOWN CONCENTRATIONS WHICH ARE USED  TO  CHECK  THE  PERFORMANCE  AND
   34  CALIBRATION  OF TESTING EQUIPMENT, AND PERIODIC USE OF BLIND SAMPLES FOR
   35  OVERALL ACCURACY.
   36    (B) AN  INTERNAL  REVIEW  AND  CERTIFICATION  PROCESS  FOR  DRUG  TEST
   37  RESULTS, CONDUCTED BY A PERSON QUALIFIED TO PERFORM THAT FUNCTION IN THE
   38  TESTING LABORATORY.
   39    (C)  SECURITY  MEASURES  IMPLEMENTED  BY  THE  TESTING  LABORATORY  TO
   40  PRECLUDE ADULTERATION OF SPECIMENS AND DRUG TEST RESULTS.
   41    (D) OTHER NECESSARY AND PROPER ACTIONS TAKEN TO  ENSURE  RELIABLE  AND
   42  ACCURATE DRUG TEST RESULTS.
   43    B.  A  LABORATORY SHALL DISCLOSE TO THE EMPLOYER A WRITTEN TEST RESULT
   44  REPORT WITHIN SEVEN WORKING DAYS AFTER RECEIPT OF THE SAMPLE. ALL  LABO-
   45  RATORY REPORTS OF A DRUG TEST RESULT SHALL, AT A MINIMUM, STATE:
   46    (1)  THE  NAME  AND ADDRESS OF THE LABORATORY WHICH PERFORMED THE TEST
   47  AND THE POSITIVE IDENTIFICATION OF THE PERSON TESTED.
   48    (2) POSITIVE RESULTS ON CONFIRMATION TESTS ONLY, OR NEGATIVE  RESULTS,
   49  AS APPLICABLE.
   50    (3) A LIST OF THE DRUGS FOR WHICH THE DRUG ANALYSES WERE CONDUCTED.
   51    (4)  THE  TYPE  OF  TESTS  CONDUCTED FOR BOTH INITIAL AND CONFIRMATION
   52  TESTS AND THE MINIMUM CUT OFF LEVELS OF THE TESTS.
   53    (5) ANY CORRELATION BETWEEN MEDICATION REPORTED BY THE EMPLOYEE OR JOB
   54  APPLICANT PURSUANT TO SUBPARAGRAPH TWO OF  PARAGRAPH  B  OF  SUBDIVISION
   55  FIVE  OF  THIS  SECTION,  AND  A POSITIVE CONFIRMED DRUG TEST RESULT. NO
       A. 6447                            19
    1  REPORT SHALL DISCLOSE THE PRESENCE OR ABSENCE OF ANY DRUG OTHER  THAN  A
    2  SPECIFIC DRUG AND ITS METABOLITES LISTED PURSUANT TO THIS SECTION.
    3    C.  THE  LABORATORY  SHALL  SUBMIT  TO  THE  OFFICE  OF ALCOHOLISM AND
    4  SUBSTANCE ABUSE SERVICES A MONTHLY REPORT WITH  STATISTICAL  INFORMATION
    5  REGARDING THE TESTING OF EMPLOYEES AND JOB APPLICANTS.  THE REPORT SHALL
    6  INCLUDE  INFORMATION  ON  THE  METHODS  OF ANALYSES CONDUCTED, THE DRUGS
    7  TESTED FOR, THE NUMBER OF POSITIVE AND NEGATIVE RESULTS FOR BOTH INITIAL
    8  AND CONFIRMATION TESTS, AND ANY OTHER INFORMATION DEEMED APPROPRIATE  BY
    9  THE OFFICE OF ALCOHOLISM AND SUBSTANCE ABUSE SERVICES. NO MONTHLY REPORT
   10  SHALL IDENTIFY SPECIFIC EMPLOYEES OR JOB APPLICANTS.
   11    D.  LABORATORIES  SHALL  PROVIDE TECHNICAL ASSISTANCE TO THE EMPLOYER,
   12  EMPLOYEE, OR JOB APPLICANT FOR THE PURPOSE OF INTERPRETING ANY  POSITIVE
   13  CONFIRMED  TEST  RESULTS WHICH COULD HAVE BEEN CAUSED BY PRESCRIPTION OR
   14  NONPRESCRIPTION MEDICATION TAKEN BY THE EMPLOYEE OR JOB APPLICANT.
   15    10. RULES.  A. THE DEPARTMENT SHALL ADOPT RULES USING RULES ADOPTED BY
   16  THE OFFICE OF ALCOHOLISM AND SUBSTANCE ABUSE SERVICES PURSUANT TO  TITLE
   17  F  OF  ARTICLE FIVE OF THE CIVIL SERVICE LAW AND CRITERIA ESTABLISHED BY
   18  THE NATIONAL INSTITUTE ON DRUG ABUSE  AS  GUIDELINES  FOR  MODELING  THE
   19  STATE DRUG TESTING PROGRAM, CONCERNING, BUT NOT LIMITED TO:
   20    (1) STANDARDS FOR DRUG TESTING LABORATORY LICENSING AND SUSPENSION AND
   21  REVOCATION OF A LICENSE.
   22    (2)  BODY SPECIMENS AND MINIMUM SPECIMEN AMOUNTS WHICH ARE APPROPRIATE
   23  FOR DRUG TESTING.
   24    (3) METHODS OF ANALYSIS AND PROCEDURES TO ENSURE RELIABLE DRUG TESTING
   25  RESULTS, INCLUDING STANDARDS FOR INITIAL TESTS AND CONFIRMATION TESTS.
   26    (4) MINIMUM CUTOFF DETECTION LEVELS FOR DRUGS OR THEIR METABOLITES FOR
   27  THE PURPOSES OF DETERMINING A POSITIVE TEST RESULT.
   28    (5) CHAIN OF  CUSTODY  PROCEDURES  TO  ENSURE  PROPER  IDENTIFICATION,
   29  LABELING, AND HANDLING OF SPECIMENS BEING TESTED.
   30    (6)  RETENTION, STORAGE, AND TRANSPORTATION PROCEDURES TO ENSURE RELI-
   31  ABLE RESULTS ON CONFIRMATION TESTS AND RETESTS.
   32    B. THIS SECTION SHALL NOT BE CONSTRUED TO  ELIMINATE  THE  BARGAINABLE
   33  RIGHTS AS PROVIDED IN THE COLLECTIVE BARGAINING PROCESS IF APPLICABLE.
   34    S  442.  PREFERENCE  TO  BUSINESSES WITH DRUG-FREE WORKPLACE PROGRAMS.
   35  WHENEVER TWO OR MORE BIDS WHICH ARE EQUAL WITH RESPECT TO PRICE,  QUALI-
   36  TY,  AND  SERVICE ARE RECEIVED BY THE STATE OR BY ANY POLITICAL SUBDIVI-
   37  SION FOR THE PROCUREMENT OF COMMODITIES OR CONTRACTUAL SERVICES,  A  BID
   38  RECEIVED  FROM A BUSINESS THAT CERTIFIES THAT IT HAS IMPLEMENTED A DRUG-
   39  FREE WORKPLACE PROGRAM SHALL BE GIVEN PREFERENCE IN THE  AWARD  PROCESS.
   40  IN ORDER TO HAVE A DRUG-FREE WORKPLACE PROGRAM A BUSINESS SHALL:
   41    1.  PUBLISH A STATEMENT NOTIFYING EMPLOYEES THAT THE UNLAWFUL MANUFAC-
   42  TURE, DISTRIBUTION, DISPENSING,  POSSESSION,  OR  USE  OF  A  CONTROLLED
   43  SUBSTANCE IS PROHIBITED IN THE WORKPLACE AND SPECIFYING THE ACTIONS THAT
   44  WILL BE TAKEN AGAINST EMPLOYEES FOR VIOLATIONS OF SUCH PROHIBITION.
   45    2.  INFORM EMPLOYEES ABOUT THE DANGERS OF DRUG ABUSE IN THE WORKPLACE,
   46  THE BUSINESS'S POLICY OF MAINTAINING A DRUG-FREE WORKPLACE,  ANY  AVAIL-
   47  ABLE  DRUG  COUNSELING  REHABILITATION, AND EMPLOYEE ASSISTANCE PROGRAMS
   48  AND THE PENALTIES THAT MAY BE IMPOSED  UPON  EMPLOYEES  FOR  DRUG  ABUSE
   49  VIOLATIONS.
   50    3. GIVE EACH EMPLOYEE ENGAGED IN PROVIDING THE COMMODITIES OR CONTRAC-
   51  TUAL  SERVICES  THAT  ARE UNDER BID A COPY OF THE STATEMENT SPECIFIED IN
   52  SUBDIVISION ONE OF THIS SECTION.
   53    4. IN THE STATEMENT SPECIFIED IN  SUBDIVISION  ONE  OF  THIS  SECTION,
   54  NOTIFY  THE EMPLOYEES THAT, AS A CONDITION OF WORKING ON THE COMMODITIES
   55  OR CONTRACTUAL SERVICES THAT ARE UNDER BID, THE EMPLOYEE WILL  ABIDE  BY
   56  THE  TERMS  OF  THE  STATEMENT  AND  WILL  NOTIFY  THE  EMPLOYER  OF ANY
       A. 6447                            20
    1  CONVICTION OF, OR PLEA OF GUILTY OR NOLO CONTENDERE TO, ANY VIOLATION OF
    2  ANY PROVISION OF ARTICLE TWO HUNDRED TWENTY OR TWO HUNDRED TWENTY-ONE OF
    3  THE PENAL LAW, OR OF ANY CONTROLLED SUBSTANCE LAW OF THE  UNITED  STATES
    4  OR  ANY  STATE, FOR A VIOLATION OCCURRING IN THE WORKPLACE NO LATER THAN
    5  FIVE DAYS AFTER SUCH CONVICTION.
    6    5. IMPOSE A SANCTION ON, OR REQUIRE THE SATISFACTORY PARTICIPATION  IN
    7  A  DRUG  ABUSE ASSISTANCE OR REHABILITATION PROGRAM IF SUCH IS AVAILABLE
    8  IN THE EMPLOYEE'S COMMUNITY BY ANY EMPLOYEE WHO IS SO CONVICTED.
    9    6. MAKE A GOOD FAITH EFFORT TO CONTINUE TO MAINTAIN A DRUG-FREE  WORK-
   10  PLACE THROUGH IMPLEMENTATION OF THIS SECTION.
   11    S  3. Title L of the criminal procedure law is amended by adding a new
   12  article 435 to read as follows:
   13                                 ARTICLE 435
   14                      DRUG OFFENDER PUNISHMENT PROGRAM
   15  SECTION 435.10 SHORT TITLE.
   16          435.15 LEGISLATIVE FINDINGS, PURPOSE, AND INTENT.
   17          435.20 DEFINITIONS.
   18          435.25 DRUG PUNISHMENT PROGRAM CONTRACTS;  PROGRAM  MANAGER  AND
   19                   ASSESSMENT AND TREATMENT PROVIDERS.
   20          435.30 DRUG PUNISHMENT PROGRAM.
   21          435.35 DRUG PUNISHMENT PROGRAM ASSESSMENT AND TREATMENT OVERVIEW
   22                   AND GOALS.
   23          435.40 DUTIES OF THE DEPARTMENT.
   24          435.45 DRUG PUNISHMENT PROGRAM FUNDS; ACCOUNTING; AUDITS.
   25          435.48 DRUG  PUNISHMENT PROGRAM; ASSESSMENT AND PLACEMENT PROCE-
   26                   DURES.
   27          435.50 RECORDS OF DRUG PUNISHMENT PROGRAM ASSESSMENT AND  TREAT-
   28                   MENT PROVIDERS; CONFIDENTIALITY.
   29          435.53 INFORMATION SYSTEMS.
   30          435.55 DRUG PUNISHMENT PROGRAM.
   31          435.60 DESIGNATED TREATMENT COMMUNITIES.
   32          435.65 CORE TREATMENT PROGRAM.
   33          435.70 DRUG OFFENDER ADVISORY BOARD.
   34          435.75 DRUG  PUNISHMENT  PROGRAM  QUALITY  ASSURANCE  COMPONENT;
   35                   DUTIES OF STATEWIDE PROGRAM MANAGER.
   36          435.80 DRUG PUNISHMENT PROGRAM EVALUATION.
   37          435.85 FINANCIAL CONSIDERATIONS FOR ASSESSMENT,  TREATMENT,  AND
   38                   TRANSPORTATION OF DRUG OFFENDERS.
   39  S 435.10 SHORT TITLE.
   40    THIS  ARTICLE  MAY  BE  CITED  AS THE "NEW YORK DRUG PUNISHMENT ACT OF
   41  2011".
   42  S 435.15 LEGISLATIVE FINDINGS, PURPOSE, AND INTENT.
   43    1. THE LEGISLATURE FINDS THAT FIGHTING CRIME  EFFECTIVELY  REQUIRES  A
   44  MULTIPRONGED  EFFORT FOCUSING ON PARTICULAR CLASSES OF OFFENDERS AND THE
   45  DEVELOPMENT  OF  PARTICULAR  PROGRAMS.  BECAUSE  THIS  STATE'S  CRIMINAL
   46  JUSTICE  SYSTEM  SENTENCES  MORE  OFFENDERS THAN THE AVAILABLE NUMBER OF
   47  PRISON BEDS AND OTHER NONPRISON PLACEMENTS, THE POTENTIAL FOR OVERCROWD-
   48  ING THIS STATE'S PRISONS BEYOND ALLOWABLE LIMITS HAS  FORCED  THE  EARLY
   49  RELEASE  OF MANY OFFENDERS, INCLUDING VIOLENT OFFENDERS. MOREOVER, SINCE
   50  THIS STATE'S CORRECTIONAL SYSTEM HAS AN INADEQUATE  NUMBER  OF  PROGRAMS
   51  FOR  A  SIGNIFICANT  NUMBER  OF OFFENDERS WHOSE CRIMINALITY IS DUE TO OR
   52  CONNECTED WITH DRUG ABUSE, THE  RECIDIVISM  RATES  FOR  THESE  OFFENDERS
   53  EXCEED  THOSE  TOLERATED  BY THE LEGISLATURE AND BY THE CITIZENS OF THIS
   54  STATE.
   55    2. THE LEGISLATURE, THEREFORE, ESTABLISHES THE FOLLOWING PUBLIC  POLI-
   56  CY:
       A. 6447                            21
    1    (A)  IN  ORDER  TO  ENSURE  THAT ADEQUATE PRISON BEDS ARE AVAILABLE TO
    2  PERMIT THE LENGTHENING OF TIME SERVED BY VIOLENT  OFFENDERS,  NONVIOLENT
    3  OFFENDERS  SHALL  BE PLACED, WHERE APPROPRIATE AND TO THE MAXIMUM EXTENT
    4  POSSIBLE, IN COMMUNITY-BASED ALTERNATIVES TO PRISON.
    5    (B)  COMMUNITY-BASED ALTERNATIVES SHALL BE EXPANDED TO ENSURE COST-EF-
    6  FECTIVE AND TIMELY RESPONSES TO CRIMINAL ACTIVITY PERPETRATED BY NONVIO-
    7  LENT OFFENDERS AND TO REDUCE PROBATION CASELOADS TO LEVELS WHICH  PERMIT
    8  INTENSIVE SUPERVISION.
    9    (C)  FOR  NONVIOLENT  OFFENDERS  WHOSE  CRIMINALITY IS RELATED TO DRUG
   10  ABUSE AND FOR WHOM REHABILITATION IS DETERMINED TO BE FEASIBLE,  COMPRE-
   11  HENSIVE,  INTENSELY  SUPERVISED  DRUG  PUNISHMENT TREATMENT PROGRAM BEDS
   12  SHALL BE PROVIDED AS PART OF A CONCERTED EFFORT TO REDUCE THE RECIDIVISM
   13  RATES OF THESE OFFENDERS.
   14    3. THE LEGISLATURE RECOGNIZES THAT, IN ORDER TO ENSURE MAXIMUM  INCAR-
   15  CERATION  OF  VIOLENT  OFFENDERS,  THE REALITIES OF ECONOMICS AND PRISON
   16  SPACE REQUIRE THAT NONVIOLENT OFFENDERS WHO ARE ASSESSED AS REHABILITAT-
   17  ABLE TO BE REHABILITATED PRIOR TO REINTEGRATION  INTO  SOCIETY  SO  THAT
   18  THEY  WILL  BE  FACTORED OUT OF THIS STATE'S PRISON PROBLEM, AND FURTHER
   19  RECOGNIZES THAT TO THIS END ENHANCED, COMPREHENSIVE  TREATMENT  PROGRAMS
   20  WITH  LONG-TERM PROSPECTS FOR REDUCING CRIME IN THIS STATE'S COMMUNITIES
   21  MUST BE DEVELOPED AND COMMUNITY RESOURCES FOR THE TREATMENT AND REHABIL-
   22  ITATION OF OFFENDERS FROM THE COMMUNITY MUST BE EXPANDED.
   23    4. THE LEGISLATURE FINDS THAT VICTIM RESTITUTION IS AN IMPORTANT  PART
   24  OF  A  COMPREHENSIVE  TREATMENT  PROGRAM  FOR REHABILITATABLE NONVIOLENT
   25  OFFENDERS, AND IT IS THE INTENT OF THE LEGISLATURE THAT VICTIM  RESTITU-
   26  TION  BE  MADE, WHERE POSSIBLE AND WHERE AGREED TO BY THE VICTIM. THERE-
   27  FORE, WHEN APPROPRIATE TO TREATMENT AND APPROVED BY THE COURT, IT IS THE
   28  INTENT OF THE LEGISLATURE THAT VICTIM RESTITUTION BE REQUIRED.
   29    5. THE LEGISLATURE RECOGNIZES THAT:
   30    (A) THE STATE'S NONVIOLENT PRISON POPULATION EXISTS PRIMARILY  BECAUSE
   31  OF DRUG ABUSE, WHICH THE LEGISLATURE FINDS MUST BE COUNTERED IN ORDER TO
   32  REDUCE THE ESCALATING CRIME RATE.
   33    (B)  THE  STATE'S  CORRECTIONAL  SYSTEM  IS  LIMITED IN ITS DRUG ABUSE
   34  TREATMENT EFFICACY BECAUSE:
   35    (1) MOST OFFENDERS WHO NEED DRUG ABUSE TREATMENT AND WHO ARE  AMENABLE
   36  TO INTERVENTION EFFORTS ARE NOT IN THE DEPARTMENT'S CUSTODY FOR A SUFFI-
   37  CIENT  TIME TO ACCOMPLISH THE INITIAL OBJECTIVE OF BREAKING THE CYCLE OF
   38  DRUG DEPENDENCE.
   39    (2) TREATMENT EFFECTIVENESS IS REDUCED BY THE AVAILABILITY OF DRUGS IN
   40  PRISONS.
   41    (3) THE STATE'S CORRECTIONAL SYSTEM DOES NOT  PROVIDE  THE  FOLLOW  UP
   42  SURVEILLANCE  OR  AFTERCARE  NECESSARY  TO  MAINTAIN POSITIVE DRUG ABUSE
   43  TREATMENT OUTCOMES.
   44    6. IT IS THE INTENT OF THE LEGISLATURE THAT NONVIOLENT  FELONY  OFFEN-
   45  DERS  WITH  DRUG  ABUSE PROBLEMS WHO ARE PLACED ON PROBATION AND WHO ARE
   46  FOUND BY THE COURT TO BE GOOD CANDIDATES FOR REHABILITATION RECEIVE DRUG
   47  ABUSE ASSESSMENT, AND,  WHERE  INDICATED,  TREATMENT,  INTENSIVE  SUPER-
   48  VISION,   AND  LIFE  SKILLS  REHABILITATION  WHILE  CONFINED  IN  SECURE
   49  SETTINGS.
   50    7. IT IS THE INTENT OF THE LEGISLATURE THAT:
   51    (A) A DRUG PUNISHMENT PROGRAM BE PROVIDED FOR ELIGIBLE DRUG  OFFENDERS
   52  WHO  ARE NOT MANAGING THEIR DRUG ABUSE PROBLEM EFFECTIVELY WITHIN AVAIL-
   53  ABLE COMMUNITY PROGRAMS UNDER TRADITIONAL PROBATION SUPERVISION AND  WHO
   54  WOULD  NOT  CURRENTLY  REQUIRE  RELOCATION  TO  PRISON  IF A MORE SECURE
   55  PROBATION ALTERNATIVE WERE AVAILABLE TO THE COURTS.
       A. 6447                            22
    1    (B) A MECHANISM BE ESTABLISHED WHEREBY STATE  FUNDS  ARE  PROVIDED  TO
    2  QUALIFIED,  LICENSED  ALCOHOL  AND  DRUG TREATMENT AGENCIES TO DEVELOP A
    3  RANGE OF COMMUNITY-BASED DRUG PUNISHMENT TREATMENT PROGRAMS FOR ELIGIBLE
    4  OFFENDERS UNDER THIS ARTICLE.
    5  S 435.20 DEFINITIONS.
    6    AS USED IN THIS ARTICLE:
    7    1.  "DRUG  OFFENDER"  OR "OFFENDER" MEANS A NONVIOLENT FELONY OFFENDER
    8  WHO IS PLACED ON PROBATION AND WHO MEETS THE FOLLOWING CRITERIA:
    9    (A) IS CONVICTED ON THE OFFENSE OF OR HAS  ADJUDICATION  WITHHELD  FOR
   10  FELONY  POSSESSION  OR  PURCHASE  OF  A CONTROLLED SUBSTANCE PURSUANT TO
   11  ARTICLE TWO HUNDRED TWENTY OF THE PENAL LAW AND HAS BEEN CONVICTED OF OR
   12  HAD ADJUDICATION WITHHELD FOR AT LEAST ONE BUT NOT MORE THAN TWO  FELONY
   13  DRUG  OFFENSES  PURSUANT TO ARTICLE TWO HUNDRED TWENTY OF THE PENAL LAW,
   14  NONE OF WHICH CONSTITUTES A VIOLENT FELONY OFFENSE AS DEFINED IN SECTION
   15  70.02 OF THE PENAL LAW; AND
   16    (B) (1) IS BELIEVED BY THE COURT, BASED UPON  REASONABLE  GROUNDS,  TO
   17  HAVE ENGAGED IN CRIMINAL ACTIVITY DUE TO DRUG ABUSE; OR
   18    (2)  HAS  VOLUNTARILY  ADMITTED TO DRUG ABUSE AND HAS REQUESTED TREAT-
   19  MENT; AND
   20    (C) IS CHARGED WITH, OR HAS  BEEN  FOUND  GUILTY  OF  A  VIOLATION  OF
   21  PROBATION ARISING DIRECTLY FROM SUSPECTED OR CONFIRMED DRUG ABUSE;
   22    (D)  (1) HAS EXPERIENCED DIFFICULTY IN, OR IS NOT AMENABLE TO, PARTIC-
   23  IPATING IN A COMMUNITY DRUG ABUSE TREATMENT PROGRAM, AND REQUIRES A MORE
   24  RESTRICTIVE TREATMENT SETTING; OR
   25    (2) AN APPROPRIATE COMMUNITY DRUG ABUSE TREATMENT PROGRAM IS CURRENTLY
   26  UNAVAILABLE.
   27    2. "COMPREHENSIVE ASSESSMENT" OR "ASSESSMENT" MEANS THE  GATHERING  OF
   28  INFORMATION NECESSARY TO EVALUATE AN OFFENDER'S PHYSICAL, PSYCHOLOGICAL,
   29  EDUCATIONAL,  VOCATIONAL, AND SOCIAL CONDITION AND FAMILY ENVIRONMENT AS
   30  THEY RELATE TO HIS ELIGIBILITY AND NEED FOR, AND  AMENABILITY  TO,  DRUG
   31  PUNISHMENT TREATMENT SERVICES.
   32    3. "DEPARTMENT" MEANS THE DEPARTMENT OF CORRECTIONAL SERVICES.
   33    4.  "REHABILITATIVE PUNISHMENT" MEANS DRUG TREATMENT SERVICES PROVIDED
   34  IN COMBINATION WITH SUCH REHABILITATIVE SERVICES AS  COUNSELING,  EDUCA-
   35  TION, AND VOCATIONAL, PARENTING, AND LIFE SKILLS TRAINING IN AN ENVIRON-
   36  MENT  OF  PHASED  DECREASING RESTRICTIVENESS, WITH PUNISHMENT COMPONENTS
   37  SUCH AS VICTIM RESTITUTION AND DRUG ABUSE TESTING TO ASSIST IN THE REHA-
   38  BILITATION OF THE DRUG OFFENDER.
   39    5. "DESIGNATED FACILITY" OR "DESIGNATED  DRUG  TREATMENT  FACILITY  OR
   40  COMMUNITY"  MEANS  ANY  INSTITUTION,  SECURE OR NONSECURE RESIDENTIAL OR
   41  NONRESIDENTIAL FACILITY, OR TREATMENT COMMUNITY  DESIGNATED  TO  PROVIDE
   42  REHABILITATIVE  PUNISHMENT  AND  DRUG  TREATMENT  SERVICES  TO OFFENDERS
   43  PURSUANT TO THIS ARTICLE.
   44    6. "DRUG PUNISHMENT  PROGRAM"  OR  "PROGRAM"  MEANS  A  REHABILITATIVE
   45  PUNISHMENT PROGRAM ADMINISTERED BY A STATEWIDE PROGRAM MANAGER IN TREAT-
   46  MENT  COMMUNITIES  WITHIN THE JUDICIAL CIRCUITS THROUGH LICENSED ALCOHOL
   47  AND DRUG ABUSE SERVICES AND PROGRAMS  PROVIDED FOR ELIGIBLE DRUG  OFFEN-
   48  DERS WHO OTHERWISE COULD HAVE BEEN INCARCERATED IN THE STATE CORRECTION-
   49  AL  SYSTEM.  "DRUG  PUNISHMENT" INCLUDES CUSTODIAL AND NONCUSTODIAL DRUG
   50  TREATMENT PHASES WITH EXTENDED CARE AS REQUIRED OR  NEEDED,  INDIVIDUAL-
   51  IZED  ASSESSMENT  AND  TREATMENT SERVICES, GUIDANCE, TRAINING, AND OTHER
   52  REHABILITATIVE PUNISHMENT  AND  TREATMENT  SERVICES  IN  AREAS  SUCH  AS
   53  HEALTH,   EDUCATION,  VOCATIONAL  TRAINING,  SPECIAL  EDUCATION,  SOCIAL
   54  SERVICES, AND PSYCHOLOGICAL COUNSELING. NO DRUG PUNISHMENT PROGRAM SHALL
   55  BE APPROVED WHICH HAS A RESIDENTIAL CAPACITY OF  ONE  HUNDRED  FIFTY  OR
       A. 6447                            23
    1  MORE  OFFENDERS IN ANY ONE PHASE.  NO PROGRAM PROVIDER SHALL BE ELIGIBLE
    2  FOR MORE THAN THREE CONTRACTS STATEWIDE.
    3    7.   "STATEWIDE   PROGRAM   MANAGER"  OR  "PROGRAM  MANAGER"  MEANS  A
    4  NOT-FOR-PROFIT ORGANIZATION SELECTED BY THE DEPARTMENT AS THE  STATEWIDE
    5  MANAGER OF THE DRUG PUNISHMENT PROGRAM SERVICE PROVIDERS.  THE STATEWIDE
    6  PROGRAM  MANAGER  SHALL  BE  EXPERIENCED  IN  DRUG ABUSE PROGRAMMING AND
    7  TREATMENT OF OFFENDERS INVOLVED  WITH  DRUGS  AND  SHALL  OPERATE  UNDER
    8  CONTRACT WITH THE DEPARTMENT PURSUANT TO SECTION 435.25 OF THIS ARTICLE.
    9  THE  STATEWIDE  PROGRAM  MANAGER SHALL NOT BE A RECIPIENT OF CONTRACTUAL
   10  SERVICES FOR THE ASSESSMENT, TREATMENT, OR EVALUATION OF OFFENDERS UNDER
   11  THIS ARTICLE.
   12    8. "DRUG ABUSE" MEANS ABUSE OF ANY DRUG, INCLUDING ALCOHOL.
   13    9. "APPLICATION PROCESS AND PROCEDURES" MEANS THE CRITERIA AND  GUIDE-
   14  LINES  DEVELOPED BY THE DEPARTMENT FOR THE ESTABLISHMENT OF DRUG PUNISH-
   15  MENT PROGRAMS, THE GRANTING OF FUNDS FOR  PROGRAMS  AUTHORIZED  BY  THIS
   16  ARTICLE,  AND  THE MONITORING, EVALUATION, AND REVIEW OF PROGRAMS FUNDED
   17  UNDER THIS ARTICLE.
   18    10. "DRUG PUNISHMENT PLAN" OR "PLAN" MEANS A DOCUMENT PREPARED BY  THE
   19  DRUG  OFFENDER  ADVISORY  BOARD,  AND  SUBMITTED  TO AND APPROVED BY THE
   20  DEPARTMENT, WHICH IDENTIFIES PROPOSED DRUG  PUNISHMENT  PROGRAMS  TO  BE
   21  IMPLEMENTED  IN  ACCORDANCE  WITH  THIS  ARTICLE AND WHICH JUSTIFIES THE
   22  FUNDING OF SUCH  PROGRAMS  WITH  REGARD  TO  LOCAL  NEED  AND  COMMUNITY
   23  SUPPORT.    INDIVIDUALIZED DRUG PUNISHMENT PLANS FOR EACH DRUG OFFENDER,
   24  AND A DRUG PUNISHMENT PLAN FOR EACH PROGRAM PROVIDER, SHALL BE DEVELOPED
   25  IN ACCORDANCE WITH THE STATEWIDE DRUG PUNISHMENT PLAN.
   26    11. "RECIPIENT" INCLUDES ANY ENTITY RECEIVING, DIRECTLY OR INDIRECTLY,
   27  AND ANY FINANCIAL AID UNDER THIS ARTICLE.
   28    12. "COMMISSIONER" MEANS THE COMMISSIONER OF CORRECTIONAL SERVICES.
   29    13. "PROGRAM EVALUATOR" MEANS A NONPROFIT PUBLIC AGENCY WHICH IS NOT A
   30  PROVIDER OF DRUG PUNISHMENT  PROGRAM  SERVICES  OR  THE  STATEWIDE  DRUG
   31  PUNISHMENT  PROGRAM  MANAGER  AND WHICH HAS SUBSTANTIAL EXPERTISE IN THE
   32  STATISTICAL ANALYSIS OF ISSUES OF LAW, MENTAL HEALTH, DRUG ABUSE  TREAT-
   33  MENT  PROCEDURES,  VICTIMS' AND INMATES' RIGHTS, AND PROGRAM OUTCOME AND
   34  COST-EFFECTIVENESS MEASUREMENT. SUCH AGENCY OR ORGANIZATION  SHALL  ALSO
   35  BE EXPERIENCED IN WORKING WITH THE DEPARTMENT.
   36  S 435.25 DRUG  PUNISHMENT PROGRAM CONTRACTS; PROGRAM MANAGER AND ASSESS-
   37             MENT AND TREATMENT PROVIDERS.
   38    1. PURSUANT TO THE PROVISIONS OF THIS ARTICLE, CONTRACTS WHICH INCLUDE
   39  SAFEGUARDS OF  ALL  CONSTITUTIONAL  RIGHTS  AFFORDED  INMATES  SHALL  BE
   40  ENTERED INTO FOR DRUG PUNISHMENT PROGRAMS.
   41    2.  THE  DEPARTMENT SHALL SELECT A STATEWIDE PROGRAM MANAGER AND SHALL
   42  CONTRACT WITH SUCH PROGRAM MANAGER FOR:
   43    (A) THE OVERSIGHT OF IMPLEMENTATION OF DRUG PUNISHMENT PROGRAM ASSESS-
   44  MENT AND TREATMENT APPROACHES.
   45    (B) THE IDENTIFICATION AND PREQUALIFICATION, BY SUBMISSION FOR  RECOM-
   46  MENDATION  BY  THE  DRUG  OFFENDER ADVISORY BOARD, OF LICENSED ORGANIZA-
   47  TIONS, INCLUDING MINORITY ORGANIZATIONS WHEN POSSIBLE, TO  PROVIDE  DRUG
   48  PUNISHMENT PROGRAM ASSESSMENT AND TREATMENT SERVICES.
   49    (C) THE QUALITY ASSURANCE MONITORING OF ALL DRUG PUNISHMENT ASSESSMENT
   50  AND  TREATMENT  PROGRAMS  AND  SERVICES, THE TRAINING OF DRUG PUNISHMENT
   51  PROGRAM PROVIDERS AND PERSONNEL, AND THE DEVELOPMENT OF TREATMENT  MANU-
   52  ALS  FOR  EACH MAJOR COMPONENT OF THE CORE TREATMENT PROGRAM PURSUANT TO
   53  SECTION 435.65 OF THIS ARTICLE, IN COOPERATION WITH  THE  DRUG  OFFENDER
   54  ADVISORY BOARD AND IN COMPLIANCE WITH THE PROVISIONS OF THIS ARTICLE AND
   55  ALL APPLICABLE RULES AND GUIDELINES PURSUANT THERETO.
       A. 6447                            24
    1    (D)  THE PROVISION OF ASSISTANCE TO DRUG PUNISHMENT PROGRAM ASSESSMENT
    2  AND TREATMENT PROVIDERS IN DEVELOPING TREATMENT COMMUNITY DESIGN  PURSU-
    3  ANT TO SECTION 435.60 OF THIS ARTICLE.
    4    (E) THE DEVELOPMENT OF AN ANNUAL REPORT ON THE PERFORMANCE OF THE DRUG
    5  PUNISHMENT PROGRAM, TO BE PRESENTED TO THE DRUG OFFENDER ADVISORY BOARD,
    6  THE  DEPARTMENT,  THE  PROGRAM EVALUATOR, THE GOVERNOR, THE PRESIDENT OF
    7  THE SENATE, AND THE SPEAKER OF THE ASSEMBLY NO LATER THAN JANUARY  FIRST
    8  OF EACH YEAR.
    9    3.  ASSESSMENT  AND TREATMENT OF OFFENDERS PURSUANT TO DRUG PUNISHMENT
   10  PROGRAM CONTRACTS UNDER THIS ARTICLE SHALL  BE  CONDUCTED  BY  QUALIFIED
   11  LICENSED  AGENCIES, WHICH SHALL EXERCISE ALL PROFESSIONAL JUDGMENT INDE-
   12  PENDENTLY OF THE DEPARTMENT.
   13    4. (A) THE DEPARTMENT  SHALL  CONTRACT  WITH  ORGANIZATIONS  FOR  DRUG
   14  PUNISHMENT PROGRAM ASSESSMENT AND TREATMENT SERVICES.
   15    (B)  DRUG  PUNISHMENT PROGRAM ASSESSMENT AND TREATMENT PROVIDERS SHALL
   16  BE SELECTED WHO HAVE THE CAPACITY TO ASSESS AND TREAT THE  UNIQUE  PROB-
   17  LEMS  PRESENTED  BY  OFFENDERS  WITH  DIFFERENT  RACIAL AND ETHNIC BACK-
   18  GROUNDS.
   19    5. THE DEPARTMENT SHALL CONTRACT WITH  A  PROGRAM  EVALUATOR  FOR  THE
   20  EVALUATION PROGRAM.
   21    6.  THE  DEPARTMENT  SHALL  RETAIN CONTRACTUAL AUTHORITY TO REJECT ANY
   22  ASSESSMENT OR TREATMENT PROVIDER FOR LACK OF QUALIFICATION FOR THE  DRUG
   23  PUNISHMENT PROGRAM OR FOR PROGRAM CONTRACT NONCOMPLIANCE, OR AS A RESULT
   24  OF  AN  UNSATISFACTORY  EVALUATION  BY  THE DRUG OFFENDER ADVISORY BOARD
   25  PURSUANT TO SECTION 435.70 OF THIS ARTICLE, THE STATEWIDE PROGRAM MANAG-
   26  ER, OR THE PROGRAM EVALUATOR.
   27    7. THE DEPARTMENT SHALL RETAIN CONTRACTUAL  AUTHORITY  TO  REJECT  THE
   28  STATEWIDE  PROGRAM  MANAGER  BASED  ON  UNSATISFACTORY EVALUATION OF THE
   29  PROGRAM MANAGER OR THE DRUG PUNISHMENT  PROGRAM  BY  THE  DRUG  OFFENDER
   30  ADVISORY BOARD BASED ON UNSATISFACTORY EVALUATION OF THE DRUG PUNISHMENT
   31  PROGRAM BY THE PROGRAM EVALUATOR, OR FOR CONTRACT NONCOMPLIANCE.
   32    8.  THE DEPARTMENT MAY PROMULGATE RULES AS NECESSARY FOR THE IMPLEMEN-
   33  TATION OF THIS SECTION.
   34  S 435.30 DRUG PUNISHMENT PROGRAM.
   35    1. THERE IS CREATED THE DRUG PUNISHMENT PROGRAM FOR OFFENDERS WHO  ARE
   36  SELECTED BASED ON CRIMINAL ACTIVITY LINKED TO DRUG ABUSE AND AMENABILITY
   37  TO  DRUG  PUNISHMENT  IN A PHASED TREATMENT PROGRAM OF SLOWLY DECREASING
   38  INTENSITY.
   39    2. THE FOLLOWING PRINCIPLES SHALL GUIDE  THE  EFFECTIVE  TREATMENT  OF
   40  OFFENDERS UNDER THE DRUG PUNISHMENT PROGRAM:
   41    (A) CLEAR CONSEQUENCES FOR BEHAVIOR.
   42    (B) INITIAL ISOLATION FROM THE GENERAL OFFENDER POPULATION.
   43    (C)  ENCOURAGEMENT OF ANTI-CRIMINAL MODELING AND REINFORCEMENT OF PRO-
   44  SOCIAL BEHAVIOR.
   45    (D) PROMOTION OF PROBLEM-SOLVING SKILLS.
   46    (E) REINFORCEMENT OF COGNITIVE-BEHAVIORAL STRATEGIES.
   47    (F) UTILIZATION OF MULTIMODAL TREATMENT APPROACHES.
   48    (G) GROUP REHABILITATIVE PUNISHMENT AND TREATMENT FORMAT.
   49    (H) HIGHLY STRUCTURED REHABILITATIVE PUNISHMENT AND TREATMENT MILIEU.
   50    (I) ALLOWANCE FOR  INTENSIVE  AND  LENGTHY  INVOLVEMENT  IN  THE  DRUG
   51  PUNISHMENT PROGRAM.
   52    (J) GRADUATED REENTRY TO THE COMMUNITY.
   53    3.  THE  FOLLOWING INTERVENTIONS, AS ESSENTIAL COMPONENTS OF EFFECTIVE
   54  DRUG PUNISHMENT, SHALL BE ADDRESSED IN DEVELOPING A  COMPREHENSIVE  DRUG
   55  PUNISHMENT PROGRAM:
   56    (A) ASSESSMENT.
       A. 6447                            25
    1    (B) DRUG ABUSE EDUCATION.
    2    (C) SKILLS-BASED INTERVENTIONS.
    3    (D) RELAPSE PREVENTION.
    4    (E) FREQUENT DRUG TESTING.
    5    (F) AIDS EDUCATION.
    6    4.  IF  THE DRUG PUNISHMENT PROGRAM IS DISCONTINUED, OR SO MODIFIED AS
    7  TO BE UNSUITABLE TO THE DRUG OFFENDER'S TREATMENT NEEDS, THE  COURT  MAY
    8  IMPOSE  ANY  APPROPRIATE SENTENCE WHICH IT MIGHT HAVE ORIGINALLY IMPOSED
    9  BEFORE PLACING THE DRUG OFFENDER INTO THE DRUG PUNISHMENT PROGRAM.
   10    5.  THE  DISTRICT  ATTORNEY,  VICTIM,  DEFENSE  ATTORNEY,  PAROLE   OR
   11  PROBATION  OFFICER,  AND LOCAL DRUG PUNISHMENT PROGRAM PROVIDER SHALL BE
   12  CONSULTED REGARDING POTENTIAL REFERRALS TO A  DRUG  PUNISHMENT  PROGRAM;
   13  HOWEVER, THE COURT SHALL MAKE THE FINAL DECISION AS TO REFERRALS.
   14    6.  THE  COURT SHALL ORDER RESTITUTION WHEN APPROPRIATE AS A CONDITION
   15  OF A DRUG PUNISHMENT PROGRAM PLACEMENT AND SHALL REQUIRE  A  FINANCIALLY
   16  ABLE  DRUG  OFFENDER  TO  PAY  FOR  ALL  OR A PORTION OF THE COST OF HIS
   17  PARTICIPATION IN THE DRUG PUNISHMENT PROGRAM AND DRUG TESTING.
   18    7. THE COURT MAY, UPON RECOMMENDATION OF THE DRUG  PUNISHMENT  PROGRAM
   19  PROVIDER,  REQUIRE  THE  DRUG OFFENDER TO PARTICIPATE IN COMMUNITY-BASED
   20  AFTERCARE SERVICES AFTER SATISFACTORY COMPLETION OF THE DRUG  PUNISHMENT
   21  PROGRAM.
   22    8.  NOTHING  IN  THIS  ARTICLE SHALL PREVENT A COURT FROM SENTENCING A
   23  PERSON CONVICTED OF A FELONY DRUG OFFENSE AS OTHERWISE PROVIDED BY LAW.
   24  S 435.35 DRUG PUNISHMENT PROGRAM ASSESSMENT AND TREATMENT  OVERVIEW  AND
   25             GOALS.
   26    ASSESSMENT  OF OFFENDERS FOR THE DRUG PUNISHMENT PROGRAM SHALL INCLUDE
   27  MULTITIERED SCREENING DESIGNED TO SELECT OFFENDERS WHOSE CRIMINAL ACTIV-
   28  ITY IS LINKED TO DRUG ABUSE AND WHO  ARE  AMENABLE  TO  DRUG  PUNISHMENT
   29  PROGRAM TREATMENT. ENTRY INTO THE DRUG PUNISHMENT PROGRAM COMMENCES WITH
   30  THE  SCREENING OF OFFENDERS FOR ELIGIBILITY USING THE CRITERIA OF SUBDI-
   31  VISION ONE OF SECTION 435.20 OF THIS ARTICLE.  OFFENDERS WHO  HAVE  BEEN
   32  REFERRED  BY A JUDGE OR PROBATION OFFICER AS ELIGIBLE FOR ASSESSMENT FOR
   33  THE PROGRAM ARE ASSESSED BY A DRUG PUNISHMENT PROGRAM COMMUNITY  ASSESS-
   34  MENT  PROVIDER. THE FINAL ASSESSMENT REPORT ISSUED BY THE PROVIDER SHALL
   35  BE PROVIDED TO THE PROBATION OFFICER AND THE COURT, AND SHALL GUIDE  THE
   36  COURT  IN  ESTABLISHING  OR  MODIFYING THE CONDITIONS OF PROBATION OF AN
   37  OFFENDER WHO IS ASSESSED AS ELIGIBLE FOR PLACEMENT IN THE  DRUG  PUNISH-
   38  MENT PROGRAM.
   39    1.  ASSESSMENT GOALS. SPECIFIC ASSESSMENT GOALS OF THE DRUG PUNISHMENT
   40  PROGRAM INCLUDE, BUT ARE NOT LIMITED TO:
   41    (A) IDENTIFYING OFFENDERS WHO ARE LIKELY TO BENEFIT FROM DRUG  PUNISH-
   42  MENT PROGRAM TREATMENT DUE TO AN EARLY ONSET OF DRUG ABUSE AND A PATTERN
   43  OF  CRIMINALITY COMBINED WITH DRUG ABUSE AND WHO, THEREFORE, PRESENT THE
   44  GREATEST RISK OF RECIDIVISM WITHIN THE CRIMINAL JUSTICE SYSTEM.
   45    (B) DISCOURAGING ADMISSION OF OFFENDERS WHO  PRESENT  AN  UNREASONABLE
   46  THREAT  TO  THE  COMMUNITY  IF  DIVERTED  FROM  A PRISON BED TO THE DRUG
   47  PUNISHMENT PROGRAM.
   48    (C) PREVENTING ADMISSION OF DRUG OFFENDERS WHO CAN BE  TREATED  EFFEC-
   49  TIVELY IN LESS RESTRICTIVE PROGRAMS.
   50    (D)  PROVIDING  DIAGNOSTIC INFORMATION AND PSYCHOSOCIAL HISTORY SUFFI-
   51  CIENT TO ENABLE DRUG PUNISHMENT  PROGRAM  TREATMENT  STAFF  TO  IDENTIFY
   52  POTENTIAL  BEHAVIOR PROBLEMS AND OTHER PROBLEM AREAS FOR THE DRUG OFFEN-
   53  DER WHICH SHOULD BE ASSESSED  IN  MORE  DETAIL  DURING  DRUG  PUNISHMENT
   54  PROGRAM INTAKE AND TREATMENT PLANNING.
   55    (E) PROVIDING A TIMELY AND INFORMATIVE REPORT TO THE PROBATION OFFICER
   56  AND  THE  COURT  DESCRIBING  A  REFERRED DRUG OFFENDER'S DRUG PUNISHMENT
       A. 6447                            26
    1  PROGRAM ELIGIBILITY STATUS AND ANY RECOMMENDATIONS FOR TREATMENT FOR THE
    2  DRUG OFFENDER.
    3    2.  TREATMENT  GOALS.  SPECIFIC TREATMENT GOALS OF THE DRUG PUNISHMENT
    4  PROGRAM INCLUDE, BUT ARE NOT LIMITED TO:
    5    (A) REDUCTION OF CRIMINAL RECIDIVISM.
    6    (B) REDUCTION OF DRUG ABUSE, WITH ABSTINENCE AS THE GOAL FOR EACH DRUG
    7  OFFENDER.
    8    (C) DEVELOPMENT OF EMPLOYMENT  SKILLS  AND  ATTAINMENT  OF  MEANINGFUL
    9  EMPLOYMENT.
   10    (D)  DEVELOPMENT  OF  A  POSITIVE  PEER  SUPPORT  NETWORK, AND ONGOING
   11  PARTICIPATION IN SERVICES TO MAINTAIN TREATMENT PROGRESS.
   12    (E) ENHANCEMENT OF EDUCATIONAL SKILLS, SELF-CARE AND  SELF-SUFFICIENCY
   13  CAPABILITIES, AND PARENTING SKILLS.
   14  S 435.40 DUTIES OF THE DEPARTMENT.
   15    THE DEPARTMENT SHALL:
   16    1.  ADMINISTER  THIS  ARTICLE  TO  EFFECTUATE  THE  INTENT AND PURPOSE
   17  MANDATED BY THE LEGISLATURE.
   18    2. CONDUCT  STATEWIDE  PUBLIC  EDUCATION  CONCERNING  THE  INTENT  AND
   19  PURPOSE  OF  THIS  ARTICLE  AND DELIVER A REPORT TO THE PRESIDENT OF THE
   20  SENATE AND THE SPEAKER OF THE ASSEMBLY REGARDING  THE  EFFECTIVENESS  OF
   21  DIVERTING  OFFENDERS WHO OTHERWISE COULD HAVE BEEN INCARCERATED IN STATE
   22  CORRECTIONAL INSTITUTIONS.
   23    3. PROVIDE TECHNICAL ASSISTANCE NECESSARY  TO  THE  IMPLEMENTATION  OF
   24  THIS ARTICLE TO LICENSED NONPROFIT AGENCIES.
   25    4.  ASSIST  THE  DRUG  OFFENDER  ADVISORY  BOARD IN PREPARATION OF THE
   26  STATEWIDE DRUG PUNISHMENT PLAN.
   27    5. DEVELOP MINIMUM STANDARDS, POLICIES AND  ADMINISTRATIVE  RULES  FOR
   28  THE  IMPLEMENTATION  OF  APPROVED  RECOMMENDATIONS  OF THE DRUG OFFENDER
   29  ADVISORY BOARD.
   30    6. DEVELOP AN APPLICATION PROCESS AND THE PROCEDURES NEEDED FOR IMPLE-
   31  MENTATION.
   32    7. APPROVE THOSE PROVIDERS WHO MEET OR EXCEED  THE  MINIMUM  STANDARDS
   33  ESTABLISHED  BY  THE  DRUG  OFFENDER ADVISORY BOARD IN THE APPROVED DRUG
   34  PUNISHMENT PLAN.
   35    8. CONDUCT AN ANNUAL OVERALL PROGRAM REVIEW, INCLUDING REVIEW  OF  THE
   36  EVALUATION  PROGRAM AND MONITORING OF EACH TREATMENT PROGRAM AS OFTEN AS
   37  NEEDED TO ENSURE PROGRAM ACCOUNTABILITY.
   38    9. PROVIDE, BY RULE, UNIFORM STANDARDS AND PROCEDURES FOR  THE  INITI-
   39  ATION  OF  INITIAL SCREENING FOR DRUG OFFENDERS BY PROBATION OFFICERS OF
   40  THE DEPARTMENT. PROCEDURES SHALL INCLUDE  SUBMISSION  OF  THE  SCREENING
   41  REFERRAL TO THE COURT PRIOR TO THE COMMENCEMENT OF ANY ASSESSMENT PROCE-
   42  DURES.
   43  S 435.45 DRUG PUNISHMENT PROGRAM FUNDS; ACCOUNTING; AUDITS.
   44    1.  ELIGIBILITY  OF  DRUG  TREATMENT  PLANS FOR FINANCIAL AID.   (A) A
   45  LICENSED TREATMENT AGENCY MAY BE ELIGIBLE  FOR  DIRECT  DRUG  PUNISHMENT
   46  PROGRAM  FINANCIAL  AID  UNDER  THIS  ARTICLE AFTER APPROVAL BY THE DRUG
   47  OFFENDER ADVISORY BOARD. UPON APPROVAL BY  THE  BOARD,  THE  APPLICATION
   48  SHALL  BE TRANSMITTED TO THE DEPARTMENT, WHICH SHALL HAVE THIRTY DAYS TO
   49  ENDORSE OR  REJECT  THE  BOARD'S  APPROVAL.  REJECTION  OF  THE  BOARD'S
   50  APPROVAL  SHALL BE FOR CAUSE, AND THE DEPARTMENT SHALL CLEARLY STATE THE
   51  REASONS IN WRITING. FAILURE OF THE  DEPARTMENT  TO  RESPOND  WITHIN  THE
   52  THIRTY-DAY PERIOD SHALL BE DEEMED AN ENDORSEMENT.
   53    (B)  IN  ORDER  TO RECEIVE FUNDING, AN ELIGIBLE ENTITY SHALL SUBMIT AN
   54  APPLICATION TO THE DEPARTMENT, WHICH INCLUDES A DRUG PUNISHMENT PLAN, AN
   55  ACCEPTABLE SITE, FACILITY DESIGN WITH CONSTRUCTION DOCUMENTS  AND  SPEC-
   56  IFICATIONS,  A CONSTRUCTION BUDGET, AND A FINANCING PLAN WITH SOURCES OF
       A. 6447                            27
    1  EQUITY AND DEBT AND SCHEDULES FOR  DELIVERY.  SUCH  FUNDING  APPLICATION
    2  SHALL  BE  PROVIDED  TO  THE  STATEWIDE  PROGRAM  MANAGER AT THE TIME OF
    3  PREQUALIFICATION, AND THE PROGRAM MANAGER SHALL  PREQUALIFY  THE  ENTITY
    4  ONLY AFTER ASCERTAINING THAT THE APPLICATION CONTAINS ALL REQUIRED MATE-
    5  RIALS.
    6    (C)  APPLICATIONS  FOR  FINANCIAL  AID MUST CONTAIN AN ESTIMATE OF THE
    7  COST OF THE PROGRAM OR, IN LIEU THEREOF, A SPECIFIC  FORMULA  OR  METHOD
    8  FOR CALCULATING THE NEEDED AMOUNT OF FUNDING.
    9    2.  COMMUNITY-BASED  TREATMENT OPTIONS AND SERVICES.  (A) DRUG PUNISH-
   10  MENT PROGRAM FUNDS MAY BE USED TO DEVELOP OR EXPAND THE RANGE OF  COMMU-
   11  NITY  DRUG  TREATMENT  SERVICES  FOR  THE DRUG PUNISHMENT PROGRAM AT THE
   12  LOCAL  LEVEL.  COMMUNITY-BASED  DRUG  PUNISHMENT  PROGRAM  OPTIONS   MAY
   13  INCLUDE, BUT ARE NOT LIMITED TO, THE FOLLOWING:
   14    (1)  SHORT-TERM AND LONG-TERM RESIDENTIAL TREATMENT OPTIONS IN ACCORD-
   15  ANCE WITH SECTION 435.55 OF THIS ARTICLE WITH EXTENDED ONGOING  CARE  AS
   16  NEEDED, WHICH INVOLVE CLOSE SUPERVISION IN A RESIDENTIAL SETTING.
   17    (2)  ENROLLMENT  OF  DRUG OFFENDERS IN RESIDENTIAL INPATIENT OR OUTPA-
   18  TIENT ALCOHOL OR DRUG ABUSE TREATMENT  CENTERS  FOR  DETOXIFICATION  AND
   19  THERAPY.  ENROLLMENT  SHALL BE BASED UPON AN ASSESSMENT PURSUANT TO THIS
   20  ARTICLE THAT A PARTICIPANT IS A DRUG OFFENDER AND  REQUIRES  DETOXIFICA-
   21  TION.  HOWEVER,  FINANCIAL AID FOR DETOXIFICATION SERVICES SHALL ONLY BE
   22  MADE FOR INPATIENT SERVICES, AND DETOXIFICATION SHALL BE COMPLETED PRIOR
   23  TO PHASE I OF TREATMENT.
   24    (3) INDIVIDUALIZED SERVICES WHICH ASSESS AND TREAT THE  SPECIAL  NEEDS
   25  OF  OFFENDERS  ELIGIBLE  UNDER  THIS  ARTICLE.  SERVICES TO THE COURT TO
   26  ASSIST IN THE ASSESSMENT OF ELIGIBLE OFFENDERS MAY INCLUDE URINE SCREEN-
   27  ING AND THE PURCHASE OF PSYCHOLOGICAL, MEDICAL, EDUCATIONAL, VOCATIONAL,
   28  DRUG, ALCOHOL, AND CLIENT-SPECIFIC PLAN  DIAGNOSTIC  EVALUATIONS.  OTHER
   29  SERVICES  WHICH  MAY BE PURCHASED ON AN INDIVIDUALIZED BASIS INCLUDE JOB
   30  TRAINING, DRUG AND ALCOHOL  COUNSELING,  INDIVIDUAL  COUNSELING,  FAMILY
   31  COUNSELING, HIGH SCHOOL GRADUATE EQUIVALENCY DIPLOMA CLASSES, AND NECES-
   32  SARY TRANSPORTATION EXPENSES, TO BE PROVIDED IN PHASES I, II, AND III OF
   33  THE DRUG PUNISHMENT PROGRAM.
   34    THESE  COMMUNITY-BASED OPTIONS SHALL BE USED IN CONJUNCTION WITH OTHER
   35  COMMUNITY PROBATION SUPERVISION PROGRAMS.
   36    (B) THE SERVICES AVAILABLE UNDER THIS ARTICLE  MAY  BE  CONTRACTED  TO
   37  QUALIFIED, LICENSED AGENCIES OR ENTITIES.
   38    (C) ANY OPTIONS OR SERVICES ESTABLISHED UNDER THIS ARTICLE SHALL SERVE
   39  DRUG OFFENDERS FROM THE ENTIRE JUDICIAL CIRCUIT.
   40    (D)  USER  FEES PAID BY A DRUG OFFENDER PARTICIPATING IN ANY OPTION OR
   41  SERVICE ESTABLISHED UNDER THIS ARTICLE SHALL NOT SUPPLANT  OR  OTHERWISE
   42  INTERFERE  WITH  THE  PAYMENT OF RESTITUTION BY THE DRUG OFFENDER TO THE
   43  VICTIM OF THE CRIME.
   44    3. LIMITATIONS ON THE USE OF  FUNDS;  ACCOUNTING;  AUDIT.    (A)  DRUG
   45  PUNISHMENT  PROGRAM  FUNDS,  WITH  THE  EXCEPTION OF SURPLUS FUNDS UNDER
   46  PARAGRAPH (C) OF SUBDIVISION FOUR OF THIS SECTION, SHALL NOT BE USED TO:
   47    (1) SUPPLANT EXISTING STATE CORRECTIONAL SYSTEM PROGRAMS;
   48    (2) CONSTRUCT, RENOVATE, OR OPERATE LOCAL CORRECTIONAL FACILITIES; OR
   49    (3) CONSTRUCT, RENOVATE, OR OPERATE STATE PRISONS.
   50    (B) ADMINISTRATIVE  COSTS  CONNECTED  WITH  THE  EXPENDITURE  OF  DRUG
   51  PUNISHMENT  PROGRAM FUNDS UNDER THIS ARTICLE SHALL NOT EXCEED A PERCENT-
   52  AGE AMOUNT ESTABLISHED BY THE COMMISSIONER IN CONSULTATION WITH THE DRUG
   53  OFFENDER ADVISORY BOARD.
   54    (C) THE CHIEF INTERNAL AUDITOR OF THE DEPARTMENT IS DIRECTED TO DEVEL-
   55  OP, SUBJECT TO APPROVAL OF THE COMMISSIONER, A UNIFORM ACCOUNTING SYSTEM
   56  CONFORMING TO GENERALLY ACCEPTED ACCOUNTING  PRINCIPLES  FOR  THE  LOCAL
       A. 6447                            28
    1  DRUG  PUNISHMENT  TREATMENT  PROGRAMS  OPERATING UNDER THE PROVISIONS OF
    2  THIS ARTICLE, AND EACH DRUG PUNISHMENT TREATMENT PROGRAM SHALL ESTABLISH
    3  AND MAINTAIN THE UNIFORM ACCOUNTING SYSTEM.
    4    (D)  (1)  THE  ANNUAL  REPORTS AND ALL BOOKS OF ACCOUNTS AND FINANCIAL
    5  RECORDS OF ALL FUNDS RECEIVED BY  GRANT,  CONTRACT,  OR  OTHERWISE  FROM
    6  STATE,  LOCAL,  OR FEDERAL SOURCES SHALL BE SUBJECT TO AUDIT ANNUALLY BY
    7  THE COMPTROLLER OR THE CHIEF INTERNAL AUDITOR  OF  THE  DEPARTMENT.  THE
    8  AUDIT  MAY  BE  PERFORMED  BY  A  LICENSED  INDEPENDENT CERTIFIED PUBLIC
    9  ACCOUNTANT SELECTED BY THE DRUG PUNISHMENT PROGRAM. THE COST OF AN AUDIT
   10  PERFORMED BY A LICENSED INDEPENDENT CERTIFIED PUBLIC ACCOUNTANT SHALL BE
   11  PAID BY THE LOCAL RECIPIENT.
   12    (2) ANY AUDIT OF A RECIPIENT SHALL BE PERFORMED BY LICENSED  INDEPEND-
   13  ENT CERTIFIED PUBLIC ACCOUNTANTS.
   14    (3) ALL AUDITS SHALL BE COMPLETED AS SOON AS PRACTICABLE AFTER THE END
   15  OF  THE  FISCAL  YEAR  OF  THE DRUG PUNISHMENT PROGRAM. ONE COPY OF EACH
   16  AUDIT SHALL BE FURNISHED TO THE BOARD, TO THE CHIEF INTERNAL AUDITOR  OF
   17  THE  DEPARTMENT,  TO  THE  PROGRAM  MANAGER, AND TO THE COMPTROLLER. THE
   18  AUDIT IS A PUBLIC RECORD.
   19    4. DRUG PUNISHMENT PLAN; FUNDING  CRITERIA;  VOLUNTARY  PARTICIPATION.
   20  (A) A DRUG PUNISHMENT PLAN SHALL BE DEVELOPED BY THE DRUG OFFENDER ADVI-
   21  SORY  BOARD  AND  SHALL SUFFICIENTLY DOCUMENT THE LOCAL NEED AND SUPPORT
   22  FOR THE PROPOSED PROGRAMS. THE DRUG OFFENDER ADVISORY BOARD SHALL SUBMIT
   23  ITS PLAN TO THE DEPARTMENT.
   24    (B) THE FORMAT FOR ANY DRUG PUNISHMENT PLAN SHALL BE SPECIFIED BY  THE
   25  DEPARTMENT  IN  THE  APPLICATION PROCESS AND PROCEDURES DEVELOPED BY THE
   26  DEPARTMENT.
   27    (C) FUNDING UNDER THIS ARTICLE SHALL BE  GRANTED  ANNUALLY,  WITH  THE
   28  DISBURSEMENT  OF  FUNDS MONTHLY FOLLOWING THE SUBMISSION AND APPROVAL OF
   29  AN EXPENDITURE-MONITORING REPORT AND A PROGRAM-MONITORING REPORT.  LOCAL
   30  DRUG PUNISHMENT TREATMENT PROGRAMS ARE ELIGIBLE TO APPLY FOR ANY UNSPENT
   31  FUNDS  WHICH EXIST AT THE BEGINNING OF THE FOURTH QUARTER. AT THE END OF
   32  THE FISCAL YEAR, ANY MONEYS UNSPENT BY THE PROGRAM SHALL REVERT  IN  THE
   33  MANNER PROVIDED BY LAW.
   34    (D)  FUNDING  UNDER  THIS  ARTICLE  SHALL  BE  GRANTED ON THE BASIS OF
   35  DOCUMENTATION OF LOCAL  DRUG  PUNISHMENT  PROGRAM  NEED,  TOGETHER  WITH
   36  CONSIDERATION OF WHETHER THE DRUG OFFENDER ADVISORY BOARD'S DRUG PUNISH-
   37  MENT  PLAN IS CONSISTENT WITH THE PURPOSE OF THIS ARTICLE, THE GEOGRAPH-
   38  ICAL AND PROGRAM CONSIDERATIONS OF THE STATE, AND FUNDING  AVAILABILITY.
   39  IN  ADDITION,  THE  DEPARTMENT  SHALL  CONSIDER  THE  FOLLOWING CRITERIA
   40  PERTAINING TO THE COMMUNITY WHEN GRANTING FUNDS UNDER THIS ARTICLE:
   41    (1) THE NUMBER OF ELIGIBLE DRUG OFFENDERS WHO  ARE  COMMITTED  TO  THE
   42  DEPARTMENT.
   43    (2)  THE  POPULATION OF THE COMMUNITY AND THE PERCENTAGE OF POPULATION
   44  BETWEEN THE AGES OF EIGHTEEN AND TWENTY-NINE.
   45    (3) THE AVAILABILITY OF LOCAL DRUG TREATMENT SERVICES.
   46    (4) LOCAL SERVICE CAPABILITY TO SUPPORT THE DRUG PUNISHMENT PROGRAM.
   47    (E) FUNDING AND EVALUATION CRITERIA SHALL BE OUTLINED IN THE  APPLICA-
   48  TION  PROCESS  AND PROCEDURES TO BE DEVELOPED BY THE DEPARTMENT IN ORDER
   49  THAT EACH APPLICANT MAY KNOW THE BASIS UPON WHICH FUNDS WILL BE GRANTED.
   50    (F) PARTICIPATION IN  THE  PROGRAMS  SET  FORTH  IN  THIS  ARTICLE  IS
   51  CONTRACTUAL  AND  VOLUNTARY.  ANY PARTICIPATING TREATMENT AGENCY MAY, BY
   52  WRITTEN AUTHORIZATION, NOTIFY THE  DRUG  OFFENDER  ADVISORY  BOARD,  THE
   53  DEPARTMENT,  AND  THE  COMPTROLLER  OF  ITS  INTENTION  TO WITHDRAW FROM
   54  PARTICIPATION IN THE DRUG PUNISHMENT PROGRAM.  WITHDRAWAL  SHALL  BECOME
   55  EFFECTIVE ON THE LAST DAY OF THE FISCAL YEAR.
       A. 6447                            29
    1    5.  CONTINUED  FUNDING;  ADDITIONAL INCENTIVE FUND; NONCOMPLIANCE WITH
    2  PLAN.  (A) IN ORDER TO REMAIN ELIGIBLE FOR CONTINUED FUNDING, A  RECIPI-
    3  ENT  MUST  SUBSTANTIALLY  COMPLY  WITH  THE  STANDARDS  AND RULES OF THE
    4  DEPARTMENT CONCERNING PROGRAM EFFECTIVENESS, AND  EACH  RECIPIENT  SHALL
    5  PARTICIPATE IN AN EVALUATION TO DETERMINE LOCAL AND STATE PROGRAM EFFEC-
    6  TIVENESS.
    7    (B)  CONTINUED FUNDING SHALL BE BASED ON DEMONSTRATED EFFECTIVENESS IN
    8  REDUCING THE NUMBER OF COMMITMENTS TO  STATE  CORRECTIONAL  INSTITUTIONS
    9  WHICH  WOULD LIKELY HAVE OCCURRED WITHOUT THE PROGRAMS FUNDED UNDER THIS
   10  ARTICLE AND ON EVIDENCE THAT THE PROGRAMS ARE NOT DEALING  WITH  PERSONS
   11  WHO OTHERWISE WOULD HAVE BEEN SUITABLE FOR REGULAR PROBATION.
   12    (C)  SUBJECT  TO  FUNDING  AVAILABILITY,  EACH PARTICIPATING AGENCY IS
   13  ELIGIBLE TO RECEIVE ADDITIONAL INCENTIVE FUNDING TO EXTEND  PROGRAMS  TO
   14  OTHER  ELIGIBLE DRUG OFFENDERS OR TO ADD NEW DRUG PUNISHMENT PROGRAMS IF
   15  IT EXCEEDS THE OBJECTIVES OF ITS INDIVIDUAL DRUG PUNISHMENT PLAN.
   16    (D) EITHER THE DRUG OFFENDER ADVISORY BOARD OR THE DEPARTMENT  MAY  AT
   17  ANY  TIME  DETERMINE THAT THERE ARE REASONABLE GROUNDS TO BELIEVE THAT A
   18  PARTICIPATING AGENCY IS NOT COMPLYING WITH ITS PLAN, OR WITH ANY MINIMUM
   19  STANDARD ESTABLISHED PURSUANT TO THIS ARTICLE, IN WHICH CASE  THE  BOARD
   20  OR  DEPARTMENT  SHALL NOTIFY, IN WRITING, THE COMMISSIONER. UPON RECEIPT
   21  OF SUCH NOTICE, THE COMMISSIONER SHALL NOTIFY THE BOARD, THE DEPARTMENT,
   22  THE STATEWIDE PROGRAM MANAGER, AND THE ADMINISTRATOR OF THE PROGRAM,  IN
   23  WRITING, THAT A DETERMINATION AS TO COMPLIANCE WILL BE MADE AND THAT THE
   24  PARTICIPATING  AGENCY  HAS SIXTY DAYS IN WHICH TO DEMONSTRATE COMPLIANCE
   25  TO THE COMMISSIONER. UPON EXPIRATION OF THE  SIXTY-DAY  PERIOD,  IF  THE
   26  COMMISSIONER FINDS THAT THE PARTICIPATING JUDICIAL DISTRICT OR AGENCY IS
   27  NOT  COMPLYING  WITH  ITS PLAN OR WITH THE MINIMUM STANDARDS ESTABLISHED
   28  PURSUANT TO THIS ARTICLE, THE COMMISSIONER SHALL REQUIRE THE  AGENCY  TO
   29  PROVIDE  A  WRITTEN  COMPLIANCE AGREEMENT FOR THE CORRECTION OF SPECIFIC
   30  DEFICIENCIES IDENTIFIED BY THE COMMISSIONER. IF  NO  SUCH  AGREEMENT  IS
   31  SUBMITTED TO THE COMMISSIONER WITHIN THE TIME LIMIT SPECIFIED OR IF SUCH
   32  DEFICIENCIES  ARE  NOT  CORRECTED  WITHIN  FORTY-FIVE DAYS AFTER SUCH AN
   33  AGREEMENT HAS BEEN APPROVED BY THE COMMISSIONER,  THE  COMMISSIONER  MAY
   34  SUSPEND ANY PART OR ALL OF THE FUNDING UNTIL COMPLIANCE IS ACHIEVED.
   35  S 435.48 DRUG PUNISHMENT PROGRAM; ASSESSMENT AND PLACEMENT PROCEDURES.
   36    OFFENDERS WHO ARE BELIEVED BY A JUDGE OR PROBATION OFFICER TO MEET THE
   37  CRITERIA OF A DRUG OFFENDER SHALL BE SCREENED, REFERRED, AND ASSESSED AS
   38  PROVIDED FOR IN THIS SECTION.
   39    1.  OFFENDERS WHO ARE BELIEVED TO MEET THE CRITERIA OF A DRUG OFFENDER
   40  SHALL BE INITIALLY SCREENED FOR THE DRUG PUNISHMENT PROGRAM BY THE JUDGE
   41  OR PROBATION OFFICER FOR ELIGIBILITY AS A DRUG OFFENDER, INCLUDING PRIOR
   42  FELONY CONVICTIONS, PRIOR PRISON TIME SERVED, AND EVIDENCE  OF  CRIMINAL
   43  ACTIVITY LINKED TO DRUG ABUSE OR VOLUNTARY ADMISSION OF DRUG ABUSE.
   44    2. WITH RESPECT TO ALL OFFENDERS WHO ARE DETERMINED TO BE ELIGIBLE FOR
   45  THE  DRUG  PUNISHMENT PROGRAM BASED ON THE INITIAL SCREENING PURSUANT TO
   46  SUBDIVISION ONE OF THIS SECTION, THE JUDGE SHALL  REQUEST,  OBTAIN,  AND
   47  CONSIDER,  AS PART OF A SUMMARY REPORT DESIGNED TO GIVE THE COURT INFOR-
   48  MATION CRITICAL TO ITS IMPOSITION OF SENTENCE OR PLACEMENT, A COMPREHEN-
   49  SIVE ASSESSMENT TO BE CONDUCTED BY A DRUG PUNISHMENT  PROGRAM  COMMUNITY
   50  ASSESSMENT  PROVIDER  LOCATED WITHIN THE JUDICIAL DISTRICT OF THE REFER-
   51  RING PROBATION OFFICER OR COURT. WHEN POSSIBLE AND APPROPRIATE,  SEVERAL
   52  DRUG   PUNISHMENT   PROGRAM  COMMUNITY  ASSESSMENT  PROVIDERS  SHALL  BE
   53  CONTRACTED TO PROVIDE ASSESSMENTS WITHIN A JUDICIAL DISTRICT.
   54    3. A REFERRAL FOR A DRUG PUNISHMENT PROGRAM  COMPREHENSIVE  ASSESSMENT
   55  SHALL  BE  ACCOMPANIED  BY  A  COPY  OF THE INITIAL SCREENING INSTRUMENT
   56  PERFORMED BY THE JUDGE OR PROBATION OFFICER AND  ALL  AVAILABLE  RECORDS
       A. 6447                            30
    1  DESCRIBING  THE OFFENDER'S DRUG ABUSE, PSYCHOSOCIAL, AND CRIMINAL HISTO-
    2  RIES, INCLUDING DRUG TESTING RESULTS, PRIOR PARTICIPATION IN DRUG  ABUSE
    3  TREATMENT, ARRESTS, PROBATION VIOLATIONS, AND ANY OTHER PERTINENT INFOR-
    4  MATION.  LEGAL  COUNSEL  OF  THE  DEPARTMENT SHALL PROVIDE FOR EXPEDITED
    5  REVIEW AND RELEASE OF  SUCH  RECORDS  TO  THE  COMPREHENSIVE  ASSESSMENT
    6  PROVIDER.
    7    4. THE DRUG PUNISHMENT PROGRAM COMPREHENSIVE ASSESSMENT SHALL ADDRESS,
    8  AT A MINIMUM, THE FOLLOWING AREAS:
    9    (A) HISTORY OF DRUG ABUSE AND DEPENDENCY.
   10    (B)  HISTORY  OF  CRIME AND HOW SUCH HISTORY RELATES TO THE OFFENDER'S
   11  DRUG ABUSE.
   12    (C) HISTORY OF DRUG ABUSE TREATMENT.
   13    (D) MENTAL HEALTH SYMPTOMS.
   14    (E) RECENT VIOLENT OR AGGRESSIVE BEHAVIOR.
   15    5. THE DRUG PUNISHMENT PROGRAM COMPREHENSIVE ASSESSMENT  PROVIDER  MAY
   16  ELECT  TO TERMINATE THE EVALUATION IF THE OFFENDER FAILS TO COOPERATE IN
   17  PROVIDING NEEDED INFORMATION. THE REFERRING JUDGE OR  PROBATION  OFFICER
   18  SHALL BE PROVIDED WITH THE RATIONALE FOR TERMINATION OF ANY DRUG PUNISH-
   19  MENT COMPREHENSIVE ASSESSMENT.
   20    6.  EACH  DRUG  PUNISHMENT  COMPREHENSIVE  ASSESSMENT  REPORT SHALL BE
   21  COMPLETED AND DELIVERED TO THE PROBATION OFFICER AND TO THE COURT WITHIN
   22  SEVENTY-TWO  HOURS  AFTER  RECEIVING  THE  DRUG  PUNISHMENT   ASSESSMENT
   23  REQUEST,  UNLESS  ADDITIONAL  TIME  IS AUTHORIZED BY THE REFERRING JUDGE
   24  BASED ON NEED THEREFOR.
   25    7. IF THE  DRUG  PUNISHMENT  PROGRAM  ASSESSMENT  PROVIDER  RECOMMENDS
   26  AGAINST  ADMISSION TO THE DRUG PUNISHMENT PROGRAM, THE ASSESSMENT REPORT
   27  SHALL RECOMMEND DRUG ABUSE TREATMENT MODALITIES AND  COMMUNITY  SETTINGS
   28  FOR  SUCH  ADDITIONAL  SERVICES  AS ARE NEEDED TO PROMOTE THE OFFENDER'S
   29  REHABILITATION AND HIS RECOVERY FROM DRUG ABUSE AND DEPENDENCY.
   30    8. A DRUG OFFENDER SHALL BE ADMITTED TO THE  DRUG  PUNISHMENT  PROGRAM
   31  ONLY  WHEN PLACED IN THE PROGRAM BY THE COURT BASED UPON THE RECOMMENDA-
   32  TION OF A DRUG PUNISHMENT PROGRAM ASSESSMENT PROVIDER.
   33    9. (A) ASSIGNMENT TO THE DRUG PUNISHMENT PROGRAM SHALL OCCUR FOLLOWING
   34  A PROBATION HEARING OR A PROBATION OR COMMUNITY CONTROL MODIFICATION  OR
   35  REVOCATION HEARING.
   36    (B) FOR ANY OFFENDER WHO MEETS THE CRITERIA OF A DRUG OFFENDER AND WHO
   37  IS  DETERMINED  BY THE DRUG PUNISHMENT PROGRAM ASSESSMENT PROVIDER TO BE
   38  ELIGIBLE FOR THE DRUG PUNISHMENT  PROGRAM,  THE  COURT  MAY  IMPOSE  THE
   39  CONDITIONS  OF PROBATION OR MODIFY THE CONDITIONS OF PROBATION OR COMMU-
   40  NITY CONTROL TO REQUIRE THE DRUG OFFENDER TO ENTER THE  DRUG  PUNISHMENT
   41  PROGRAM  AND  TO  REMAIN  IN  SUCH  PROGRAM FOR A TERM OF UP TO EIGHTEEN
   42  MONTHS, DURING WHICH TERM THE DRUG OFFENDER MUST  PARTICIPATE  FULLY  IN
   43  AND  SUCCESSFULLY COMPLETE THE DRUG PUNISHMENT PROGRAM OR FACE THE LIKE-
   44  LIHOOD OF INCARCERATION IN PRISON.
   45    (C) THE COURT SHALL IMPOSE, AS A CONDITION OF A DRUG  OFFENDER'S  DRUG
   46  TREATMENT  PROBATION, THAT HE SIGN A FORM WHICH SHALL BE PROVIDED BY THE
   47  DEPARTMENT AND WHICH GIVES  THE  DRUG  OFFENDER'S  INFORMED  CONSENT  TO
   48  TREATMENT AND CONSENT TO THE RELEASE OF THE RECORDS AND INFORMATION.
   49    10.  IF  THERE  IS NOT AN AVAILABLE BED IN AN EXISTING DRUG PUNISHMENT
   50  PROGRAM FACILITY WITHIN THE JUDICIAL DISTRICT, THE DRUG OFFENDER MAY  BE
   51  PLACED  ON  A  WAITING  LIST  AND SHALL BE ADMITTED TO A DRUG PUNISHMENT
   52  PROGRAM FACILITY AT THE EARLIEST POSSIBLE DATE.
   53  S 435.50 RECORDS OF DRUG PUNISHMENT  PROGRAM  ASSESSMENT  AND  TREATMENT
   54             PROVIDERS; CONFIDENTIALITY.
   55    DRUG  TEST  RESULTS  MAY  BE  DIVULGED  TO THE DRUG PUNISHMENT PROGRAM
   56  TREATMENT COMMUNITY AND DEPARTMENT PERSONNEL WHO ARE INVOLVED  WITH  THE
       A. 6447                            31
    1  DRUG  OFFENDER.  ALL  RECORDS  OF DRUG PUNISHMENT PROGRAM ASSESSMENT AND
    2  TREATMENT PROVIDERS SHALL BE MAINTAINED BY THE INDIVIDUAL  PROVIDER  AND
    3  SHALL  INCLUDE  THE DRUG OFFENDER'S ASSESSMENT AND TREATMENT INFORMATION
    4  AND SUCH OTHER INFORMATION AS MAY BE REQUIRED UNDER RULES OF THE DEPART-
    5  MENT.   UNLESS WAIVED BY EXPRESS AND INFORMED CONSENT BY THE DRUG OFFEN-
    6  DER OR HIS GUARDIAN OR,  IF  THE  DRUG  OFFENDER  IS  DECEASED,  BY  HIS
    7  PERSONAL  REPRESENTATIVE  OR  BY  THE  PERSON WHO STANDS NEXT IN LINE OF
    8  INTESTATE SUCCESSION, THE PRIVILEGED  AND  CONFIDENTIAL  STATUS  OF  THE
    9  CLINICAL  ASSESSMENT  AND  TREATMENT  RECORD SHALL NOT BE LOST BY EITHER
   10  AUTHORIZED OR UNAUTHORIZED DISCLOSURE.
   11    1. DRUG PUNISHMENT PROGRAM ASSESSMENT AND TREATMENT RECORDS SHALL  NOT
   12  BE PUBLIC RECORDS AND SHALL NOT BE RELEASED, EXCEPT:
   13    (A)  TO SUCH PERSONS AND AGENCIES AS ARE DESIGNATED BY THE DRUG OFFEN-
   14  DER OR HIS GUARDIAN.
   15    (B) TO PERSONS AUTHORIZED BY ORDER OF COURT, EXCLUDING MATTERS  PRIVI-
   16  LEGED BY OTHER PROVISIONS OF LAW.
   17    (C) TO A QUALIFIED RESEARCHER, A STAFF MEMBER OF THE DESIGNATED TREAT-
   18  MENT  FACILITY,  OR AN EMPLOYEE OF THE DEPARTMENT WHEN THE ADMINISTRATOR
   19  OF THE FACILITY OR THE COMMISSIONER DEEMS IT NECESSARY FOR TREATMENT  OF
   20  THE  DRUG  OFFENDER,  MAINTENANCE  OF  ADEQUATE  RECORDS, COMPILATION OF
   21  TREATMENT DATA, OR EVALUATION OF PROGRAMS.
   22    (D) FOR STATISTICAL  AND  RESEARCH  PURPOSES  IF  THE  INFORMATION  IS
   23  ABSTRACTED  IN  SUCH A WAY AS TO PROTECT THE IDENTITY OF INDIVIDUAL DRUG
   24  OFFENDERS.
   25    2. ANY LAW ENFORCEMENT AGENCY, DESIGNATED TREATMENT FACILITY,  GOVERN-
   26  MENTAL OR COMMUNITY AGENCY, OR OTHER ENTITY RECEIVING INFORMATION PURSU-
   27  ANT  TO  THIS  SECTION SHALL MAINTAIN SUCH INFORMATION AS A CONFIDENTIAL
   28  RECORD AS PROVIDED IN THIS SECTION.
   29    3. (A) THE DEPARTMENT SHALL PROVIDE TO THE COURTS FORMS TO  BE  SIGNED
   30  AS  A  CONDITION  OF DRUG TREATMENT PROBATION, PROVIDING THE DRUG OFFEN-
   31  DERS' INFORMED CONSENT TO TREATMENT AND CONSENT TO  RELEASE  OF  RECORDS
   32  AND INFORMATION.
   33    (B)  ALL  DRUG PUNISHMENT PROGRAM ASSESSMENT AND TREATMENT RECORDS ARE
   34  CONFIDENTIAL TO THE EXTENT DESCRIBED IN THIS SECTION.
   35    4. THE DEPARTMENT SHALL  HAVE  FULL  ACCESS  TO  ALL  DRUG  PUNISHMENT
   36  PROGRAM  RECORDS  TO  ENSURE  COORDINATION  OF  DRUG  PUNISHMENT PROGRAM
   37  SERVICES, AND SHALL PROVIDE TO THE  PROGRAM  EVALUATOR  ALL  INFORMATION
   38  NEEDED TO PERFORM THE EVALUATION PROGRAM.
   39  S 435.53 INFORMATION SYSTEMS.
   40    1. FOR THE PURPOSE OF ASSISTING IN ADMINISTRATION, AND DRUG PUNISHMENT
   41  TREATMENT  DECISION-MAKING  WHEN APPLICABLE, ALL DRUG PUNISHMENT PROGRAM
   42  ASSESSMENT AND TREATMENT PROVIDERS SHALL MAINTAIN A CENTRAL  IDENTIFICA-
   43  TION FILE ON THE DRUG OFFENDERS THEY ASSESS OR TREAT.
   44    2.  ALL  DRUG  PUNISHMENT  PROGRAM  ASSESSMENT AND TREATMENT PROVIDERS
   45  SHALL COLLECT, MAINTAIN, AND REPORT TO THE  DEPARTMENT  ALL  INFORMATION
   46  NECESSARY  TO  COMPLY WITH MANDATORY REPORTING, PURSUANT TO DEPARTMENTAL
   47  RULES. COMPLIANCE WITH THIS  SUBDIVISION  SHALL  BE  MADE  PART  OF  THE
   48  CONTRACTUAL DUTIES OF EACH DRUG PUNISHMENT PROGRAM PROVIDER.
   49    3.  A  STATEWIDE AUTOMATED TRACKING SYSTEM FOR DRUG PUNISHMENT PROGRAM
   50  OFFENDERS SHALL BE DEVELOPED AND IMPLEMENTED BY THE  DIVISION  OF  STATE
   51  POLICE.
   52  S 435.55 DRUG PUNISHMENT PROGRAM.
   53    THE DRUG PUNISHMENT PROGRAM SHALL BE AS FOLLOWS:
   54    1. PHASE I: INTENSIVE RESIDENTIAL. UP TO SIX MONTHS OF INTENSIVE RESI-
   55  DENTIAL  TREATMENT  IN  A DESIGNATED MODIFIED TREATMENT COMMUNITY SECURE
   56  RESIDENTIAL INSTITUTION. PHASE I INSTITUTIONS SHALL CONSIST OF  SEPARATE
       A. 6447                            32
    1  SECURE  INTAKE  RESIDENTIAL UNITS, AND MAY BE DESIGNED FOR COED PROGRAM-
    2  MING, ACCORDING TO THE NEED FOR  TREATMENT  SLOTS  WITHIN  THE  JUDICIAL
    3  DISTRICT.
    4    (A)  UPON  ADMISSION TO A DRUG PUNISHMENT PROGRAM TREATMENT COMMUNITY,
    5  DRUG OFFENDERS SHALL BE HOUSED IN A SEPARATE INTAKE  UNIT  IN  ORDER  TO
    6  PARTICIPATE IN A SERIES OF SPECIALIZED INTENSIVE ORIENTATION ACTIVITIES,
    7  INCLUDING, BUT NOT LIMITED TO, ACTIVITIES DESIGNED TO INITIATE AWARENESS
    8  AND UNDERSTANDING BY EACH DRUG OFFENDER OF THE CONSEQUENCES OF HIS FAIL-
    9  URE IN THE DRUG PUNISHMENT PROGRAM.
   10    (B)  AFTER  ENTERING  EACH DRUG PUNISHMENT PROGRAM TREATMENT PHASE, AN
   11  INDIVIDUALIZED DRUG PUNISHMENT PLAN SHALL  BE  DEVELOPED  FOR  THE  DRUG
   12  OFFENDER  BY  A  TREATMENT  TEAM  FROM THE DRUG PUNISHMENT PROGRAM, WITH
   13  NOTICE TO AND RIGHT OF MODIFICATION BY THE DEPARTMENT. SUCH  PLAN  SHALL
   14  INCLUDE, BUT IS NOT LIMITED TO:
   15    (1)  A  DESCRIPTION  OF  MEASURABLE  GOALS FOR THE DRUG OFFENDER, WITH
   16  SPECIFIC TREATMENT INTERVENTIONS RECOMMENDED TO MEET EACH GOAL.
   17    (2) MEASURABLE BEHAVIORAL CRITERIA FOR SUCCESSFUL  COMPLETION  OF  THE
   18  TREATMENT PHASE WHICH THE DRUG OFFENDER HAS JUST ENTERED.
   19    (3)  A  DESCRIPTION  OF THE TREATMENT PLANNED FOR THE TREATMENT PHASE,
   20  THE STAFF RESPONSIBLE FOR MONITORING TREATMENT, AND THE DATES OF  ANTIC-
   21  IPATED DRUG PUNISHMENT PLAN REVIEW.
   22    (C)  FOLLOWING  COMPLETION  OF THE INTAKE PROCESS AND DEVELOPMENT OF A
   23  DRUG PUNISHMENT PLAN, DRUG OFFENDERS MUST COMPLETE A PROGRAM  OF  UP  TO
   24  SIX MONTHS OF COMPREHENSIVE DRUG ABUSE TREATMENT PRIOR TO BEING ASSIGNED
   25  TO A DRUG PUNISHMENT PROGRAM PHASE II TREATMENT UNIT.
   26    (D) ROUTINE AND RANDOM DRUG TESTING SHALL BE CONDUCTED DURING PHASE I.
   27    DURING  PHASE  I,  ENTRY  INTO  AND EXIT FROM INSTITUTIONAL FACILITIES
   28  SHALL BE MONITORED, BUT THE PURPOSE OF SUCH MONITORING SHALL NOT  BE  TO
   29  PHYSICALLY  PROHIBIT  ABSCONDING.  AN  ABSCONDING  SHALL BE CONSIDERED A
   30  VIOLATION OF A CONDITION OF PROBATION.
   31    2. PHASE II: GRADUATED REENTRY. UP TO THREE MONTHS OF EMPLOYMENT EXPE-
   32  RIENCE AND TRANSITION WORK IN A COMMUNITY REENTRY  RESIDENTIAL  SETTING.
   33  PHASE  II  DRUG PUNISHMENT PROGRAM FACILITIES SHALL CONSIST OF COMMUNITY
   34  REENTRY RESIDENTIAL FACILITIES.
   35    (A) FOLLOWING TRANSFER  TO  PHASE  II,  THE  DRUG  OFFENDER  SHALL  BE
   36  ASSIGNED  A PRIMARY DRUG PUNISHMENT PROGRAM COUNSELOR TO ASSIST THE CASE
   37  MANAGEMENT COUNSELOR IN DEVELOPING A DRUG PUNISHMENT PLAN FOR THE  PHASE
   38  AND  IN  MONITORING  THE DRUG OFFENDER'S PROGRESS THROUGH THE PHASE. THE
   39  DRUG PUNISHMENT PROGRAM COUNSELOR SHALL PROVIDE, ON A FORM  PROVIDED  BY
   40  THE  DRUG OFFENDER ADVISORY BOARD, A COPY OF THE DRUG PUNISHMENT PLAN TO
   41  THE SUPERVISING  PROBATION  OFFICER  AND  SHALL  PROVIDE  BRIEF  MONTHLY
   42  UPDATES  ON  THE  DRUG OFFENDER'S PROGRAM PERFORMANCE TO THE SUPERVISING
   43  PROBATION OFFICER AND THE COURT.
   44    (B) ROUTINE AND RANDOM DRUG TESTING SHALL BE  CONDUCTED  DURING  PHASE
   45  II.
   46    (C) A CASE MANAGEMENT COUNSELOR SHALL IDENTIFY VOCATIONAL TRAINING AND
   47  EMPLOYMENT  OPPORTUNITIES,  HOUSING,  AND OTHER SUPPORT SERVICES FOR THE
   48  DRUG OFFENDER IN THE COMMUNITY.
   49    (D) PRIOR TO A DRUG  OFFENDER'S  COMPLETION  OF  PHASE  II,  THE  CASE
   50  MANAGEMENT  COUNSELOR  SHALL  IDENTIFY  AN  OUTPATIENT  COUNSELOR FROM A
   51  DESIGNATED DRUG PUNISHMENT PROGRAM PROVIDER AGENCY WHO SHALL BE  RESPON-
   52  SIBLE FOR DELIVERING AT LEAST NINE MONTHS OF OUTPATIENT FOLLOW-UP TREAT-
   53  MENT  SERVICES, IN CLOSE PROXIMITY TO THE DRUG OFFENDER'S PLACE OF RESI-
   54  DENCE, DURING PHASE III. THE OUTPATIENT SERVICE PROVIDER SHALL RECEIVE A
   55  COPY OF THE DRUG OFFENDER'S AFTERCARE PLAN AS DESCRIBED IN PARAGRAPH (E)
       A. 6447                            33
    1  OF THIS SUBDIVISION FROM THE CASE MANAGER FOR THE SUPERVISED  OUTPATIENT
    2  PHASE OF THE DRUG PUNISHMENT PROGRAM.
    3    (E)  A  DRUG  OFFENDER'S AFTERCARE PLAN SHALL INCLUDE A DESCRIPTION OF
    4  THE FOLLOWING:
    5    (1) TREATMENT AND REHABILITATION GOALS AND KEY AREAS OF DIFFICULTIES.
    6    (2) DRUG PUNISHMENT PLAN ACTIVITIES COMPLETED BY THE DRUG OFFENDER.
    7    (3) THE DRUG OFFENDER'S AREAS OF PROGRESS AND DISCIPLINARY ACTIONS.
    8    (4) THE PRESENT STATUS OF THE DRUG OFFENDER WITH RESPECT TO  HIS  DRUG
    9  PUNISHMENT PLAN.
   10    (5)  THE  DRUG PUNISHMENT PLAN GOALS THAT SHOULD BE ADDRESSED IN PHASE
   11  III, DURING WHICH  PHASE  TREATMENT  SHALL  BE  PROVIDED  IN  THE  LEAST
   12  RESTRICTIVE  SETTING  IN  WHICH  THE  GOALS FOR THE DRUG OFFENDER CAN BE
   13  ACCOMPLISHED.
   14    3. PHASE III: SUPERVISED OUTPATIENT. AT LEAST NINE  MONTHS  OF  SUPER-
   15  VISED  COMMUNITY  OUTPATIENT  TREATMENT,  DECREASING IN INTENSITY AS THE
   16  DRUG OFFENDER RESPONDS TO TREATMENT  AND  BECOMES  APPROPRIATELY  ESTAB-
   17  LISHED IN THE COMMUNITY.
   18    (A) THE DEPARTMENT SHALL DEVELOP AND IMPLEMENT STANDARDS FOR PROVIDING
   19  SUPERVISION  OF THE OFFENDER, WHICH SHALL BE COMPARABLE TO THOSE ASSOCI-
   20  ATED WITH THE COMMUNITY CONTROL PROGRAM.
   21    (B) DURING PHASE III, THE DRUG OFFENDER SHALL RESIDE IN HIS COMMUNITY.
   22  THE PROBATION OFFICER SHALL MAINTAIN A PER WEEK MINIMUM OF TWO  FACE-TO-
   23  FACE CONTACTS, ONE OF WHICH IS IN THE DRUG OFFENDER'S RESIDENCE. NO LESS
   24  THAN  ONE CONTACT EVERY OTHER WEEK SHALL BE ANY EVENING CONTACT, AND THE
   25  PROBATION OFFICER SHALL VISIT THE DRUG OFFENDER'S RESIDENCE NO LESS THAN
   26  EVERY OTHER WEEKEND AND SHALL MAINTAIN DAILY TELEPHONE CONTACT WITH  THE
   27  DRUG OFFENDER, INCLUDING ON WEEKENDS.
   28    (C) ROUTINE AND RANDOM DRUG TESTING SHALL BE CONDUCTED AT LEAST WEEKLY
   29  DURING PHASE III.
   30    (D)  THE  DRUG  OFFENDER  SHALL PARTICIPATE IN FULL-TIME EMPLOYMENT OR
   31  VOCATIONAL TRAINING DURING PHASE III.
   32    (E) MAJOR GOALS OF PHASE III INCLUDE, BUT ARE NOT LIMITED TO:
   33    (1) REHEARSAL AND REFINEMENT OF THE DRUG OFFENDER'S RELAPSE PREVENTION
   34  STRATEGIES.
   35    (2) CONTINUED WORK TOWARD  COMPLETION  OF  THE  DRUG  OFFENDER'S  DRUG
   36  PUNISHMENT PLAN.
   37    (3)  MAINTENANCE  OF  BEHAVIOR  CHANGES  ACHIEVED BY THE DRUG OFFENDER
   38  DURING THE FIRST TWO PHASES OF TREATMENT.
   39    (F) FOLLOW-UP TREATMENT  SHALL  PROVIDE  AT  LEAST  THREE  THREE-MONTH
   40  LEVELS  OF  DECREASING  INTENSITY  TO  ENSURE ADEQUATE MONITORING OF AND
   41  SUPPORT FOR THE DRUG OFFENDER IN A GRADUATED TRANSITION  TO  INDEPENDENT
   42  LIVING  WHICH INCLUDES ATTENDANCE IN WEEKLY GROUP SESSIONS AND SELF-HELP
   43  GROUPS, WHICH MAY INCLUDE ALCOHOLICS ANONYMOUS, NARCOTICS ANONYMOUS, AND
   44  COCAINE ANONYMOUS.
   45    (G) AFTER THE DRUG OFFENDER HAS SUCCESSFULLY COMPLETED ALL  PHASES  OF
   46  THE  DRUG  PUNISHMENT  PROGRAM, AND WITHIN ONE MONTH AFTER COMPLETION OF
   47  THE FOLLOW-UP PROGRAM, THE DRUG  OFFENDER'S  TREATMENT  COUNSELOR  SHALL
   48  PREPARE  A  DRUG PUNISHMENT PROGRAM COMPLETION SUMMARY THAT INCLUDES THE
   49  DRUG OFFENDER'S PROGRESS IN OUTPATIENT TREATMENT AND REHABILITATION  AND
   50  ANY  RECOMMENDATIONS  FOR FURTHER TREATMENT, COUNSELING, OR OTHER SOCIAL
   51  OR REHABILITATIVE SERVICES FOR THE DRUG OFFENDER.
   52    4. TERMINATION FROM DRUG PUNISHMENT PROGRAM. AN OFFENDER PLACED IN THE
   53  DRUG PUNISHMENT PROGRAM AS A RESULT  OF  A  CONDITION  OF  PROBATION  IS
   54  SUBJECT  TO  REVOCATION  OF  PROBATION.  THE  DEPARTMENT  SHALL ASSIGN A
   55  PROBATION OFFICER TO THE FACILITY PROVIDING SERVICES AS PROVIDED IN THIS
   56  SECTION. THE TREATMENT PROVIDER SHALL REPORT TO THE  ASSIGNED  PROBATION
       A. 6447                            34
    1  OFFICER  SUCH  BEHAVIOR  WHICH  MAY CONSTITUTE A VIOLATION OF ANY OF THE
    2  CONDITIONS OF PROBATION. THE PROVIDER SHALL RECOMMEND TO  THE  PROBATION
    3  OFFICER  WHAT  ACTION  SHOULD  BE  TAKEN  WITH  RESPECT  TO  THE ALLEGED
    4  VIOLATIONS,  AND  THE  OFFICER  SHALL PROVIDE A REPORT TO THE COURT WITH
    5  RECOMMENDATIONS.
    6    5. DISCIPLINE IN DRUG PUNISHMENT PROGRAM  TREATMENT  COMMUNITIES.    A
    7  SERIES  OF  GRADUATED  SANCTIONS  SHALL  BE  DEVELOPED  BY THE STATEWIDE
    8  PROGRAM MANAGER, SUBJECT TO APPROVAL OF  THE  DEPARTMENT  AND  THE  DRUG
    9  OFFENDER  ADVISORY  BOARD,  FOR  USE IN THE TREATMENT COMMUNITIES OF THE
   10  DRUG PUNISHMENT PROGRAM. THE SANCTIONS  SHALL  BE  DESIGNED  TO  PROVIDE
   11  CLEAR  CONSEQUENCES  FOR  A  DRUG  OFFENDER'S  MISCONDUCT  AS WELL AS TO
   12  PROVIDE DISCIPLINE WITHIN THE TREATMENT COMMUNITY. THE  RANGE  OF  SANC-
   13  TIONS PROVIDED FOR EACH PROGRAM PHASE SHALL BE APPROPRIATE SANCTIONS FOR
   14  THAT PHASE OF TREATMENT.
   15  NOTHING CONTAINED IN THIS SECTION SHALL CONFER A RIGHT TO OR AN EXPECTA-
   16  TION OF A RIGHT TO TREATMENT.
   17  S 435.60 DESIGNATED TREATMENT COMMUNITIES.
   18    1.   DESIGNATED  TREATMENT  COMMUNITIES  FOR  DRUG  OFFENDERS  MAY  BE
   19  CONTRACTED FOR OR SITED AND CONSTRUCTED BY THE  DEPARTMENT  PURSUANT  TO
   20  DEPARTMENTAL RULE, IN CONSULTATION WITH THE STATEWIDE PROGRAM MANAGER TO
   21  ENSURE  THAT TREATMENT COMMUNITY DESIGN IS COMPATIBLE WITH TREATMENT AND
   22  OTHER PROGRAM NEEDS. THE DEPARTMENT IS AUTHORIZED TO  CONTRACT  FOR  THE
   23  CONSTRUCTION  OF  THE DRUG PUNISHMENT PROGRAM TREATMENT COMMUNITY INSTI-
   24  TUTIONS. PHASE I INSTITUTIONAL DRUG PUNISHMENT PROGRAM FACILITIES  SHALL
   25  CONSIST  OF  SECURE INTAKE AND RESIDENTIAL UNITS. PHASE II INSTITUTIONAL
   26  DRUG PUNISHMENT PROGRAM FACILITIES SHALL CONSIST  OF  COMMUNITY  REENTRY
   27  FACILITIES  AND  MAY  BE  LOCATED  ON  A SINGLE SITE WITH PHASE I UNITS,
   28  PROVIDED THE PHASE I INSTITUTIONAL FACILITY IS SITED IN CLOSE  PROXIMITY
   29  TO  THE  PROGRAM'S  TREATMENT COMMUNITY RESOURCES. AN ASSESSMENT OF NEED
   30  FOR ADDITIONAL PHASE I INSTITUTIONAL FACILITIES SHALL BE CONDUCTED PRIOR
   31  TO THE SITING OR CONSTRUCTION OF MORE THAN ONE PHASE I  SECURE  RESIDEN-
   32  TIAL  INSTITUTIONAL  FACILITY  FOR  THE  DRUG  PUNISHMENT PROGRAM IN ANY
   33  PARTICULAR JUDICIAL DISTRICT.
   34    2. THE PHASE I PORTION OF TREATMENT  COMMUNITIES  FOR  DRUG  OFFENDERS
   35  SHALL  CONSIST  OF  SEPARATE  AND SECURE INSTITUTIONAL FACILITIES ESTAB-
   36  LISHED UNDER THE AUTHORITY OF THE DEPARTMENT.
   37    3. DESIGNATED  TREATMENT  COMMUNITIES  FOR  DRUG  OFFENDERS  SHALL  BE
   38  ADEQUATELY STAFFED BY THE DESIGNATED ASSESSMENT AND TREATMENT PROVIDERS,
   39  AND  THE  DEPARTMENT SHALL PROVIDE A PROBATION OFFICER FOR EACH RESIDEN-
   40  TIAL FACILITY.
   41    4. MINIMUM STANDARDS AND REQUIREMENTS FOR DESIGNATED  DRUG  PUNISHMENT
   42  PROGRAM TREATMENT COMMUNITIES SHALL BE CONTRACTUALLY PRESCRIBED PURSUANT
   43  TO SECTION 435.25 OF THIS ARTICLE.
   44    5.  NOTHING IN THIS ARTICLE SHALL BE CONSTRUED TO REQUIRE OR ALLOW THE
   45  DEPARTMENT TO PROVIDE ASSESSMENT OR TREATMENT SERVICES TO DRUG OFFENDERS
   46  IN THE DRUG PUNISHMENT PROGRAM, OTHER THAN THE COMMENCEMENT  OF  INITIAL
   47  SCREENING OF AN OFFENDER WHO MAY MEET THE CRITERIA OF A DRUG OFFENDER BY
   48  THE DEPARTMENT'S PROBATION OFFICER.
   49    6. NOTHING IN THIS ARTICLE SHALL BE CONSTRUED TO PERMIT DRUG OFFENDERS
   50  TO  BE  HOUSED OR TREATED IN LOCAL JAILS PURSUANT TO THE DRUG PUNISHMENT
   51  PROGRAM.
   52  S 435.65 CORE TREATMENT PROGRAM.
   53    1. ALL DRUG OFFENDERS IN THE DRUG PUNISHMENT PROGRAM SHALL COMPLETE  A
   54  CORE TREATMENT PROGRAM, INCLUDING, BUT NOT LIMITED TO:
   55    (A) DRUG ABUSE TREATMENT, INCLUDING:
   56    (1) RELAPSE PREVENTION.
       A. 6447                            35
    1    (2) BOTH ROUTINE AND RANDOM DRUG TESTING.
    2    (3) DRUG ABUSE EDUCATION.
    3    (4) AIDS EDUCATION.
    4    (B) MENTAL HEALTH SERVICES.
    5    (C)  PREVOCATIONAL  AND  VOCATIONAL  SERVICES, INCLUDING EMPLOYABILITY
    6  SKILLS TRAINING AND JOB TRAINING REALISTICALLY DESIGNED TO LEAD TO MEAN-
    7  INGFUL JOB PLACEMENT.
    8    (D) DIAGNOSTIC EVALUATION.
    9    (E) INDIVIDUAL THERAPY, INCLUDING TREATMENT OF CRIMINAL THOUGHT  PROC-
   10  ESSES, AND INCLUDING GROUP AND FAMILY THERAPY WHERE APPROPRIATE.
   11    (F)  INDEPENDENT LIVING SKILLS, PARENTING SKILLS, AND SELF-SUFFICIENCY
   12  SKILLS.
   13    (G) EDUCATIONAL SERVICES,  INCLUDING  SPECIAL  EDUCATION  AND  PRE-GED
   14  LITERACY SERVICES WHERE NEEDED.
   15    (H) RECREATIONAL ACTIVITIES.
   16    (I) VICTIM RESTITUTION WHERE APPROPRIATE.
   17    (J)  CASE  MANAGEMENT  SERVICES,  GENERAL  GROUP COUNSELING, SELF-HELP
   18  GROUPS, AND GRADUATED REENTRY INTO THE COMMUNITY.
   19    2. A COMPREHENSIVE EDUCATIONAL AND  VOCATIONAL  COMPONENT  WITHIN  THE
   20  DRUG  PUNISHMENT  PROGRAM  SHALL  INCLUDE  A RANGE OF SKILLS DEVELOPMENT
   21  OPPORTUNITIES TO ENABLE EACH DRUG OFFENDER TO OBTAIN SKILLS COMMENSURATE
   22  WITH HIS INTERESTS AND ABILITIES.
   23    (A) THE GOALS OF THE EDUCATIONAL AND VOCATIONAL COMPONENTS OF THE DRUG
   24  PUNISHMENT PROGRAM ARE TO:
   25    (1) ENHANCE BASIC LIFE SKILLS,
   26    (2) DEVELOP MARKETABLE VOCATIONAL SKILLS, AND
   27    (3) IMPROVE LITERACY SKILLS,
   28  SO AS TO ALLOW THE DRUG OFFENDER TO MAINTAIN TREATMENT BENEFITS AND GAIN
   29  MEANINGFUL EMPLOYMENT IN THE COMMUNITY.
   30    (B) SPECIFIC OBJECTIVES OF THE EDUCATIONAL AND  VOCATIONAL  COMPONENTS
   31  OF THE DRUG PUNISHMENT PROGRAM INCLUDE THE DEVELOPMENT OR IMPROVEMENT OF
   32  READING  SKILLS  AND THE PLACEMENT OF EACH DRUG OFFENDER INTO VOCATIONAL
   33  TRAINING OR MEANINGFUL EMPLOYMENT DURING PHASES II AND III.
   34    (C) DURING THE DRUG PUNISHMENT PROGRAM INTAKE ORIENTATION,  AN  EDUCA-
   35  TIONAL  AND  VOCATIONAL  COMPONENT OF THE INDIVIDUALIZED DRUG PUNISHMENT
   36  PLAN SHALL BE DEVELOPED FOR EACH DRUG OFFENDER, WHICH INCLUDES LITERACY,
   37  EMPLOYABILITY, AND VOCATIONAL SKILLS, ASSESSMENT,  INDIVIDUALIZED  PLAN-
   38  NING,  PARTICIPATION IN EDUCATIONAL AND VOCATIONAL ACTIVITIES, AND POST-
   39  PROGRAM PLACEMENT.
   40    (D) ADULT EDUCATION TEACHERS FOR DRUG OFFENDERS MAY BE PROVIDED BY THE
   41  LOCAL SCHOOL BOARD. ADULT BASIC EDUCATION MAY BE OFFERED DURING PHASE II
   42  OF THE DRUG PUNISHMENT PROGRAM IN LOCAL COMMUNITY COLLEGES OR  IN  OTHER
   43  SETTINGS.
   44    3.  THE CORE TREATMENT PROGRAM SHALL BE PROVIDED THROUGHOUT ALL PHASES
   45  OF A DRUG OFFENDER'S INDIVIDUAL DRUG PUNISHMENT  PLAN,  INCLUDING  PHASE
   46  III AFTERCARE.
   47  S 435.70 DRUG OFFENDER ADVISORY BOARD.
   48    1. THE DRUG OFFENDER ADVISORY BOARD IS CREATED TO SERVE IN AN ADVISORY
   49  CAPACITY  TO  THE DEPARTMENT AND THE STATEWIDE PROGRAM MANAGER AND SHALL
   50  REPRESENT THE GEOGRAPHICAL AND ETHNIC DIVERSITY OF THE STATE. MEMBERSHIP
   51  OF THE BOARD SHALL CONSIST OF THE FOLLOWING:
   52    (A) A DESIGNEE OF THE DEPARTMENT.
   53    (B) A DESIGNEE OF THE DIVISION OF PROBATION AND CORRECTIONAL  ALTERNA-
   54  TIVES.
   55    (C) A DESIGNEE OF THE PROGRAM EVALUATOR.
       A. 6447                            36
    1    (D)  A  DESIGNEE  OF  THE  OFFICE  OF  ALCOHOLISM  AND SUBSTANCE ABUSE
    2  SERVICES.
    3    (E) A JUDGE APPOINTED BY THE OFFICE OF COURT ADMINISTRATION.
    4    (F) A SHERIFF APPOINTED BY THE NEW YORK STATE SHERIFF'S ASSOCIATION.
    5    (G)  A  DISTRICT  ATTORNEY  APPOINTED  BY  THE NEW YORK STATE DISTRICT
    6  ATTORNEY'S ASSOCIATION.
    7    (H) A PUBLIC DEFENDER APPOINTED BY THE NEW YORK STATE DEFENDERS  ASSO-
    8  CIATION.
    9    (I)  A  TEACHER WHO HAS KNOWLEDGE IN THE AREAS OF ADULT BASIC LITERACY
   10  EDUCATION AND VOCATIONAL EDUCATION, APPOINTED  BY  THE  COMMISSIONER  OF
   11  EDUCATION.
   12    (J)  REPRESENTATIVES FROM THREE NONPROFIT DRUG TREATMENT AGENCIES WITH
   13  EXPERIENCE IN TREATING DRUG ABUSING OFFENDERS, APPOINTED BY THE  DEPART-
   14  MENT.
   15  THE  SHERIFF,  DISTRICT ATTORNEY, JUDGE, AND PUBLIC DEFENDER SHALL SERVE
   16  ON THE ADVISORY BOARD DURING THEIR TERMS OF OFFICE. IN ORDER TO  PROVIDE
   17  STAGGERED  TERMS,  TWO  OF  THE  REPRESENTATIVES FROM THE NONPROFIT DRUG
   18  TREATMENT AGENCIES AND THE TEACHER SHALL BE INITIALLY APPOINTED TO TERMS
   19  OF THREE YEARS, AND THEREAFTER TO TERMS  OF  TWO  YEARS.  THE  REMAINING
   20  MEMBERS  SHALL BE FILLED IN THE SAME MANNER AS ORIGINAL APPOINTMENTS FOR
   21  ANY UNEXPIRED TERM. MEMBERS OF THE ADVISORY BOARD MAY BE REAPPOINTED  IN
   22  ACCORDANCE WITH THE REQUIREMENTS OF THIS SUBDIVISION.
   23    2. MAJOR RESPONSIBILITIES OF THE BOARD ARE:
   24    (A)  TO  PREPARE  AND SUBMIT FOR DEPARTMENT APPROVAL A DRUG PUNISHMENT
   25  PLAN IN ACCORDANCE WITH THE PROVISIONS OF THIS ARTICLE,  AND  TO  ENSURE
   26  THAT  THE  ASSESSMENT,  TREATMENT, AND EVALUATION COMPONENTS OF THE DRUG
   27  PUNISHMENT PROGRAM ARE CONDUCTED IN AN EFFECTIVE AND TIMELY MANNER.
   28    (B) TO REVIEW REQUESTS FOR APPLICATIONS OF PROVIDERS TO RENDER ASSESS-
   29  MENT OR TREATMENT SERVICES IN THE DRUG PUNISHMENT PROGRAM.
   30    (C) TO REVIEW PREQUALIFIED PROPOSALS  FOR  THE  PURPOSE  OF  MAKING  A
   31  RECOMMENDATION TO THE DEPARTMENT.
   32    (D)  TO  REVIEW SITE ACQUISITION FOR DRUG PUNISHMENT PROGRAM TREATMENT
   33  INSTITUTIONAL COMMUNITIES.
   34    (E) TO REVIEW ARCHITECTURAL PROTOTYPES OF PHASE I AND PHASE II  TREAT-
   35  MENT INSTITUTIONAL COMMUNITIES.
   36    (F)  TO  REVIEW  TRAINING  AND TREATMENT CURRICULA FOR DRUG PUNISHMENT
   37  PROGRAM PROVIDERS AND STAFF.
   38    (G) TO PROVIDE OVERVIEW AND COORDINATION OF  DRUG  PUNISHMENT  PROGRAM
   39  PROVIDERS,  THE  DEPARTMENT,  THE  PROGRAM  EVALUATOR, AND THE TREATMENT
   40  COMMUNITIES OF THE DRUG PUNISHMENT PROGRAM.
   41    3. THE BOARD SHALL ALSO:
   42    (A) ASSESS STATEWIDE NEEDS AND ADVISE THE DEPARTMENT AND THE  LEGISLA-
   43  TURE  REGARDING  SPECIFIC DRUG TREATMENT PROGRAM OPTIONS NEEDED FOR DRUG
   44  OFFENDERS.
   45    (B) RECOMMEND THE ESTABLISHMENT OF  LOCAL  ELIGIBILITY  STANDARDS  FOR
   46  LOCAL DRUG TREATMENT PROGRAMS WHICH MEET THE NEEDS OF THE PLAN.
   47    (C) RECOMMEND DRUG TREATMENT GUIDELINES.
   48    (D) RECOMMEND DRUG PUNISHMENT PROGRAM POLICIES.
   49    (E) RECOMMEND TO THE DEPARTMENT THOSE PROVIDERS WHO MEET OR EXCEED THE
   50  MINIMUM STANDARDS ESTABLISHED BY THE BOARD.
   51    (F)  PROVIDE OVERVIEW OF THE QUALITY ASSURANCE CONDUCTED BY THE STATE-
   52  WIDE PROGRAMS MANAGER OF THE DRUG TREATMENT SERVICES IN THE PROGRAM  AND
   53  REPORT AND ADVISE THE DEPARTMENT OF NEEDED MODIFICATIONS.
   54    (G)  INFORM  AND  EDUCATE  THE  GENERAL  PUBLIC REGARDING THE NEED FOR
   55  DIVERSION OF ELIGIBLE DRUG OFFENDERS FROM  CONFINEMENT  IN  CORRECTIONAL
   56  INSTITUTIONS TO DRUG TREATMENT PROGRAMS.
       A. 6447                            37
    1    4. NO MEMBER OF THE BOARD SHALL BE A RECIPIENT OF CONTRACTUAL SERVICES
    2  FOR  THE  ASSESSMENT,  TREATMENT,  OR EVALUATION OF OFFENDERS UNDER THIS
    3  ARTICLE.
    4    5. THE BOARD SHALL MEET REGULARLY TO TRANSACT BUSINESS AND SHALL ELECT
    5  ITS OWN CHAIRMAN, VICE CHAIRMAN, SECRETARY, AND NECESSARY COMMITTEES.
    6    6. BOARD MEMBERS SHALL RECEIVE PER DIEM AND TRAVEL EXPENSES.
    7  S 435.75 DRUG  PUNISHMENT PROGRAM QUALITY ASSURANCE COMPONENT; DUTIES OF
    8             STATEWIDE PROGRAM MANAGER.
    9    IN ORDER TO ENSURE THE QUALITY AND APPROPRIATENESS OF THE DELIVERY  OF
   10  SERVICES  WITHIN  THE  DRUG  PUNISHMENT  PROGRAM,  THE STATEWIDE PROGRAM
   11  MANAGER SHALL:
   12    1. CONDUCT AN ANNUAL UTILIZATION REVIEW TO ENSURE THE APPROPRIATE  USE
   13  AND  EFFICIENT  SCHEDULING  OF  DRUG PUNISHMENT PROGRAM RESOURCES AND TO
   14  ASSIST IN THE MAINTENANCE OF HIGH QUALITY CARE AT ALL TREATMENT INSTITU-
   15  TIONAL COMMUNITIES. THE UTILIZATION REVIEW SHALL  INCLUDE  AN  OBJECTIVE
   16  REVIEW, THROUGHOUT THE DRUG PUNISHMENT PROGRAM, OF THE FOLLOWING:
   17    (A) ADMISSIONS AND TERMINATIONS DECISIONS.
   18    (B) TRANSITIONAL CARE PLANNING.
   19    (C) DISCHARGE PLANNING.
   20    (D) CONTINUED STAY DECISIONS.
   21    (E) USE OF ADJUNCT REFERRAL SERVICES.
   22    2.  CONDUCT  ONGOING  CLIENT  CARE  MONITORING  TO ENSURE THAT QUALITY
   23  SERVICES ARE DELIVERED. CLIENT CARE MONITORING SHALL CONSIST OF  REGULAR
   24  REVIEWS  OF  THE INDIVIDUALIZED DRUG PUNISHMENT PLANS OF DRUG OFFENDERS,
   25  APPROPRIATE REVIEWS OF  DIFFICULT  CASES,  AND  TIMELY  AND  APPROPRIATE
   26  CRISIS MANAGEMENT. CRISIS MANAGEMENT IS APPROPRIATE WHERE:
   27    (A)  THE  DRUG  OFFENDER  IS  DETERMINED  TO BE A DANGER TO HIMSELF OR
   28  OTHERS;
   29    (B) THE DRUG OFFENDER IS AT HIGH RISK FOR RELAPSE; OR
   30    (C) THE DRUG OFFENDER HAS DIFFICULTY CARRYING OUT HIS DRUG  PUNISHMENT
   31  PLAN.
   32    3.  CONDUCT ONGOING QUALITY MONITORING AND EVALUATION OF THE APPROPRI-
   33  ATENESS OF TREATMENT PROVIDED  TO  DRUG  OFFENDERS,  FOCUSING  ON  STAFF
   34  PERFORMANCE RATHER THAN ON THE OFFENDERS.
   35    4.  PROVIDE  STAFF  DEVELOPMENT  PROGRAMS  FOR DRUG PUNISHMENT PROGRAM
   36  ASSESSMENT AND  TREATMENT  PROVIDERS,  INCLUDING  INITIAL  TRAINING  AND
   37  ORIENTATION.
   38    5.  PROVIDE TREATMENT COMMUNITY DESIGN ASSISTANCE PURSUANT TO CONTRAC-
   39  TUAL AUTHORIZATION AS PROVIDED IN PARAGRAPH (D) OF  SUBDIVISION  TWO  OF
   40  SECTION 435.25 OF THIS ARTICLE.
   41  S 435.80 DRUG PUNISHMENT PROGRAM EVALUATION.
   42    IN  ORDER  TO  DETERMINE  THE  EFFECTIVENESS  OF  THE  DRUG PUNISHMENT
   43  PROGRAM, THE DEPARTMENT SHALL CONTRACT WITH A PROGRAM EVALUATOR  OF  THE
   44  STATEWIDE  DRUG  PUNISHMENT  PROGRAM TO CONDUCT AN ONGOING COMPREHENSIVE
   45  EVALUATION PROGRAM PURSUANT TO THIS PART.
   46    1. THE GOALS OF THE EVALUATION PROGRAM ARE:
   47    (A) TO DETERMINE THE EFFECTIVENESS OF THE DRUG PUNISHMENT  PROGRAM  IN
   48  REDUCING  CRIMINAL  BEHAVIOR,  ARRESTS,  AND  COMMITMENTS  TO  THE STATE
   49  CORRECTIONAL SYSTEM.
   50    (B) TO EVALUATE THE POST-TREATMENT COMMUNITY ADJUSTMENT OF DRUG OFFEN-
   51  DERS IN THE AREAS OF DRUG ABUSE, EMPLOYMENT,  INVOLVEMENT  IN  TREATMENT
   52  SERVICES, AND USE OF OTHER COMMUNITY SERVICES.
   53    (C)  TO  EXAMINE THE COST EFFECTIVENESS OF THE DRUG PUNISHMENT PROGRAM
   54  RELATIVE TO THE COSTS OF TRADITIONAL INSTITUTIONAL COMMITMENT AND COMMU-
   55  NITY SUPERVISION.
       A. 6447                            38
    1    (D) TO ASSESS IMPROVEMENTS MADE BY DRUG OFFENDERS THROUGHOUT THE PHAS-
    2  ES OF THE DRUG PUNISHMENT PROGRAM IN THE AREAS  OF  SKILLS  DEVELOPMENT,
    3  EMOTIONAL FUNCTIONING, AND MOTIVATION.
    4    (E) TO DETERMINE WHETHER DRUG PUNISHMENT PROGRAM ASSESSMENT AND TREAT-
    5  MENT  ARE  PROVIDED AS INTENDED AND IN ACCORDANCE WITH CURRICULA MANUALS
    6  AND OTHER PROVIDER GUIDELINES.  THE EVALUATION PROGRAM  SHALL  DETERMINE
    7  DRUG  PUNISHMENT  PROGRAM  EFFECTIVENESS  THROUGH  THE USE OF MEASURABLE
    8  OUTCOMES THAT INCLUDE ANALYSIS, USING ACCEPTABLE TESTING  STANDARDS,  OF
    9  THE  PATTERNS  OF  DRUG OFFENDERS' AVOIDANCE OF OR RELAPSE INTO CRIMINAL
   10  BEHAVIOR, THE PATTERNS  OF  DRUG  OFFENDERS'  EMPLOYMENT  PROGRESS,  THE
   11  PAYMENT  OF  VICTIM  RESTITUTION BY DRUG OFFENDERS, AND OTHER INDICES OF
   12  THE PROGRESS OR FAILURE OF DRUG OFFENDERS DURING AND AFTER  THEIR  TERMS
   13  IN  THE  DRUG  PUNISHMENT PROGRAM. EVALUATION DATA SHALL BE COLLECTED AT
   14  EACH PHASE OF THE DRUG PUNISHMENT PROGRAM, INCLUDING INITIAL  SCREENING,
   15  ASSESSMENT,  INTAKE,  PHASES  I, II, AND III OF TREATMENT, AND FOLLOWING
   16  THE RELEASE OR TERMINATION OF DRUG OFFENDERS FROM  THE  DRUG  PUNISHMENT
   17  PROGRAM.
   18    2. EVALUATION PROGRAM STAFF SHALL CONDUCT THREE PRIMARY ACTIVITIES:
   19    (A)  EVALUATION  OF  POST-TREATMENT OUTCOMES TO EXAMINE THE EFFECTS OF
   20  TREATMENT ON DRUG OFFENDER OUTCOMES FOLLOWING  COMPLETION  OF  THE  DRUG
   21  PUNISHMENT  PROGRAM.  MAJOR  AREAS TO BE ADDRESSED INCLUDE THE IMPACT OF
   22  THE PROGRAM'S TREATMENT INTERVENTIONS ON POST TREATMENT CRIMINAL  BEHAV-
   23  IOR,  DRUG  ABUSE,  EMPLOYMENT,  AND SOCIAL FUNCTIONING. THIS EVALUATION
   24  COMPONENT SHALL IDENTIFY PATTERNS OF RECIDIVISM AND SHALL  ALSO  ANALYZE
   25  THE COST EFFECTIVENESS OF THE DRUG PUNISHMENT PROGRAM.
   26    (B)  ANALYSIS OF PRETREATMENT DRUG OFFENDER CHARACTERISTICS AND BEHAV-
   27  IORS TO ESTABLISH A BASELINE OF CRIMINAL BEHAVIOR,  DRUG  ABUSE,  MENTAL
   28  HEALTH STATUS, EMPLOYMENT, AND IMPAIRMENT IN PSYCHOSOCIAL FUNCTIONING OF
   29  SUCH  PRETREATMENT  DRUG OFFENDERS, TO ASSIST IN EVALUATING THE PROGRESS
   30  MADE BY DRUG OFFENDERS DURING THE DRUG PUNISHMENT PROGRAM AND IN IDENTI-
   31  FYING FACTORS THAT INFLUENCE DRUG PUNISHMENT PROGRAM OUTCOME.
   32    (C) EVALUATION OF PROGRESS BY DRUG OFFENDERS, AND EVALUATION OF TREAT-
   33  MENT INTEGRITY, TO EXAMINE EVIDENCE OF PROGRESS  BY  DRUG  OFFENDERS  AT
   34  PREDETERMINED  MARKERS  DURING THE ENTIRE PERIOD OF THEIR INVOLVEMENT IN
   35  THE DRUG PUNISHMENT PROGRAM. EVALUATION SHALL ASSESS  WHETHER  TREATMENT
   36  INTERVENTIONS ARE PROVIDED AS INTENDED AND ARE OF SUFFICIENT QUALITY AND
   37  INTENSITY TO MEET THE DRUG PUNISHMENT PROGRAM GOALS.
   38  S 435.85 FINANCIAL  CONSIDERATIONS FOR ASSESSMENT, TREATMENT, AND TRANS-
   39             PORTATION OF DRUG OFFENDERS.
   40    1. PROVIDERS OF ASSESSMENT, TREATMENT, AND TRANSPORTATION SERVICES  TO
   41  DRUG OFFENDERS PURSUANT TO THIS ARTICLE SHALL SEEK REIMBURSEMENT FOR THE
   42  EXPENSES  INCURRED IN PROVIDING ASSESSMENT, TREATMENT, OR TRANSPORTATION
   43  FROM AN INSURANCE COMPANY, HEALTH CARE CORPORATION, OR OTHER  SOURCE  AS
   44  TO ANY DRUG OFFENDER WHO IS COVERED BY AN INSURANCE POLICY OR SUBSCRIBES
   45  TO A HEALTH CARE CORPORATION OR OTHER SOURCE FOR SUCH EXPENSES.
   46    2.  UPON  A  SHOWING  THAT REIMBURSEMENT UNDER SUBDIVISION ONE OF THIS
   47  SECTION IS NOT AVAILABLE, THE COSTS OF ASSESSMENT, TREATMENT, AND TRANS-
   48  PORTATION  SHALL  BE  COMPENSATED  IN  ACCORDANCE  WITH   THE   CONTRACT
   49  PROVISIONS  MUTUALLY  AGREED  UPON  BY  THE DEPARTMENT AND THE PROVIDER,
   50  WHICH MAY INCLUDE PROSPECTIVE PAYMENTS PURSUANT TO SUBDIVISION  FOUR  OF
   51  THIS SECTION.
   52    3.  A  DRUG  OFFENDER WHO HAS HEALTH INSURANCE, SUBSCRIBES TO A HEALTH
   53  CARE CORPORATION, OR RECEIVES HEALTH CARE BENEFITS FROM ANY OTHER SOURCE
   54  SHALL ASSIGN SUCH BENEFITS TO THE SERVICE PROVIDER, AS APPROPRIATE.
   55    4. IN ORDER TO CONTAIN COSTS WHILE ENHANCING ADEQUACY AND  ACCESSIBIL-
   56  ITY OF TREATMENT FOR DRUG OFFENDERS, THE DEPARTMENT SHALL NEGOTIATE WITH
       A. 6447                            39
    1  DRUG   PUNISHMENT  PROGRAM  ASSESSMENT,  TREATMENT,  AND  TRANSPORTATION
    2  PROVIDERS TO ESTABLISH PROSPECTIVE  PAYMENT  ARRANGEMENTS  THAT  PROVIDE
    3  FINANCIAL INCENTIVES FOR THE CONTAINMENT OF THE COSTS OF THE PROGRAM.
    4    5. THE PROSPECTIVE PAYMENT SYSTEM ESTABLISHED PURSUANT TO THIS SECTION
    5  SHALL INCLUDE, AT A MINIMUM, THE FOLLOWING ELEMENTS:
    6    (A)  A  MAXIMUM  ALLOWABLE  PAYMENT  AMOUNT ESTABLISHED FOR INDIVIDUAL
    7  PROVIDER SERVICES, WHICH IS PRESET AT THE BEGINNING OF THE  BUDGET  YEAR
    8  OF  THE  PROVIDER AND FIXED FOR THE ENTIRETY OF THAT BUDGET YEAR, EXCEPT
    9  WHEN EXTENUATING AND UNUSUAL CIRCUMSTANCES WARRANT RENEGOTIATION.
   10    (B) TIMELY PAYMENT TO THE PROVIDER OF THE NEGOTIATED PAYMENT AMOUNT.
   11    (C) ACCEPTANCE BY THE PROVIDER OF THE  NEGOTIATED  PAYMENT  AMOUNT  AS
   12  PAYMENT  IN  FULL,  WHICH  SHALL  INCLUDE  ANY DEDUCTIBLE OR COINSURANCE
   13  PROVIDED FOR.
   14    (D)  UTILIZATION  REVIEWS  FOR  APPROPRIATENESS  OF   THE   PROVIDER'S
   15  SERVICES.
   16    6.  NOTHING  CONTAINED  IN THIS SECTION PROHIBITS THE INCLUSION OF ANY
   17  OTHER COST-EFFECTIVE FUNDING FORMULA.
   18    S 4. This act shall take effect on January 1, 2014; provided, however,
   19  that any rules and regulations necessary to implement the provisions  of
   20  this act on its effective date are authorized and directed to be promul-
   21  gated, amended or repealed on or before such effective date.
feedback